Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek

Aktuální text a fecha 2000-12-31

§ 1

Léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek náležejících do anatomicko terapeuticko chemických (dále jen „ATC“) skupin uvedených v příloze č. 2 zákona jsou uvedeny v příloze, která je součástí této vyhlášky.

§ 2

Tato vyhláška nabývá účinnosti dnem 1. dubna 1997.

Ministr:

PhDr. Stráský v. r.

Příloha k vyhlášce č. 57/1997 Sb.

Léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek

ODDÍL A

Léčivé přípravky plně hrazené ze zdravotního pojištění jsou v seznamu léčivých přípravků plně hrazených ze zdravotního pojištění a v přehledu jednotlivých léčivých látek s výší jejich úhrad (dále jen „seznam“) označeny jejich kódem a názvem s uvedením lékové formy a velikosti balení.

Výše úhrady jednotlivých léčivých látek v korunách za uvedené jednotkové množství těchto léčivých látek je stanovena v sedmém sloupci příslušných řádků seznamu.

V seznamu mají použité zkratky tento význam

a) způsob podání (aplikace)

inhal.	inhalační aplikační formy (spraye, prášky a roztoky k inhalaci)
intraderm.	aplikační cesta některých alergenů (nitrokožně)
lok.	lokální (zevní) aplikační formy
parent.	injekční aplikační formy (injekce, suché injekce, infúze)
p.o.	perorální aplikační formy (tablety, tobolky, dražé, potahované tablety)
p.rect.	rektální aplikační formy
PRICK test	k diagnostice
subkut.	aplikační cesta některých alergenů
sublng	perorální aplikační formy pod jazyk (apikace do dutiny ústní)
transd.	transdermální (kožní) aplikační formy (náplasti)
vag.	vaginální (poševní) aplikační formy

b) lékové formy

LF	lékové formy
aer	aerosol
aer dos	aerosol s dávkovačem
cap	kapsle, tobolka
cap inh	kapsle inhalační (inhaleta)
cap ret	kapsle retardovaná
crm	krém
crm fett	krém mastný
crm vag	krém vaginální
drg	dražé
drg ret	dražé retardované
emp	náplast
enm	enema, klyzma
foa	pěna
gel	gel
gel oph	gel oční
gel vag	gel vaginální
glo	globule
glo vag	globule vaginální
gra	granulát
gtt	kapky k vnitřnímu použití
gtt oph	kapky oční
gít oph+nas	kapky oční a nosní
gtt oto	kapky ušní
inf	infúze
inf sic	lyophilisát pro infúze
inh	inhalát
inh sol	roztok k inhalaci
inj	injekce
inj sic	lyophilisát pro injekce
kit	kit, souprava
lac	lak
liq	roztok k zevnímu použití
lot	emulze
ole	olej
pla	náplast
plv	prášek (nikoliv zásyp)
plv ads	zásyp (pulvis adspersorius)
plv por	prášek k perorální aplikaci
PRICK sol	roztok diagnostického alergenu
pst	pasta
sir	sirup
sol	roztok k vnitřnímu použití
sol nas	roztok nasální
sph	šampon
spn	houba
spr	spray
spr nas	spray nasální
sup	čípek
sus	suspenze
sus oph	suspenze oční
tab	tableta
tab eff	tableta effervescentní
tab ent	tableta acidorezistentní obdukovaná
tab fc	tableta potahovaná
tab obd	tableta obdukovaná (potahovaná)
tab ret	tableta retardovaná
tab vag	tableta vaginální
tct	tinktura
ung	mast
ung oph	mast oční

c) jednotky množství dávek léčivých látek (popř. mezinárodní jednotky)

amp	ampule
BA	jedno originální balení
C2	centimetr čtvereční
DF	jedna dávka lékové formy
Fl	mezinárodní jednotka
GM	gram
g	gram
U	mezinárodní jednotka
KU	tisíc U
kU	tisíc U
MU	milion U
MG	miligram
mg	miligram
ML	mililitr
ml	mililitr
ks	kus
RG	mikrogram

Léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek

ODDÍL B

1	A01AA	léčiva k profylaxi zubního kazu (fluorid sodný)	p.o.
1.1	A01AA01	fluorid sodný	p.o.	1.1	MG	0,88
64958	ZYMAFLUOR 1/4MG	tbl 200x0.55mg	NCH	CH
00211	NATRIUM FLUORATUM SLOVAKOFARMA	tbl 250x0,55mg	SLO	SK
2	A01AB	protiinfekční léčiva pro lokální aplikaci	lok.	H
---	---	---	---	---	---	---	---
2.1	A01AB10	Natamycin	lok.	20	MG	7,48
88317	PIMAFUCIN	gtt 1x20 ml 2,5%	YEL	NL
2.2	A01AB03	Chlorhexidin	lok.	100 0	ML	178,70	H
3	A01AC	kortikosteriody pro lokální aplikaci	lok.	L/DER,STO,ORL
---	---	---	---	---	---	---	---
3.1	A01AC01	Triamcinolon	lok.	1	GM	13,69	L/DER,STO, ORL
03613	KENALOG IN ORABASE	pst 5gm 0.1%	BMS	GB
3.2	A01AC02	dexametason	lok.	1	GM	11,68	L/DER,STO, ORL
4	A02A	adsorbční antacida	p.o.
---	---	---	---	---	---	---	---
4.1	A02AD	kombinace hliníku, vápníku a hořčíku (pevné lékové formy)	p.o.	10	DF	7,67
00156	GASTROGEL SLOVAKOFARMA	tbl 50x500mg	SLO	SK
4.2	A02AD	kombinace hliníku, vápníku a hořčíku (tekuté lékové formy)	p.o.	50	ML	7,67

4.3	A02AD01	kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí - pevné lékové formy)	p.o.	10	DF	7,67

4.4	A02AD01	kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí - tekuté lékové formy)	p.o.	50	ML	7,67

4.5	A02AD04	hydrotalcit (pevné lékové formy)	p.o.	10	DF	7,67

4.6	A02AD04	hydrotalcit (tekuté lékové formy)	p.o.	50	ML	7,67
5	A02BA	antiulceróza ze skupiny H2-antagonistů	p.o.
---	---	---	---	---	---	---	---
5.1	A02BA01	cimetidin	p.o.	0.80	GM	4,05
64926	LOCK-2	tbl obd 100x200mg	CAI	IND
87755	CIMETIDINE CADILA	tbl obd 100x200 mg	CAD	IND
5.2	A02BA02	ranitidin nad 75 miligramů do 150 miligramů včetně v jedné tabletě	p.o.	0.30	GM	4,05
12346	HISTAC 150	tbl obd 20x150mg	RXY	IND
96056	RANISAN	tbl obd 30x150mg	PMP	CZ
45321	RANISAN	tbl obd 500x150mg	PMP	CZ
91280	RANITAL 150MG	tbl obd 30x150mg	LEK	SLO
5.3	A02BA02	ranitidin nad 150 miligramů v jedné tabletě	p.o.	0.30	GM	3,85
12347	HISTAC 300	tbl obd 10x300mg	RXY	IND
76477	RANITAL 300MG	tbl obd 30x300mg	LEK	SLO
5.4	A02BA03	famotidin do 20 mg včetně v 1 tabletě	p.o.	40	MG	4,05
96193	FAMOSAN	tbl obd 20x20	PMP	CZ
80537	QUAMATEL 20	tbl obd 28x20 mg	GED	H
94207	ULFAMID	tbl 20x20mg	KRK	SLO
47262	FAMOSAN 20MG	tbl obd 500x20mg	PMP	CZ
5.5	A02BA03	famotidin nad 20 mg v 1 tabletě	p.o.	40	MG	3,85
96194	FAMOSAN	tbl obd 20x40mg	PMP	CZ
47263	FAMOSAN 40MG	tbl obd 500x40mg	PMP	CZ
80538	QUAMATEL 40MG	tbl obd 14x40mg	GED	H
67539	ULCERAN 40	tab. obd 500x40 mg	MOE	CY
67537	ULCERAN 40	tab. obd 30x40 mg	MOE	CY
67536	ULCERAN 40	tab. obd 10x40 mg	MOE	CY
83206	FAMOSAN	tbl obd 10x40mg	PMP	CZ
5.6	A02BA04	nizatidin	p.o.	0.30	GM	4,05

5.7	A02BA06	roxatidin	p.o.	0.15	GM	4,05

5.8	A02BA07	ranitidin bismut citrát	p.o.	0.8	GM	30,01
6	A02BA	antiulceróza ze skupiny H2-antagonistů	parent.	H
---	---	---	---	---	---	---	---
6.1	A02BA01	Cimetidin	parent.	0.80	GM	32,06	H
91782	LOCK - 2E	inj. 5x2 ml	CAD	IND
6.2	A02BA02	ranitidin	parent.	0.30	GM	68,43	H

6.3	A02BA03	famotidin	parent.	40	MG	68,43	H
7	A02BB	antiulceróza ze skupiny prostaglandinů	p.o.	Z
---	---	---	---	---	---	---	---
7.1	A02BB01	misoprostol	p.o.	0.80	MG	51,86	Z
97404	CYTOTEC	tbl 50x200rg	SEA	GB
8	A02BC	antiulceróza ze skupiny inhibitorů protonové pumpy	p.o.	L/GIT,INT
---	---	---	---	---	---	---	---
8.1	A02BC01	omeprazol (do 10 mg v jedné dávce včetně)	p.o.	20	MG	25,22	L/GIT,INT
53974	HELICID 10	cps 14x10mg	LEX	CZ
57408	HELICID 10	cps 28x10mg	LEX	CZ
8.2	A02BC01	Omeprazol (nad 10 mg v jedné dávce)	p.o.	20	MG	13,00	L/GIT,INT
03076	LOMAC	cps 28x20mg	CIA	IND
75974	LOMAC	cps 14x20mg	CIA	IND
53346	GASEC-20	cps 28x20mg	MHA	CH
56500	HELICID 20	cps 14x20mg	LEX	CZ
59897	HELICID 20	cps 28x20mg	LEX	CZ
60160	ULTOP	cps 14x20mg	KRK	SLO
75166	ORTANOL	cps 14x20mg	LEK	SLO
70933	ORTANOL	cps 28x20mg	LEK	SLO
8.3	A02BC02	pantoprazol	p.o.	40	MG	13,00	L/GIT,INT

8.4	A02BC03	lansoprazol	p.o.	30	MG	13,00	L/GIT,INT
9	A02BC	antiulceróza ze skupiny inhibitorů protonové pumpy	parent.	H
---	---	---	---	---	---	---	---
9.1	A02BC01	Omeprazol	parent.	20	MG	185,06	H
76644	LOSEC 40 MG PRO INFUS.	inj sic 5x40 mg	AST	S
9.2	A02BC02	pantoprazol	parent.	40	MG	185,06	H
10	A02BX	ostatní léčiva peptického vředu	p.o.
---	---	---	---	---	---	---	---
10.1	A02BX	ostatní léčiva peptického vředu (bismut subsalicylat)	p.o.	3	DF	22,29

10.2	A02BX02	sukralfát	p.o.	4	GM	10,46
91217	VENTER	tbl 50x1 gm	KRK	SLO
93131	VENTER	gra 50x2gm	KRK	SLO
10.3	A02BX03	pirenzepin	p.o.	0.1	GM	8,55
91602	GASTROZEPIN	tbl 50 (5x10) x 25 mg	SLO	SK
10.4	A02BX05	zásaditý citronan bismutitý	p.o.	0.48	GM I	23,07
11	A02BX	ostatní léčiva peptického vředu	parent.	H
---	---	---	---	---	---	---	---
11.1	A02BX03	pirenzepin	parent.	20	MG	105,58	H
12	A02DA	antiflatulencia a spasmolytika ATC skupiny A03A	p.o.
---	---	---	---	---	---	---	---
12.1	A02DA01	silikony (pevné lékové formy)	p.o.	0.50	GM	11,24
91846	CEOLAT	ctb 20x80mg	SVP	D
12.2	A02DA01	silikony (tekuté lékové formy)	p.o.	0.50	GM	19,89
55950	SAB SIMPLEX	sus 50x15ml(sacky)	PDA	D
93500	SAB SIMPLEX	sus 1x30ml	PDA	D
93501	SAB SIMPLEX	sus 4x30ml	PDA	D
84580	LEFAX	sus 1x50ml	ASH	D
12.3	A03AA04	mebeverin	p.o.	0.30	GM	4,94

12.4	A03AA05	trimebutin	p.o.	0.30	GM	4,94

12.5	A03AX58	alverin	p.o.	0.18	GM	4,99
13	A03AB	anticholinergika s kvarterní oniovou skupinou	p.o.
---	---	---	---	---	---	---	---
13.1	A03AB03	oxyfenon	p.o.	25	MG	2,30

13.2	A03AB06	otilonium bromid	p.o.	0.12	GM	12,42

13.3	A03AB11	poldin	p.o.	12	MG	2,30

13.4	A03AB20	trospium chlorid	p.o.	40	MG	12,42
12528	SPASMEX 15	tbl 50x15mg	PFL	D
12527	SPASMEX 15	tbl 30x15mg	PFL	D
12525	SPASMEX 5	tbl 30x5mg	PFL	D
14	A03AD	muskulotropní spasmolytika	p.o.
---	---	---	---	---	---	---	---
14.1	A03AD01	papaverin	p.o.	0.1	GM	0,68

14.2	A03AD02	drotaverin	p.o.	0.1	GM	4,94
02551	NO-SPA	tbl 20x40mg	CHN	H
15	A03AD	muskulotropní spasmolytika	parent.
---	---	---	---	---	---	---	---
15.1	A03AD01	papaverin	parent.	0.1	GM	17,94
03576	PAPAVERIN SPOFA	inj. 10x2 ml/60 mg	SPX	CZ
15.2	A03AD02	drotaverin	parent.	0.1	GM	25,32
02552	NO-SPA	inj 5x2ml/40mg	CHN	H
16	A03BA	alkaloidy beladony s terciální aminovou skupinou	p.o.
---	---	---	---	---	---	---	---
16.1	A03BA01	atropin	p.o.	1.5	MG	0,49
000444	ATROPIN SPOFA	tbl 20x0.5mg	LEX	CZ
17	A03BA	alkaloidy beladony s terciální aminovou skupinou	parent.
---	---	---	---	---	---	---	---
17.1	A03BA01	atropin (1 mg a více v 1 ampuli)	parent.	1.5	MG	7,82
00394	ATROPIN BIOTIKA 1MG	inj 10x1ml/1mg	HBS	SK
17.2	A03BA01	atropin (do 1mg v 1 ampuli)	parent.	1.5	MG	15,15
00392	ATROPIN BIOTIKA 0.5MG	inj 10x1 ml/0.5mg	HBS	SK
18	A03BB	alkaloidy beladony s kvarterní aminovou skupinou	p.o.
18.1	A03BB01	butylskopolamin	p.o.	60	MG	14,61
01317	BUSCOPAN	drg 20x10 mg	BOE	D
19	A03BB	alkaloidy beladony s kvarterní aminovou skupinou	p.rect.
19.1	A03BB01	butylskopolamin	p.rect.	60	MG	14,66
20	A03BB	alkaloidy beladony s kvarterní aminovou skupinou	parent.
20.1	A03BB01	butylskopolamin	parent.	60	MG	38,71
98169	BUSCOPAN	inj 5x1ml/20mg	BOE	D
21	A03DA	syntetická anticholinergika v kombinaci s analgetiky	p.o.
---	---	---	---	---	---	---	---
21.1	A03DA	syntetická anticholinergika v komb. s analgetiky	p.o.	2	DF	3,96

21.2	A03DA02	pitofenon kombinace s analgetiky (pevné lékové formy)	p.o.	2	DF	3,96
88708	ALGIFEN	tbl 20	LEX	CZ
21.3	A03DA02	pitofenon kombinace s analgetiky (tekuté lékové formy)	p.o.	2	ML	5,28
91981	ALGIFEN	gtt 1x10ml 500mg/ml	GNO	CZ
22	A03DA	syntetická anticholinergika v kombinaci s analgetiky	p.rect.
---	---	---	---	---	---	---	---
22.1	A03DA02	pitofenon kombinace s analgetiky	p.rect.	2	DF	12,90
91517	ALGIFEN	sup 5	LEX	CZ
23	A03DA	syntetická anticholinergika v kombinaci s analgetiky	parent.
---	---	---	---	---	---	---	---
23.1	A03DA02	pitofenon kombinace s analgetiky	parent.	2	DF	51,42
88709	ALGIFEN	inj 5x5ml	HBS	SK
24	A03EA	spasmolytika, psycholeptika, analgetika v kombinaci	p.rect.
---	---	---	---	---	---	---	---
24.1	A03EA	antispasmodika, psycholeptika, analgetika v komb.	p.rect.	2	DF	12,17
91261	SPASMOPAN	sup 5	LEX	CZ
25	A03FA	prokinetika (cisaprid)	p.o.	L/GIT,INT,PDD,PSY
---	---	---	---	---	---	---	---
25.1	A03FA02	cisaprid (pevné lékové formy, do 5 mg v 1 tabletě včetně)	p.o.	30	MG	37,30	L/GIT,INT,P DD,PSY

25.2	A03FA02	cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě)	p.o.	30	MG	34,20	L/GIT,INT,P DD,PSY

25.3	A03FA02	cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě)	p.o. 30	MG 32,50	L/GIT,INT,P DD,PSY

25.4	A03FA02	cisaprid (tekuté lékové formy)	p.o.	30	MG	45,16	L/GIT,INT,P DD,PSY
93392	PREPULSID	sus 1x200ml	JAN	B
47213	PREPULSID	sus 20x10ml sacky	JAG	I
47214	PREPULSID	sus 50x10ml sacky	JAG	I
26	A03FA	prokinetika (ostatní)	p.o.
26.1	A03FA01	metoclopramid	p.o.	30	MG	4,15
93104	DEGAN	tbl 40x10mg	LEK	SLO
56594	MCP HEXAL 10	tbl 20x10mg	FST	D
56695	MCP HEXAL 10	tbl 50x10mg	FST	D
56696	MCP HEXAL 10	tbl 100x10mg	FST	D
56698	MCP HEXAL KAPKY	gtt 1x100ml/400mg	WPH	D
26.2	A03FA03	domperidon	p.o.	30	MG	4,15

26.3	A03FA05	alizaprid	p.o.	0.15	GM	4,15

26.4	A03FA	itoprid	p.o.	0.15	GM	30,00
27	A03FA	prokinetika	p.rect.
---	---	---	---	---	---	---	---
27.1	A03FA01	metoclopramid	p.rect.	30	MG	41,50

27.2	A03FA02	cisaprid	p.rect.	30	MG	50,05

27.3	A03FA03	domperidon	p.rect.	0.12	GM	41,50
28	A03FA	prokinetika	parent.	O
---	---	---	---	---	---	---	---
28.1	A03FA01	metoclopramid	parent.	30	MG	20,04	O
93105	DEGAN	inj 50x2ml/10mg	LEK	SLO
28.2	A03FA05	alizaprid	parent.	0.15	GM	16,47	O
29	A04AA	antiemetika ze skupiny serotoninových antagonistů	p.o.	X
---	---	---	---	---	---	---	---
29.1	A04AA01	ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně)	p.o.	16	MG	826,30	X
84744	EMESET- 4	tbl obd 1x6x4mg	CIA	IND
84794	EMESET- 4	tbl obd 10x6x4mg	CIA	IND
29.2	A04AA01	ondansetron (pevné lékové formy nad 4 mg v jedné tabletě)	p.o.	16	MG	612,50	X
84443	EMESET- 8	tbl obd 1x6x8mg	CIA	IND
84793	EMESET- 8	tbl obd 10x6x8mg	CIA	IND
29.3	A04AA01	ondansetron (pevné rychle rozpustné lékové formy do 4 mg v jedné tabletě včetně)	p.o.	16	MG	944,40	X

29.4	A04AA01	ondansetron (pevné rychle rozpustné lékové formy nad 4 mg v jedné tabletě)	p.o.	16	MG	700,00	X

29.5	A04AA01	ondansetron (tekuté lékové formy)	p.o.	16	MG	882,60	X

29.6	A04AA01	ondansetron (léková forma čípků)	per rect.	16	MG	774,65	X

29.7	A04AA02	granisetron	p.o.	2	MG	612,50	X

29.8	A04AA03	tropisetron	p.o.	5	MG	612,50	X

29.9	A04AA04	dolasetron	p.o.	200	MG	612,50 X	X
30	A04AA	antiemetika ze skupiny serotoninových antagonistů	parent.	X
---	---	---	---	---	---	---	---
30.1	A04AA01	ondansetron (do 4 mg v jedné ampuli včetně)	parent.	16	MG	1326,60	X
84441	EMESET	inj 5x2ml/4mg	CIA	IND
30.2	A04AA01	ondansetron (nad 4 mg v jedné ampuli)	parent.	16	MG	1114,90	X
84442	EMESET	inj 5x4ml/8mg	CIA	IND
30.3	A04AA02	granisetron	parent.	3	MG	731,90	X

30.4	A04AA03	tropisetron (nad 2,5 mg v jedné ampuli)	parent.	5	MG	731,90	X
66849	NAVOBAN	inj 10x5ml	SAN	CH
96863	NAVOBAN	inj 1x5ml	SAN	CH
30.5	A04AA03	tropisetron (do 2,5 mg včetně v jedné ampuli)	parent. 5	MG	1259,60	X
56247	NAVOBAN	inj 1x2ml/2mg	NPA	CH
30.6	A04AA04	dolasetron	parent.	100	MG	731,90	X
31	A04AD	různá antiemetika	p.o.
---	---	---	---	---	---	---	---
31.1	A04AD	různá antiemetika (theoklát embraminu)	p.o.	50	MG	3,30
88321	MEDRIN	tbl 20x25mg	LEX	CZ
31.2	A04AD	různá antiemetika (theoklát moxastinu)	p.o.	0.1	GM	3,32
32	A04AD	různá antiemetika	p.rect.
---	---	---	---	---	---	---	---
32.1	A04AD	různá antiemetika (theoklát moxastinu)	p.rect.	0.1	GM	9,38
33	A05AA	hepatika ze skupiny žlučových kyselin	p.o.	L/GIT,INF
---	---	---	---	---	---	---	---
33.1	A05AA01	kyselina chenodeoxycholová	p.o.	1	GM	21,46	L/GIT,INF
85721	CHENOFALK	cps 100x250mg	FAK	D
33.2	A05AA02	kyselina ursodeoxycholová	p.o.	0.75	GM	27,08	L/GIT,INF
91017	URSOFALK	cps 100x250mg	FAK	D
97864	URSOSAN	cps 50x250mg	PMP	CZ
34	A05AX	ostatní hepatika	p.o.
34.1	A05AX	jiná léčiva onemocnění žlučníku (fenipentol)	p.o.	3	DF	1,61
00146	FEBICHOL	cps 50x100mg	SLO	SK
34.2	A05AX02	hymekromon	p.o.	1.20	GM	5,96
93157	ISOCHOL (DRAZOVKA)	drg 30x400mg	LEX	CZ
97881	ISOCHOL (BLISTR 3X10)	drg 30x400mg	LEX	CZ
35	A05BA	léčiva onemocnění jater	p.o.
---	---	---	---	---	---	---	---
35.1	A05BA	léčiva onemocnění jater (fosfolipidy)	p.o.	4	DF	11,73

35.2	A05BA	léčiva onemocnění jater (Silymarin v kombinaci)	p.o.	0.21	GM	5,81

35.3	A05BA03	Silymarin (do 70 mg včetně v jedné tabletě)	p.o.	0.21	GM	5,81
01147	SILYMARIN AL 50	drg 100x50mg	APA	D
35.4	A05BA03	silymarin (nad 70 mg v jedné tabletě)	p.o.	0.21	GM	4,40
36	A05BA	léčiva onemocnění jater	parent.	H
---	---	---	---	---	---	---	---
36.1	A05BA	léčiva onemocnění jater (fosfolipidy)	parent.	1	DF	44,58	H
92325	ESSENTIALE N	inj. 5x5ml	NAT	D
36.2	A05BA03	Silymarin	parent.	0.35	GM	2446,10	H
31341	LEGALON SIL	inj sic 4x350mg	MAU	D
37	A06A	osmoticky působící nevstřebatelné cukry	p.o., p.rect.	L/GIT,INT,GER
---	---	---	---	---	---	---	---
37.1	A06AD10	kombinace minerálních solí (k přípravě Golytelyho roztoku)	p.o.	4	DF	242,70
69482	FORTRANS	plv 1x4 (sacky)	BEF	F
37.2	A06AD11	laktulóza	p.o.	6,7	GM	5,28	L/GIT,INT, GER, PDD,CHI
02816	LACTULOSA INFUSIA	sir 1x500 ml 50%	IHO	CZ
86612	LACTULOSA INFUSIA	sir 1x250 ml 50%	IHO	CZ
37.3	A06AD12	laktitol	p.o.	10	GM	3,71	L/GIT,INT, GER,CHI
37.4	A06AG10	sorbitol v kombinaci s kont. laxativem	p.rect.	2	DF	174,01
38	A07AA	střevní antimykotická léčiva	p.o.
---	---	---	---	---	---	---	---
38.1	A07AA01	neomycin	p.o.	5	GM	609,91	H

38.2	A07AA02	nystatin	p.o.	1.5	MU	5,96

38.3	A07AA03	natamycin	p.o.	0.3	GM	41,60
02046	PIMAFUCIN	tbl obd 20x100 mg	YEU	NL
39	A07EA	kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu	p.rect., p.o.
---	---	---	---	---	---	---	---
39.1	A07EA06	budesonid	p.rect.	2	MG	250,00	L/GIT,INT

Léčbu perorálním budesonidem ordinuje gastroenterolog nebo internista v akutní atace, popřípadě v chronické fázi Crohnovy choroby, zejména tam, kde vzniká potřeba léčby steroidy a současně nutnost minimalizovat jejich systémové účinky.

39.2	A07EA06	budesonid	p.o.	9	MG	120,00	P
12701	ENTOCORT 3MG	cps 50x250mg	APN	S
12702	ENTOCORT 3MG	cps 100x2mg	APN	S
39.3	A07EB01	kyselina kromoglyková	p.o.	80	MG	7,63	P

Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.

| 93797 | NALCROM | cps 100x100mg | FIS | GB | | 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT | | --- | --- | --- | --- | --- |

Mesalazin per os – tablety s řízeným uvolňováním:

Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.

| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 17,21 | L/GIT,INT,REV | | 72968 | SALAZOPYRIN EN | tbl 100x500 mg | KBP | S | | | | | 04304 | SULFASALAZIN EN | tbl 100x500 mg | KRK | SLO | | | | | 02159 | SULFASALAZIN | tbl 50x500 mg | KRK | SLO | | | | | 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 26,30 | L/GIT,INT | | 93235 | SALOFALK | tbl ent 100x250 mg | FAK | D | | | | | 75567 | SALOFALK 500 | tbl obd ent100x500mg | FAK | D | | | | | 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 46,44 | P | | 85929 | PENTASA SR 500 MG (LAHVIČKA) | tbl ret 100x500 mg | FEI | DK | | | | | 86616 | PENTASA SR 500 MG (BLISTR) | tbl ret 100x500 mg | FEI | DK | | | | | 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 86,66 | L/GIT | | 93770 | SALOFALK KLYSMEN | enm 7x60gm | FAK | D | | | | | 76700 | ASACOL 4GM | enm 1x100ml/4gm | TLT | CH | | | | | 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 GM | 142,78 | L/GIT | | | 93239 | SALOFALK 250 | sup 30x250mg | FAK | D | | | | | 93238 | SALOFALK 250 | sup 10x250mg | FAK | D | | | | | 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 119,40 | L/GIT | | 75568 | SALOFALK 500 | sup 10x500mg | FAK | D | | | | | 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 42.1 | A07FA | protiprůjmové mikroorganismy | p.o. | 2 | ML | 3,76 | L/PDD,GIT,GER | | 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D | | | | | 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D | | | | | 42.2 | A07FA01 | organismy produkující kyselinu mléčnou | p.o. | 4 | DF | 3,86 | L/PDD,GIT, GER | | | | | | | | | | | 42.3 | A07FA | protiprůjmové mikroorganismy (Escherichia coli) | p.o. | 1 | DF | 43,99 | L/PDD | | | | | | | | | | | 42.4 | A07BC | diosmectin (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD | | 43 | A09AA | enzymové přípravky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu Wobenzymem indikuje onkolog, chirurg nebo lymfolog u lymfedému po radikálních operacích pro malignitu.

| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | FI | 1,03 | | | 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO | | | | | 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 8,80 | P | | | | | | | | | | | 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 FI v 1 tabletě včetně) | p.o. | 5000 | FI | 1,47 | | | 02420 | PANCREOLAN FORTE | tbl ent 30x220mg | LEX | CZ | | | | | 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 FI včetně v jedné tabletě) | p.o. | 5000 | FI | 1,45 | | | 21362 | PANGROL 400 | tbl obd 48 | BCE | D | | | | | 43.5 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 FI včetně v jedné tabletě) - formy mikropelet | p.o. | 5000 | FI | 1,90 | | | | | | | | | | | | 43.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 FI v jedné tabletě) | p.o. | 5000 | FI | 1,61 | | | 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,79 | | | 45 | A10A | insuliny (rozpustné humánní) | parent. | L/DIA | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 45.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA | | | | | | | | | | | 45.2 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40 | U | 19,84 | L/DIA | | 40876 | INSULIN - HM R | inj 1x10ml/1 ku | LEX | CZ | | | | | 54038 | ACTRAPID HM | inj 1x10ml/1ku | NOO | DK | | | | | 88345 | ACTRAPID HM | inj 1x10ml/400ut | NOO | DK | | | | | 45.3 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulinových pump | parent. | 40 | U | 27,96 | L/DIA | | 76316 | VELOSULIN HM | inj 1x10ml/1 ku | NOO | DK | | | | | 45.4 | A10AB04 | insulin-analog krátce působící, lahv. | parent. | 40 | U | 28,28 | L/DIA | | | | | | | | | | | 45.5 | A10AB04 | insulin-analog krátce působící, cartridge 100U/ML | parent. | 40 | U | 30,49 | L/DIA | | 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 46.1 | A10AB03 | insulin vepřový rychle účinkující | parent. | 40 | U | 16,52 | | | 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ | | | | | 47 | A10A | insuliny (suspenzní humánní) | parent. | L/DIA | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 47.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA | | | | | | | | | | | 47.2 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40 | U | 19,84 | L/DIA | | 40875 | INSULIN-HM NPH | inj 1x10ml/1 ku | LEX | CZ | | | | | 54037 | MONOTARD HM 100 M.J./ML | inj 1x10ml/1ku | NOO | DK | | | | | 53893 | INSULATARD HM | inj 1x10ml/1ku | NOO | DK | | | | | 62967 | INSULATARD HM | inj 1x10ml/400ut | NOO | DK | | | | | 88346 | MONOTARD HM | inj 1x10ml/400ut | NOO | DK | | | | | 47.3 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA | | | | | | | | | | | 47.4 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40 | U | 19,84 | L/DIA | | 54036 | MIXTARD 30 HM | inj 1x10ml/1ku | NOO | DK | | | | | 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1ku | LEX | CZ | | | | | 57536 | MIXTARD 50 HM 100M.J./ML | inj 1x10ml/1ku | NOO | DK | | | | | 62968 | MIXTARD 30 | inj 1x10ml/400ut | NOO | DK | | | | | 47.5 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40 | U | 19,84 | L/DIA | | 54342 | ULTRATARD HM 100M.J./ML | inj 1x10ml/1ku | NOO | DK | | | | | 90980 | ULTRATARD HM | inj 1x10ml/400ut | NOO | DK | | | | | 48 | A10A | insulíny (suspenzní monokomponentní) | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 48.1 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40 | U | 12,66 | | | 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ | | | | | 48.2 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40 | U | 12,66 | | | 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ | | | | | 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40 | U | 12,66 | | | 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 49.1 | A10BA02 | metformin | p.o. | 2 | GM | 7,33 | | | 53960 | METFORMIN 500 LECIVA | tbl obd 100x500mg | LEX | CZ | | | | | 53961 | METFORMIN 850 LECIVA | tbl obd 50x850mg | LEX | CZ | | | | | 56503 | SIOFOR 500 | tbl obd 60x500mg | BCE | D | | | | | 56504 | SIOFOR 850 | tbl obd 60x850mg | BCE | D | | | | | 92477 | GLUCOPHAGE 850MG | tbl obd 30x850mg | LIP | F | | | | | 92478 | GLUCOPHAGE 850MG | tbl obd 100x850mg | LIP | F | | | | | 92694 | GLUCOPHAGE 500MG | tbl obd 50x500mg | LIP | F | | | | | 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,47 | | | 02558 | SILUBIN RETARD | drg 60x100 mg | GRU | D | | | | | 08498 | ADEBIT | tbl 40x50mg | CHN | H | | | | | 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,26 | | | | | | | | | | | | 49.4 | A10BG02 | rosiglitason | p.o. | 4 | MG | 29,70 | Z | | 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,30 | | | | | | | | | | | | 50.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10 | MG | 0,93 | | | 91783 | BETANASE | tbl 10x10x5mg | CAD | IND | | | | | 91880 | MANINIL 5 | tbl 120x5mg | BCE | D | | | | | 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1,37 | | | 94523 | GLUCOBENE | tbl 120x1.75mg | MCK | D | | | | | 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,93 | | | 94525 | GLUCOBENE | tbl 120x3.5mg | MCK | D | | | | | 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,78 | | | | | | | | | | | | 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,40 | | | 00120 | DIRASTAN | tbl 5x10x500 mg | SLO | SK | | | | | 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,79 | | | | | | | | | | | | 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,49 | | | | | | | | | | | | 50.9 | A10BB07 | glipizid | p.o. | 10 | MG | 4,33 | | | 87110 | ANTIDIAB | tbl obd 30x5 mg | KRK | SLO | | | | | 88628 | MINIDIAB | tbl 30x5 mg | PHA | I | | | | | 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,82 | | | 99336 | GLURENORM | tbl 30x30 mg | SLO | SK | | | | | 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 6,90 | | | | | | | | | | | | 50.12 | A10BB12 | glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2 | MG | 6,90 | | | | | | | | | | | | 50.13 | A10BB12 | glymepirid nad 2 mg v jedné tabletě | p.o. | 2 | MG | 5,86 | | | | | | | | | | | | 50.14 | A10BD02 | metformin a glibenklamid | p.o. | 3 | DF | 5,85 | | | | | | | | | | | | 50.15 | A10BX02 | repaglinid | p.o. | 1 | DF | 5,00 | Z | | 51 | A11CA | vitamin A a jeho deriváty | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | KU | 1,17 | | | 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK | | | | | 52 | A11CA | vitamin A a jeho deriváty | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 10,75 | | | 00396 | AXEROPHTHOL BIOTIKA | inj 5x1ml/50ku | BTA | SK | | | | | 53 | A11CC | vitamin D a jeho deriváty (kalcitriol) | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce:

a) léčba renální osteodystrofie u nemocných s chronickou renální insuficiencií (především u dialyzovaných nemocných),

b) léčba křivice rezistentní na vitamin D,

c) léčba osteomalacie rezistentní na vitamin D,

d) léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.

| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 48,59 | P | | 91548 | ROCALTROL | cps 30x0.25rg | HLR | CH | | | | | 58255 | ROCALTROL 0.25MCG | cps 30x0.25rg | RPS | D | | | | | 91550 | ROCALTROL | cps 30x0.50rg | HLR | CH | | | | | 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | KU | 13,10 | | | 00679 | INFADIN RYBI TUK | sol 100ml 0.1mg/1ml | SLO | SK | | | | | 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | KU | 0,78 | | | 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK | | | | | 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | KU | 0,54 | | | | | | | | | | | | 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 17,13 | | | 94445 | TACHYSTIN | gtt 1x20ml/20mg | ANW | D | | | | | 54.5 | A11CC03 | alfakalcidol | p.o. | 1 | RG | 32,26 | P |

Léčbu alfakalcidolem ordinuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce:

a) léčba renální osteodystrofie u nemocných s chronickou renální insuficiencií (především u dialyzovaných nemocných),

b) léčba křivice rezistentní na vitamin D,

c) léčba osteomalacie rezistentní na vitamin D,

d) léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.

| 54.6 | A11CC05 | cholekalciferol | p.o. | 0.5 | MG | 3,91 | | | 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje internista, endokrinolog, urolog, pediatr nebo lékař pracující na dialyzační jednotce: léčba těžkých forem renální osteopatie nereagující na perorální léčbu kalcitriolem.

| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 174,20 | P | | 76423 | CALCIJEX | inj 25x1ml/2rg | ABB | USA | | | | | 94426 | CALCIJEX | inj 25x1ml/1rg | ABB | USA | | | | | 56568 | CALCIJEX | inj 100x1 ml/2rg | ABB | USA | | | | | 64631 | CALCIJEX 1MCG/ML | inj 25x1ml/1rg | ABN | CND | | | | | 64632 | CALCIJEX 2MCG/ML | inj 25x1ml/2rg | ABN | CND | | | | | 75281 | CALCIJEX | inj 100x1ml/1rg | ABB | USA | | | | | 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 56.1 | A11CC01 | ergokalciferol | parent. | 6 | KU | 0,78 | | | 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK | | | | | 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1 ml/7.5mg | BTA | SK | | | | | 56.2 | A11CC05 | cholekalciferol | parent. | 1 | KU | 0,93 | | | 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 57.1 | A11DA thiamin (vit. B1), prostý | parent. | 75 | MG | 5,38 | H | | | | | | | | | | | | 57.2 | A11DA01 thiamin (vit. B1) | parent. | 50 | MG | 5,38 | H | | | 00616 | THIAMIN LECIVA | inj 10x2 ml/100 mg | LEX | CZ | | | | | 58 | A11GA | vitamin C | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 3,91 | H | | 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5 ml/500 mg | HBS | SK | | | | | 92730 | ACIDUM ASCORBICUM BIOTIKA | inj 50x5 ml/500 mg | HBS | SK | | | | | 59 | A11HA | vitamin B2, B6 a E | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 59.1 | A11HA02 | pyridoxin (vitamín B6) | parent. | 0.16 | GM | 15,84 | H | | 00584 | PYRIDOXIN LECIVA | inj 5x1 ml/50mg | LEX | CZ | | | | | 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H | | | | | | | | | | | 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H | | | | | | | | | | | 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,11 | H | | 60 | A11JA | kombinace vitamínů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 121,42 | H | | 94847 | VITALIPID N INFANT | inf 10x10 ml | KBP | S | | | | | 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 121,42 | H | | 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 61.1 | A12AA | vápník (na obsah vápníku) | p.o. | 0.5 | GM | 1,14 | | | | | | | | | | | | 61.2 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | | | 00064 | CALCIUM SLOVAKOFARMA | tbl 50x500 mg | SLO | SK | | | | | 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | | | 53439 | VITACALCIN TABLETY | tbl 60x250mg | SLO | SK | | | | | 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | tbl 1000x0.5gm | MVM | CZ | | | | | 61.4 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem | p.o. | 1 | DF | 5,28 | | | | | | | | | | | | 61.5 | A12AA07 | chlorid vápenatý (tekuté lékové formy, na obsah vápníku) | p.o. | 0.2 | GM | 0,64 | | | | | | | | | | | | 61.6 | A12AA12 | octan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 10,00 | | | | | | | | | | | | 61.7 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | | | | | | | | | | | | 61.8 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,38 | L/INT,GYN, ORT,REV | | | | | | | | | | | 61.9 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,01 | L/INT,GYN, ORT,REV | | 62 | A12AA | soli vápníku | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 59,93 | | | 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK | | | | | 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,98 | | | 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10 ml 10% | HBS | SK | | | | | 63 | A12BA | soli draslíku | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 63.1 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1 | GM | 9,78 | | | | | | | | | | | | 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,44 | | | | | | | | | | | | 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,49 | | | 91600 | KALNORMIN | tbl 30x1gm | IDA | H | | | | | 55661 | KALIUM CHLORATUM INFUSIA - BLISTR | tbl obd 100x500 mg | IHO | CZ | | | | | 64 | A12BA | soli draslíku | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,20 | O | | 02132 | CARDILAN | inj 10x10 ml | HBS | SK | | | | | 02031 | TROMCARDIN | inj 5x10 ml | TRM | D | | | | | 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 50,54 | O | | 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | | | | | 65 | A12CC | soli hořčíku | p.o. | L/INT,NEU,PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 65.1 | A12CC | hořčík (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H | | | | | 65.2 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | | | | | | | | | | 65.3 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | | | | | | | | | | 65.4 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | | | | | | | | | | 65.5 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | 70535 | TBL.MAGNESII LACTICI 0.5 MVM | tbl 1000x0.5gm | MVM | CZ | | | | | 65.6 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | | | | | | | | | | 65.7 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU, PSY,GYN | | 66 | A12CC | soli hořčíku | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 20,38 | O | | 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK | | | | | 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 10,31 | O | | 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK | | | | | 67 | A12CD | soli fluoru | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 4,06 | | | 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D | | | | | 68 | A14A | anabolické steroidy | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 68.1 | A14AB01 | nandrolon | parent. | 2 | MG | 2,98 | | | 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ | | | | | 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 356,82 | O | | | | | | | | | | | 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 102,25 | O | | 86092 | THIOCTACID 600 T | inj 5x24ml/600mg | ASD | D | | | | | 45320 | THIOCTACID 600 T | inj 5x24ml/600mg | HOD | D | | | | | 55380 | THIOGAMMA 600 INJECT | inj 20x20ml/600mg | SLH | D | | | | | 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D | | | | | 84378 | THIOGAMMA 600 INJECT | inj 5x20ml/600mg | SLH | D | | | | | 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D | | | | | 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D | | | | | 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D | | | | | 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D | | | | | 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 110,08 | Z | | 12319 | TRANSMETIL 500 MG | inj 5x500mg+5ml | KNO | I | | | | | 69.4 | A16AA02 | ademetionin | p.o. | 1 | GM | 59,83 | Z | | | | | | | | | | | 69.5 | A16AB02 | imiglucerasa | parent. | 1 | DF | 97,76 | Z | | 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,67 | | | 94114 | WARFARIN | tbl 100x5 mg | ORN | SF | | | | | 94113 | WARFARIN | tbl 100x3 mg | ORN | SF | | | | | 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 4,59 | | | | | | | | | | | | 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 5,47 | | | 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 29367,29 | U | | | | | | | | | | | 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 29367,29 | U | | 66533 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | A | | | | | 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | A | | | | | 85771 | KYBERNIN P | inj 1x500ut+10ml aq | CTO | D | | | | | 85772 | KYBERNIN P | inj 1x1ku+20ml aqua | CTO | D | | | | | 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | O | | 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A | | | | | 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ | | | | | 00477 | HEPARIN RETARD LECIVA | inj 5x1ml/25ku | LEX | CZ | | | | | 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O | | 94857 | FRAGMIN | inj 10x0.2ml/2.5ku | PHA | S | | | | | 73.2 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O | | 94858 | FRAGMIN | inj 10x0.2ml/5ku | PHA | S | | | | | 73.3 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3 | KU | 64,67 | O | | 94855 | FRAGMIN | inj 10x1ml/10ku | PHA | S | | | | | 94856 | FRAGMIN | inj 10x4ml/10ku | PHA | S | | | | | 73.4 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O | | | | | | | | | | | 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O | | | | | | | | | | | 73.6 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O | | | | | | | | | | | 73.7 | B01AB05 | enoxaparin nad 80 mg v jedné ampuli | parent. | 3 | KU | 64,67 | O | | | | | | | | | | | 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O | | | | | | | | | | | 73.9 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O | | | | | | | | | | | 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O | | 62402 | FRAXIPARINE | inj. 10x0,8ml/7,6ku | SWI | F | | | | | 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3 | KU | 64,67 | O | | | | | | | | | | | 73.12 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3 | KU | 55,00 | H | | | | | | | | | | | 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 88,08 | O | | 76570 | FLUXUM 3200UT AXA | inj 6x0.3ml/3200ut | ASW | I | | | | | 73.14 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 80,89 | O | | 56535 | FLUXUM 4250UI AXA | inj 6x0.4ml/4250ut | ASW | I | | | | | 73.15 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 81,87 | O | | 76571 | FLUXUM 6400UI AXA | inj 6x0,4ml/6400ut | ASW | I | | | | | 73.16 | B01AB08 reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O | | | | | | | | | | | | 73.17 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3 | KU | 88,08 | O | | | | | | | | | | | 73.18 | B01AB11 | sulodexid | parent. | 600 | U | 63,44 | O | | | | | | | | | | | 73.19 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT, NEU, DIA,GER | | 74 | B01AC | antiagregancia trombocytů | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu tiklopidinem a clopidogrelem ordinuje internista, kardiolog nebo neurolog:

a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,

b) necitlivost na kyselinu acetylsalicylovou zjištěná agregačním vyšetřením v hemokoagulační laboratoři,

c) podání pacientům po interavaskulárních intervencích (stenty, PTCA, rotablace, atherektomie, laserové atheroplastiky a pod.), podání obvykle v kombinaci s kyselinou acetylsalicylovou po dobu časově omezenou (obvykle jeden měsíc po výkonu).

Léčbu indobufenem ordinuje internista, kardiolog nebo neurolog:

a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,

b) nutnost pouze krátkodobého antiagregačního účinku (např. před chirurgickým výkonem).

Léčbu dipyridamolem včetně kombinací indikuje neurolog nebo internista k sekundární prevenci ischemických mozkových příhod u pacientů, kteří netolerují vyšší dávky kyseliny acetylosalicylové nebo při selhání antiagregační léčby, které se projeví cévní mozkovou příhodou.

| 74.1 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 30,40 | P | | 66938 | TAGREN | tbl 30x250 mg | KRK | SLO | | | | | 74.2 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,54 | | | 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK | | | | | 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK | | | | | 74.3 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | | | | | | | | | | | | 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | | | 99295 | ANOPYRIN 100MG | tbl 20x100mg | SLO | SK | | | | | 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK | | | | | 01288 | GODASAL 100 | tbl 50 | PFL | D | | | | | 74.5 | B01AC07 | dipyridamol | p.o. | 400 | MG | 9,54 | P | | | | | | | | | | | 74.6 | B01AC10 | indobufen | p.o. | 0.3 | GM | 13,11 | P | | | | | | | | | | | 74.7 | B01AC | lysin acetylosalicylát (do 160 mg ekvivalentu kys. acetylosalicylové včetně v jedné dávce) | p.o. | 1 | DF | 0,68 | | | | | | | | | | | | 74.8 | B01AC04 | clopidogrel | p.o. | 75 | MG | 33,92 | P | | | | | | | | | | | 74.9 | B01AC | lysin acetylosalicylát (nad 160 mg ekvivalentu kys. acetylosalicylové v jedné dávce) | p.o. | 1 | DF | 0,64 | | | | | | | | | | | | 74.10 | B01AC30 | dipyridamol a kyselina acetylosalicylová v kombinaci | p.o. | 1 | DF | 17,00 | P | | 75 | B01AC | antiagregancia trombocytů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 224,45 | H | | | | | | | | | | | 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H | | | | | | | | | | | 75.3 | B01AC13 | abciximab | parent. | 1 | DF | 14735,36 | H | | 56610 | REOPRO 2MG/ML | inj 1x5ml | CEO | NL | | | | | 75.4 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X | | | | | | | | | | | 75.5 | B01AC17 | tirofiban | parent. | 1 | DF | 8000,00 | H | | 76 | B01AD | trombolytika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Alteplasa a urokináza na všech pracovištích:

a) léčba akutního infarktu myokardu, kteří byli v posledních 12 měsících léčeni streptokinázou, nebo mají v anamnéze alergickou reakci na streptokinázu.

Na pracovištích, která mají specializovaný léčebný postup ve smlouvě se zdravotní pojišťovnou:

a) intrakoronární trombolýza,

b) trombolýza akutních a subakutních uzávěrů periferních cév.

| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3608,44 | U | | 10937 | STREPTASE | inj sic 1x750 ku | BEH | D | | | | | 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3426,91 | U | | 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S | | | | | 62461 | STREPTASE | inj sic 1x1.5 MU | HMD | D | | | | | 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P | | | | | | | | | | | 76.4 | B01AD04 | urokináza (do 100 KU v jedné dávce včetně) | parent. | 3 | MU | 53928,40 | U/P | | | | | | | | | | | 76.5 | B01AD04 | urokináza (nad 500 KU v jedné dávce) | parent. | 3 | MU | 42565,93 | U/P | | | | | | | | | | | 76.6 | B01AD04 | urokináza (nad 100 do 500 KU v jedné dávce včetně) | parent. | 3 | MU | 45346,56 | U/P | | | | | | | | | | | 76.7 | B01AD07 | retepláza | parent. | 20 | U | 43265,44 | U/P | | | | | | | | | | | 76.8 | B01AX03 | lepirudin | parent. | 1 | DF | 2300,0C | H | | 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | | | | | | | | | | | | 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | | | | | | | | | | | | 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | | | 97410 | EXACYL | tbl fc 20x500mg | SFH | F | | | | | 97412 | EXACYL | sol 5x10 ml/1gm | KBP | S | | | | | 57480 | EXACYL | tbl obd 20x500 mg | SWP | P | | | | | 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 20,14 | | | 02123 | PAMBA | tbl 10x250mg | CWO | D | | | | | 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | | | | | | | | | | | | 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 63,74 | | | 97411 | EXACYL | inj 5x5ml/500mg | SWI | F | | | | | 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 196,40 | | | 69793 | PAMBA | inj 5x5ml/50mg | CWO | D | | | | | 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H | | 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ | | | | | 80 | B02BA | Vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,66 | | | 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK | | | | | 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 19,00 | L/OPH,HEM | | 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,27 | | | | | | | | | | | | 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,64 | | | 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK | | | | | 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 83,29 | O | | 02213 | DICYNONE | inj. 100x2ml/250mg | OML | CH | | | | | 01821 | DICYNONE | inj. 20x2ml/250mg | OML | CH | | | | | 82 | B02BB | lidský fibrinogen | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5355,18 | U | | 83 | B02BC | lokální hemostatika | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 7,19 | | | 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ | | | | | 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 1,47 | | | | | | | | | | | | 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,69 | | | | | | | | | | | | 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 56,80 | | | | | | | | | | | | 83.5 | B02BC | lokální hemostatika - karboxycelulosa (zásyp) | lok. | 1 | GM | 15,40 | | | 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu koagulačním faktorem VIII ordinuje hematolog:

a) prevence a léčba krvácivých stavů u nemocných s vrozeným či získaným nedostatkem faktoru VIII,

b) u nemocných s výskytem inhibitoru proti fakotru VIII v nízkém titru (do 5 Bethesda jednotek),

c) vepřový faktor VIII je indikován u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek proti vepřovému faktoru VIII.

Léčbu koagulačním faktorem IX ordinuje hematolog:

prevence a léčba krvácivých stavů u nemocných s prokázaným deficitem faktoru IX, eventuálně u nemocných s přítomností inhibitoru faktoru VIII.

84.1	B02BD02	koagulační faktor VIII (středně čištěný, z tuzemské plazmy zakázkovou frakcionací)	parent.	500	U	5083,42	B/P
84.2	B02BD02	koagulační faktor VIII (středně čištěný)	parent.	500	U	5083,42	B/P
88800	PORCINE FACTOR VIII:C(HYATE:C)	inj 20ml/400-700ut	SPY	GB
84.3	B02BD04	koagulační faktor IX (středně čištěný, z tuzemské plazmy zakázkovou frakcionací)	parent.	350	U	3284,67	B/P

84.4	B02BD04	koagulační faktor IX (středně čištěný)	parent.	350	U	3284,67	B/P

84.5	B02BD01	kombinace koagulačních faktorů IX,II,VII a X	parent.	350	U	3284,67	B/P

84.6	B02BD02	koagulační faktor VIII (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací)	parent.	500	U	6109,88	B/P

84.7	B02BD02	koagulační faktor VIII (vysoce čištěný)	parent.	500	U	6109,88	B/P

84.8	B02BD04	koagulační faktor IX (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací)	parent.	350	U	4174,27	B/P

84.9	B02BD04	koagulační faktor IX (vysoce čištěný)	parent.	350	U	4174,27	B/P

84.10	B02BD02	koagulační faktor VIII středně čištěný s von Willebrandovým faktorem	parent.	500	U	7820,64	B/P

84.11	B02BD02	koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem	parent.	500	U	8553,83	B/P
85	B02BD	koagulační faktory (ostatní koagulační faktory)	parent.	X
---	---	---	---	---	---	---	---
85.1	B02BD	srážecí faktory	parent.	350	U	2975,02	X
85667	FIBROGAMMIN P	inj 1x250ut+1x4ml	BEH	D
85668	FIBROGAMMIN P	inj 1x1.25ku+1x20ml	BEH	D
85.2	B02BD03	aktivita obcházející inhibitor faktoru VIII	parent.	10	KU	331888,41	X

85.3	B02BD05	koagulační faktor VII	parent.	6	KU	87982,20	X

85.4	B02BD08	eptakog alfa (aktivovaný)	parent.	2.5	KU	1508,65	X
89825	NOVOSEVEN 1,2 MG (=60 KU)	inj. sic. 1x1,2 mg + sol	NOO	DK
89826	NOVOSEVEN 2,4 MG (=120 KU)	inj. sic. 1x2,4 mg + sol	NOO	DK
92641	NOVOSEVEN 4,8 MG (=240 KU)	inj. sic. 1x4,8 + sol	NOO	DK
86	B03AA	soli dvojmocného železa	p.o.
---	---	---	---	---	---	---	---
86.1	B03AA02	fumarát železnatý (pevné lékové formy)	p.o.	0.1	GM	2,74

86.2	B03AA02	fumarát železnatý (tekuté lékové formy)	p.o.	0.1	GM	2,98
00677	FERRONAT	sus 1x100ml/3gm	GNO	CZ
86.3	B03AA03	glukonát železnatý (pevné lékové formy)	p.o.	0.1	GM	5,33

86.4	B03AA03	glukonát železnatý (tekuté lékové formy)	p.o.	0.1	GM	5,33

86.5	B03AA05	chlorid železnatý (pevné lékové formy)	p.o.	0.1	GM	5,33

86.6 B03AA05	chlorid železnatý (tekuté lékové formy)	p.o.	0.1 GM	5,67
85662	FERRO 66	gtt1x20 ml	PRA	D
86.7	B03AA07	síran železnatý (pevné lékové formy)	p.o.	0.1	GM	1,12
04370	FERRONAT RETARD	tbl obd 30	LEX	CZ
86.8	B03AA07	síran železnatý (tekuté lékové formy)	p.o.	0.1	GM	5,33

86.9	B03AB	soli trojmocného železa (tekuté lékové formy)	p.o.	0.1	GM	5,47
87	B03AC	soli trojmocného železa	parent.	O
---	---	---	---	---	---	---	---
87.1	B03AC	železo trojmocné	parent.	0.1	GM	29,67	O
04084	FERRUM LEK I.M.	inj 50x2ml/100mg	LEK	SLO
87.2	B03AC02	hydroxid železitý se sacharózou	parent.	0.1	GM	31,48	O
02788	FERRUM LEK I.V.	inj 50x5ml/100mg	LEK	SLO
87.3	B03AC03	komplex železo-sorbitol-citronová kyselina	parent.	0.1	GM	25,56	O
88	B03AD	soli dvojmocného železa v kombinaci s kyselinou listovou	p.o.	L/GYN,HEM
---	---	---	---	---	---	---	---
88.1	B03AD	chlorid železnatý/ kyselina listová	p.o.	0.1	GM	5,18	L/GYN,HEM

88.2	B03AD	glukonat železnatý/ kyselina listová	p.o.	0.1	GM	5,18	L/GYN,HEM

88.3	B03AD02	fumarat železnatý/ kyselina listová	p.o.	0.1	GM	2,10	L/GYN,HEM,INT
89141	FERRETAB COMP.	cps 100	LAR	A
89140	FERRETAB COMP.	cps 30	LAR	A
88.4	B03AD03	síran železnatý/ kyselina listová	p.o.	0.1	GM	5,18	L/GYN,HEM
89	B03AE	soli dvojmocného železa v ostatních kombinacích	p.o.
---	---	---	---	---	---	---	---
89.1	B03AE01	dvojmocné soli železa/kyselina listová/vitamin B12	p.o.	0.1	GM	5,57

89.2	B03AE02	dvojmocné soli železa/kyselina listová/vitaminy	p.o.	0.1	GM	5,33

89.3	B03AE10	chlorid železnatý/ kyselina listová	p.o.	0.1	GM	5,33

89.4	B03AE10	fumarat železnatý/ kyselina listová	p.o.	0.1	GM	5,33

89.5	B03AE10	glukonat železnatý/ kyselina listová	p.o.	0.1	GM	5,33

89.6	B03AE10	různé kombinace bez kyseliny listové	p.o.	0.1	GM	1,70

89.7	B03AE10	síran železnatý/ kyselina listová	p.o.	0.1	GM	5,57
96043	AKTIFERRIN COMPOSITUM	cps 100	MCK	A
89.8	B03AE10	síran železnatý/serin (pevné lékové formy)	p.o.	0.1	GM	5,00

89.9	B03AE10	síran železnatý/serin -tekuté lékové formy (kapky)	p.o.	0.1	GM	6,89
99138	AKTIFERRIN	gtt 1x30ml	MCK	D
89.10	B03AE10	síran železnatý/serin -tekuté lékové formy (sirup)	p.o.	0.1	GM	9,00
90	B03BA	vitamin B12 a jeho deriváty	parent.
---	---	---	---	---	---	---	---
90.1	B03BA01	cyanokobalamin (do 0,3 mg v jedné ampuli včetně)	parent.	0.02	MG	0,49
00641	VITAMIN B12 LECIVA 300RG	inj 5x1ml/300rg	LEX	CZ
90.2	B03BA01	cyanokobalamin (nad 0,3 mg v jedné ampuli)	parent.	0.02	MG	0,20
92503	NEUROBENE	inj 6x1ml/1000rg	MCK	D
00643	VITAMIN B12 LECIVA 1000RG	inj 5x1ml/1000rg	LEX	CZ
97506	VITAMIN B12-RATIOPHARM	inj 6x1ml/1000rg	MCK	D
66949	VITAMIN B12	inj 5x2ml/1000rg	POL	PL
91	B03BB	kyselina listová a její deriváty	p.o.
---	---	---	---	---	---	---	---
91.1	B03BB01	kyselina listová	p.o.	10	MG	1,33
76064	ACIDUM FOLICUM LECIVA	drg 30x10mg	LEX	CZ
92	B03XA	ostatní protianemická léčiva	parent.	K/P
---	---	---	---	---	---	---	---

Léčbu erythropoetinem ordinuje onkolog, hematolog, internista nebo pediatr:

a) léčba klinicky významné anémie (s hladinou hemoglobinu nižší než 90 g/l, s vyššími hodnotami při manifestních příznacích anémie) u nemocných zařazených do dialyzačního programu, nemocných s chronickým renálním selháním, nemocných s nádorovým onemocněním po radikální cytostatické léčbě nebo ozáření,

b) léčba anémie u nemocných s aplastickou anémií, erythroblastoftýzou, myelodysplastickým syndromem a anémií po transplantaci kostní dřeně,

c) léčba těžké anémie nezralých dětí.

| 92.1 | B03XA01 | erythropoetin do 10 KU v jedné ampuli včetně | parent. | 2 | KU | 1011,84 | K/P | | 85532 | EPREX | inj 6x10ku/ml+str. | CIL X | CH | | | | | 94346 | EPREX | inj 6x1 Oku/ml | CIL X | CH | | | | | 92.2 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 2 | KU | 860,00 | K/P | | 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2815,72 | B | | | | | | | | | | | 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2815,72 | B | | 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D | | | | | 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml | PDE | D | | | | | 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml | PDE | D | | | | | 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E | | | | | 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E | | | | | 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E | | | | | 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E | | | | | 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ | | | | | 10117 | HUMAN ALBUMIN 20% | inf 1x50 ml | BTP | D | | | | | 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B | | 94 | 805AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 185,84 | O | | 00589 | RHEODEXTRAN INFUSIA (SOL.PHYS.) | inf 1x500ml 10% | IHO | CZ | | | | | 00590 | RHEODEXTRAN INFUSIA 10% V GLUC. | inf 1x500ml | IHO | CZ | | | | | 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 108,80 | O | | 00431 | DEXTRAN INFUSIA 6% V F1/1 | inf 1x500ml(sklo) | IHO | CZ | | | | | 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123,86 | O | | 96380 | TENSITON I.V.(KREVNI EXPANDER) | inf 1x500ml(lahev) | IHO | CZ | | | | | 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 227,87 | O | | 56063 | GELIFUNDOL | inf 10x500ml | BTP | D | | | | | 02536 | GELIFUNDOL | inf 1x500ml | BTP | D | | | | | 62639 | HAEMACCEL 3,5% | inf 10x500 ml | HMD | D | | | | | 56412 | GELOFUSINE | inf 1x500 ml | BME | CH | | | | | 94.5 | B05AA07 | hydroxyethyl- škrob | parent. | 500 | ML | 390,05 | O | | 98352 | ELOHAST 6% | inf 1x500ml(plast) | LPD | A | | | | | 98351 | ELOHAST 6% | inf 1x500ml(sklo) | LPD | A | | | | | 72155 | HAES-STERIL 6% | inf 1x500ml(plast) | FRE | D | | | | | 72154 | HAES-STERIL 6% | inf 1x500ml(sklo) | FRE | D | | | | | 44431 | HEMOHES 6% | inf 1x500 ml (p) | BME | D | | | | | 44467 | HEMOHES 10% | inf 1x500 ml (p) | BME | D | | | | | 55897 | HEMOHES 6% | inf 10x500ml(pe) | BME | D | | | | | 55902 | HEMOHES 10% | inf 10x500ml(pe) | BME | D | | | | | 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 95.1 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,71 | O | | 43919 | 10% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | | | 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I | | | | | 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | | | 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | | | 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml (sklo) | IHO | CZ | | | | | 92531 | 10% DEXTROSE IN WATER F. INJ. USP | inf. 1x250ml (sklo) | SFR | I | | | | | 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,94 | O | | 47000 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | E | | | | | 47017 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | CH | | | | | 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | | | 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf 1x500ml | MVM | CZ | | | | | 92534 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | | | 96877 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BMM | D | | | | | 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | | | 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,84 | O | | 43918 | 10% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | | | 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I | | | | | 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | | | 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml (sklo) | SFR | I | | | | | 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml (sklo) | IMA | SK | | | | | 86346 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x100ml (sklo) | IHO | CZ | | | | | 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,82 | O | | 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml(pp) | SFR | I | | | | | 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | | | 47001 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | E | | | | | 47018 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | CH | | | | | 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | | | 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | | | 92533 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(sklo) | SFR | I | | | | | 92535 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(pp) | SFR | I | | | | | 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | | | 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | | | 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | MKS | CZ | | | | | 96878 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BMM | D | | | | | 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,01 | O | | 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | | | 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1x100ml | HUA | H | | | | | 86356 | INFUSIO GLUCOSI 20% INFUSIA | inf 1x100ml(sklo) | IHO | CZ | | | | | 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,70 | O | | 75194 | GLUCOSE - LOSUNG 20 SALVIA (PLAST) | inf 1x1000m 20% | CLS | D | | | | | 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | | | 95.7 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,90 | O | | 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | | | 43934 | 5% DEXTROSE IN WATER USP SIFRA | inf 30x250ml(vak) | SFR | I | | | | | 46995 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | E | | | | | 47012 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | CH | | | | | 53818 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(pvc) | IHO | CZ | | | | | 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | | | 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | | | 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | | | 92520 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | | | 92526 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(vak) | SFR | I | | | | | 96872 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BMM | D | | | | | 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | | | 95.8 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,89 | O | | 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml(sklo) | SFR | I | | | | | 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(pp) | SFR | I | | | | | 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(vak) | SFR | I | | | | | 46996 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | E | | | | | 47013 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | CH | | | | | 57748 | GLUCOSE 5% INFUSION-HUMAN | inf 1x500ml(plast) | HUA | H | | | | | 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | | | 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf 1x500ml | MVM | CZ | | | | | 83695 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x500ml | CPL | IND | | | | | 86341 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x500ml(plast) | IHO | CZ | | | | | 92521 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(sklo) | SFR | I | | | | | 92523 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | | | 92527 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(vak) | SFR | I | | | | | 96873 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BMM | D | | | | | 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | | | 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,76 | O | | 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | | | 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml(vak) | SFR | I | | | | | 46994 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | E | | | | | 47011 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | CH | | | | | 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | | | 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x100ml(sklo) | IHO | CZ | | | | | 92519 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | | | 92525 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(vak) | SFR | I | | | | | 96871 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMM | D | | | | | 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I | | | | | 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 3,96 | O | | 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml(vak) | SFR | I | | | | | 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | | | 83696 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x1000ml | CPL | IND | | | | | 92528 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | | | 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | | | 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 91,31 | O | | | | | | | | | | | 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 98,74 | O | | | | | | | | | | | 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,18 | O | | 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | | | | | 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml (sklo) | IMA | SK | | | | | 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 31,97 | O | | 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml (sklo) | IMA | SK | | | | | 95.15 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100 | ML | 8,26 | O | | 75199 | GLUCOSE-LOSUNG 40 SALVIA (SKLO) | inf 1x1000ml40% | CLS | D | | | | | 75206 | GLUCOSE-LOSUNG 40 SALVIA (PLAST) | inf 1x1000ml 40% | CLS | D | | | | | 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 98,64 | O | | 02587 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | D | | | | | 02588 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | E | | | | | 02589 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | CH | | | | | 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 38,76 | H | | | | | | | | | | | 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 74,49 | H | | | | | | | | | | | 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 77,86 | H | | 55971 | SALVIAMIN 12,5 E | inf 1x1000 ml | CTT | F | | | | | 55969 | SALVIAMIN 12,5 E | inf 1x500 ml | CTT | F | | | | | 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 48,39 | H | | 92631 | SALVIAMIN 10 E | inf 1x1000 ml | CTT | F | | | | | 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 175,28 | H | | 45303 | INTRALIPID 10% | inf 1x100ml | PAU | S | | | | | 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ML | 196,40 | H | | | | | | | | | | | 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 55,48 | H | | 59154 | IVELIP 10% | inf 6x1000ml | CTT | F | | | | | 75442 | INTRALIPID | inf 12x500ml 10% | PAU | S | | | | | 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 74,20 | H | | 59157 | IVELIP 20% | inf 12x500ml | CTT | F | | | | | 59158 | IVELIP 20% | inf 6x1000ml | CTT | F | | | | | 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,47 | H | | 69765 | ARDEANUTRISOL FR 5 | inf 1x500ml | ARD | CZ | | | | | 69764 | ARDEANUTRISOL FR 5 | inf 1x300ml | ARD | CZ | | | | | 86464 | ARDEANUTRISOL FR 5 | inf 12x500ml | ARD | CZ | | | | | 92222 | ARDEANUTRISOL FR 5 | inf 12x300ml | ARD | CZ | | | | | 86463 | ARDEANUTRISOL FR 5 | inf 12x400ml | ARD | CZ | | | | | 86459 | ARDEANUTRISOL FR 5 | inf 1x400ml | ARD | CZ | | | | | 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 17,74 | H | | 69771 | ARDEANUTRISOL FR 20 | inf 1x500ml | ARD | CZ | | | | | 86473 | ARDEANUTRISOL FR 20 | inf 1x400ml | ARD | CZ | | | | | 86478 | ARDEANUTRISOL FR 20 | inf 12x500ml | ARD | CZ | | | | | 86477 | ARDEANUTRISOL FR 20 | inf 12x400ml | ARD | CZ | | | | | 96.11 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 15,54 | H | | 69768 | ARDEANUTRISOL FR 10 | inf 1x500ml | ARD | CZ | | | | | 86466 | ARDEANUTRISOL FR 10 | inf 1x400ml | ARD | CZ | | | | | 86471 | ARDEANUTRISOL FR 10 | inf 12x500ml | ARD | CZ | | | | | 86470 | ARDEANUTRISOL FR 10 | inf 12x400ml | ARD | CZ | | | | | 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 8,02 | H | | 68869 | INFUSIO SORBITOLI 5 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | | | 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,10 | H | | 68878 | INFUSIO SORBITOLI 20 IMUNA | inf 1x500 (vak) | IMA | SK | | | | | 96.14 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 8,60 | H | | 68873 | INFUSIO SORBITOLI 10 IMUNA | inf 1x500 (sklo) | IMA | SK | | | | | 71730 | INFUSIO SORBITOLI 100 G/L MVM | inf 1x500ml | MVM | CZ | | | | | 89919 | INFUSIO SORBITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | | | 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 16,62 | H | | | | | | | | | | | 96.16 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100 | ML | 22,83 | H | | 86224 | ARDEANUTRISOL XY 10 | inf 12x500ml | ARD | CZ | | | | | 69716 | ARDEANUTRISOL XY 10 | inf 1x500ml | ARD | CZ | | | | | 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,20 | H | | | | | | | | | | | 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 61,83 | H | | 72160 | AMINO-MEL 3,5% G | inf 6x1000ml | LPD | A | | | | | 72159 | AMINO-MEL 3,5% G | inf 10x500ml | LPD | A | | | | | 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A | | | | | 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A | | | | | 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A | | | | | 91305 | NUTRAMIN C | inf 1x500ml | IHO | CZ | | | | | 96204 | NUTRAMIN U | inf 1x500ml | IHO | CZ | | | | | 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH | | | | | 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH | | | | | 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH | | | | | 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH | | | | | 02456 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1000ml | BMB | CH | | | | | 02457 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | BMB | CH | | | | | 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH | | | | | 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH | | | | | 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH | | | | | 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH | | | | | 02462 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | BMB | CH | | | | | 02463 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | BMB | CH | | | | | 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D | | | | | 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | IHO | CZ | | | | | 45383 | AMINOROZTOK NEO SX 8% INFUSIA | inf 1x500ml | IHO | CZ | | | | | 46010 | SALVIAMIN HEPAR | inf 1x500ml | CTT | F | | | | | 54013 | NEONUTRIN C | inf 1x500ml | IHO | CZ | | | | | 56624 | NUTRIFLEX BASAL | inf 5x1000ml | VIF | CH | | | | | 56625 | NUTRIFLEX BASAL | inf 5x2000ml | VIF | CH | | | | | 56626 | NUTRIFLEX SPECIAL | inf 5x1000ml | VIF | CH | | | | | 56627 | NUTRIFLEX SPECIAL | inf 5x1500ml | VIF | CH | | | | | 56628 | NUTRIFLEX PLUS | inf 5x1000ml | VIF | CH | | | | | 56629 | NUTRIFLEX PLUS | inf 5x2000ml | VIF | CH | | | | | 56630 | NUTRIFLEX PERI | inf 5x1000ml | VIF | CH | | | | | 56631 | NUTRIFLEX PERI | inf 5x2000ml | VIF | CH | | | | | 56632 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | VIF | CH | | | | | 56633 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | VIF | CH | | | | | 56634 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1000ml | VIF | CH | | | | | 56635 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | VIF | CH | | | | | 69641 | ARDEAELYTOSOL ARGE | inf 1x250ml | ARD | CZ | | | | | 69642 | ARDEAELYTOSOL ARGE | inf 1x500ml | ARD | CZ | | | | | 69643 | INFUSIO ARGML ARDEAPHARMA | inf 1x250ml | ARD | CZ | | | | | 69644 | INFUSIO ARGML ARDEAPHARMA | inf 20x250ml | ARD | CZ | | | | | 72159 | AMINO-MEL 3.5% G | inf 10x500ml | LPD | A | | | | | 72160 | AMINO-MEL 3.5% G | inf 6x1000ml | LPD | A | | | | | 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A | | | | | 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A | | | | | 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A | | | | | 81692 | NUTRAMIN K | inf 10x500ml | VUA | CZ | | | | | 88988 | ARDEAELYTOSOL ARGE | inf 20x250ml | ARD | CZ | | | | | 88989 | ARDEAELYTOSOL ARGE | inf 12x500ml | ARD | CZ | | | | | 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 11,54 | O | | 43907 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 16x250ml(sklo) | SFR | I | | | | | 43912 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 30x250ml(vak) | SFR | I | | | | | 46070 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BMR | E | | | | | 46080 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BME | CH | | | | | 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFH | E | | | | | 70525 | INFUSIO NATRII CHLOR.ISOTON.MVM | inf 1x250ml | MVM | CZ | | | | | 86047 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | | | 92509 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(sklo) | SFR | I | | | | | 92515 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(vak) | SFR | I | | | | | 97682 | CHLORID SODNÝ 0.9% BRAUN | inf 1x250ml(plast) | BMM | D | | | | | 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(sklo) | BFF | I | | | | | 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFF | I | | | | | 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 22,09 | O | | 43906 | 0,9% SODIUM CHL. IN WATER F. INJ. | inf 49x100ml(sklo) | SFR | I | | | | | 43906 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 49x100ml(sklo) | SFR | I | | | | | 46065 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BMR | E | | | | | 46075 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BME | CH | | | | | 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFH | E | | | | | 92508 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x100ml(sklo) | SFR | I | | | | | 96882 | CHLORID SODNÝ 0.9% BRAUN | inf 1x100ml(sklo) | BMM | D | | | | | 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(sklo) | BFF | I | | | | | 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFF | l | | | | | 97.3 | B05BB01 | Chlorid sodný 0.9% (nad než 250 ml v balení) | parent. | 100 | ML | 3,81 | O | | 92513 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(pp) | SFR | I | | | | | 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E | | | | | 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFH | E | | | | | 43915 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 4x2000ml(vak) | SFR | I | | | | | 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFH | E | | | | | 83698 | SODIUM CHLORIDE I.V.B.P.CORE | inf 1x1000ml 0.9% | CPL | IND | | | | | 92511 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(sklo) | SFR | I | | | | | 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I | | | | | 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | IMA | SK | | | | | 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 42,82 | O | | 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | 92518 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,46 | H | | 75372 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | | | | | 75374 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | | | | | 75360 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | | | | | 75362 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | | | | | 75370 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | | | | | 75368 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | | | | | 75358 | ELO-MEL ISOTON | inf 6x1000ml(plast) | LPD | A | | | | | 75356 | ELO-MEL ISOTON | inf 6x1000ml(sklo) | LPD | A | | | | | 75366 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(plast) | LPD | A | | | | | 75364 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(sklo) | LPD | A | | | | | 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,07 | H | | 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ | | | | | 85112 | ARDEAELYTOSOL R 1/1 | inf 12x500ml | ARD | CZ | | | | | 83702 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x1000ml | CPL | IND | | | | | 83701 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x500ml | CPL | IND | | | | | 98238 | DARROW'S SOLUTION | inf 1x500ml | BME | D | | | | | 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | | | 91841 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 10x1000ml | BXT | GB | | | | | 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | | | 96889 | RINGERLACTAT DAB 7 BRAUN | inf 1x1000ml(pe) | BME | D | | | | | 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ | | | | | 96892 | RINGER'S INJECTION BRAUN | inf 1x1000ml | BME | D | | | | | 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXT | GB | | | | | 69440 | RINGER-LOSUNG SALVIA (PLAST) | inf 1x1000ml | CLS | D | | | | | 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml (vak) | IMA | SK | | | | | 84545 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x3000ml (vak) | IMA | SK | | | | | 69438 | RINGER-LACTAT SALVIA (PLAST) | inf 1x1000ml | CLS | D | | | | | 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml (vak) | IMA | SK | | | | | 97013 | INFUSIO DARROWI INSTITUTE HUMAN | inf 1x500ml | HUA | H | | | | | 69442 | RINGER-LOSUNG SALVIA (SKLO) | inf 1x1000ml | CLS | D | | | | | 69439 | RINGER-LACTAT SALVIA (SKLO) | inf 1x1000ml | CLS | D | | | | | 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ | | | | | 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml (vak) | IMA | SK | | | | | 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml (vak) | MKS | CZ | | | | | 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BME | D | | | | | 96888 | RINGERLACTAT DAB 7 BRAUN | inf 1x500ml (pe) | BME | D | | | | | 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml (vak) | IMA | SK | | | | | 84554 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x2000ml (vak) | IMA | SK | | | | | 69235 | RINGER'S SOLUTION U. S. P. BIEFFE | inf 1x500ml (sklo) | BFF | I | | | | | 92599 | INFUSIO DARROWI IMUNA | inf 1x2000ml (vak) | IMA | SK | | | | | 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml (vak) | IMA | SK | | | | | 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml (sklo) | IHO | CZ | | | | | 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml (sklo) | IMA | SK | | | | | 84543 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x1000ml (vak) | IMA | SK | | | | | 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | | | 69736 | ARDEALYTOSOL H 1/1 | inf 1x500ml | ARD | CZ | | | | | 69695 | ARDEALYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ | | | | | 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml (sklo) | IMA | SK | | | | | 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml (vak) | MKS | CZ | | | | | 86486 | ARDEALYTOSOL H 1/1 | inf 12x500ml | ARD | CZ | | | | | 92775 | INFUSIO DARROWI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ | | | | | 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml (vak) | IMA | SK | | | | | 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml (sklo) | IHO | CZ | | | | | 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | | | 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,04 | H | | 12382 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | | | 12388 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | | | 12389 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | | | 12390 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | | | 12395 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | | | 12401 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | | | 12402 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | | | 12403 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | | | 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | | | 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | | | 62369 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x500ml(sklo) | IMA | SK | | | | | 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ | | | | | 70552 | INFUSIO HRS MEDICAMENTA | inf 1x500ml | MVM | CZ | | | | | 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf 1x500ml | MVM | CZ | | | | | 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf 1x500ml | MVM | CZ | | | | | 85566 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x1000ml(vak) | IMA | SK | | | | | 92624 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x2000ml(vak) | IMA | SK | | | | | 92625 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x3000ml(vak) | IMA | SK | | | | | 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,02 | H | | 69698 | ARDEALYTOSOL THAM 1/1 | inf 1x500 ml | ARD | CZ | | | | | 85176 | ARDEAELYTOSOL THAM 1/1 | inf 1x400ml | ARD | CZ | | | | | 99 | B05BC | roztoky k osmotické diuréze | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100 | ML | 12,17 | H | | 31365 | MANNISOL A INFUSION-HUMAN | inf 1x500ml | HUA | H | | | | | 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | | | 46028 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | | | 55612 | INFUSIO MANNITOLI 10 IMUNA | inf 1x2000ml(vak) | IMA | SK | | | | | 55613 | INFUSIO MANNITOLI 10 IMUNA | inf 1x3000ml(vak) | IMA | SK | | | | | 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | | | 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | | | 85598 | INFUSIO MANNITOLI 10 IMUNA | inf 1x1000ml(vak) | IMA | SK | | | | | 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | | | 97744 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | | | 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 19,31 | H | | 46026 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | | | 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | | | 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf 1x250ml | MVM | CZ | | | | | 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | | | 97743 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | | | 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100 | ML | 13,78 | H | | 43765 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x500ml | SFR | I | | | | | 43766 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x1000ml | SFR | I | | | | | 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | | | 44583 | 20% MANNITOL IN WATER F.INJ.USP | inf 12x500ml | SFR | I | | | | | 44584 | 20% MANNITOL IN WATER F.INJ.USP | inf 6x1000ml | SFR | I | | | | | 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | | | 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | | | 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | | | 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | | | 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 21,70 | H | | 43764 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x250ml | SFR | I | | | | | 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | | | 44582 | 20% MANNITOL IN WATER F.INJ.USP | inf 16x250ml | SFR | I | | | | | 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | | | 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | | | 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf 1x250ml | MVM | CZ | | | | | 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | | | 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1133,11 | H | | 100 | B05C | roztoky k irigaci | lok. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 100.1 | B05CB01 | chlorid sodný | lok. | 1000 | ML | 37,29 | H | | | | | | | | | | | 100.2 | B05CX02 | sorbitol | lok. | 1000 | ML | 37,29 | H | | | | | | | | | | | 100.3 | B05CX03 | glycin | lok. | 1000 | ML | 54,04 | H | | | | | | | | | | | 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 54,04 | H | | 101 | B05D roztoky k peritoneální dialýze | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 101.1 | B05D | přípravky pro peritoneální dialýzu | parent. | 1000 | ML | 138,72 | H | | 45631 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL | | | | | 45632 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | | | 45633 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45634 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | | | 45635 | GAMBROSOL 10 M GEMINI 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45636 | GAMBROSOL 10 M GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | | | 45637 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL | | | | | 45638 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | | | 45639 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL | | | | | 45640 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | | | 45643 | GAMBROSOL 10 H GEMINI 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45644 | GAMBROSOL 10 H GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | | | 45667 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL | | | | | 45668 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | | | 45669 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45670 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | | | 45671 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL | | | | | 45672 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | | | 45673 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL | | | | | 45674 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | | | 45699 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | NPB | NL | | | | | 45700 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | | | 45701 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45702 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | | | 45703 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | NPB | NL | | | | | 45704 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | | | 45705 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | NPB | NL | | | | | 45706 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | | | 45709 | GAMBROSOL 10 L GEMINI 10 | sol 4x2000ml(vak) | NPB | NL | | | | | 45710 | GAMBROSOL 10 L GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | | | 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | | | 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | | | 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | | | 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | | | 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | | | 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | | | 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I | | | | | 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I | | | | | 55848 | PERITONEAL DIALSOL+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I | | | | | 58502 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | GBL | S | | | | | 58503 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | GBL | S | | | | | 58504 | GAMBROSOL 10 H | sol 4x2500ml(sy10) | GBL | S | | | | | 58505 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | GBL | S | | | | | 58506 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | GBL | S | | | | | 58507 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | GBL | S | | | | | 58515 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | GBL | S | | | | | 58532 | GAMBROSOL 10 M | sol 4x2500ml(ge10) | GBL | S | | | | | 58542 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | GBL | S | | | | | 58543 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | GBL | S | | | | | 58544 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | GBL | S | | | | | 58545 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | GBL | S | | | | | 58546 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | GBL | S | | | | | 58547 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | GBL | S | | | | | 58548 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | GBL | S | | | | | 58549 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | GBL | S | | | | | 58550 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | GBL | S | | | | | 58551 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | GBL | S | | | | | 58552 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | GBL | S | | | | | 58553 | GAMBROSOL 10 L | sol 6x1500ml(sy10) | GBL | S | | | | | 58570 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | GBL | S | | | | | 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I | | | | | 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I | | | | | 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I | | | | | 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I | | | | | 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I | | | | | 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I | | | | | 69182 | PERITONEAL DIAL.SOL.+DEXTR. 1.5% | sol 1x2000ml(vak) | BFF | I | | | | | 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I | | | | | 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL | | | | | 76616 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x5000ml(vak) | BXT | IRL | | | | | 76623 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2500ml(vak) | BXT | IRL | | | | | 76625 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x5000ml(vak) | BXT | IRL | | | | | 76632 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2500ml(vak) | BXT | IRL | | | | | 76634 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x5000ml(vak) | BXT | IRL | | | | | 85923 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2000ml(vak) | BFF | I | | | | | 85924 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I | | | | | 85925 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2000ml(vak) | BFF | I | | | | | 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I | | | | | 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 124,74 | O | | 00524 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 6x20ml 4.2% | LEX | CZ | | | | | 55448 | NATRIUM HYDROGENCAR.LECIVA 4.2% | inj 10x10ml | LEX | CZ | | | | | 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 11,00 | O | | 31352 | ALKALIGEN-INSTITUTE HUMAN | inf 1x400ml | HUA | H | | | | | 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 103.1 | B05X | přídavky do i.v. roztoků | parent. | 100 | ML | 257,49 | H | | 69597 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x500ml | ARD | CZ | | | | | 86799 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x400ml | ARD | CZ | | | | | 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ | | | | | 86798 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x250ml | ARD | CZ | | | | | 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ | | | | | 103.2 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 17,40 | H | | 70523 | INFUSIO KALII CHLORATI CONC.MVM | inf 1x250ml | MVM | CZ | | | | | 103.3 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 22,88 | H | | 69727 | ARDEAELYTOSOL NATRIUMCHLOR.5.85 | inf 1x200ml | ARD | CZ | | | | | 103.4 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 24,93 | H | | 87726 | ARDEAELYTOSOL NATRIUMCHLOR. 10% | inf 1x200ml | ARD | CZ | | | | | 103.5 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,68 | H | | 86596 | ARDEAELYTOSOL AMMONCL 1/1 | inf 12x500ml | ARD | CZ | | | | | 69576 | ARDEAELYTOSOL AMMONCL 1/1 | inf 1x500ml | ARD | CZ | | | | | 103.6 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 52,35 | H | | | | | | | | | | | 103.7 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,46 | H | | 72998 | SOLUTIO SHILS I.ARDEAPHARMA | inf 1x50ml | ARD | CZ | | | | | 103.8 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 127,87 | H | | | | | | | | | | | 103.9 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 27,67 | H | | | | | | | | | | | 103.10 | B05XB02 | alanylglutamin | parent. | 1 | ML | 4,39 | H | | | | | | | | | | | 103.11 | B05XC | vitamíny | parent. | 1 | DF | 43,99 | H | | | | | | | | | | | 103.12 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,63 | H | | 104 | B05Z | roztoky k hemodialyze a hemofiltraci | lok. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 166,19 | H | | 87560 | ARDEADIALYSOL MAX I | inf 1x250ml | ARD | CZ | | | | | 87562 | ARDEADIALYSOL MAX I | inf 1x300ml | ARD | CZ | | | | | 87576 | ARDEADIALYSOL MAX I | inf 1x400ml | ARD | CZ | | | | | 69646 | ARDEADIALYSOL MAX I | inf 1x500ml | ARD | CZ | | | | | 87612 | ARDEADIALYSOL MAX II | inf 1x250ml | ARD | CZ | | | | | 87613 | ARDEADIALYSOL MAX II | inf 1x300ml | ARD | CZ | | | | | 87614 | ARDEADIALYSOL MAX II | inf 1x400ml | ARD | CZ | | | | | 69649 | ARDEADIALYSOL MAX II | inf 1x500ml | ARD | CZ | | | | | 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 125,72 | H | | | | | | | | | | | 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 166,19 | H | | 105 | C01AA | kardioglykosidy z náprstníku | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,03 | | | | | | | | | | | | 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,03 | | | | | | | | | | | | 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,15 | | | 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ | | | | | 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ | | | | | 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ | | | | | 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,03 | | | 106 | C01AA | kardioglykosidy z náprstníku | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 6,99 | | | 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ | | | | | 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 6,99 | | | | | | | | | | | | 106.3 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 23,46 | | | 107 | C01BA | anttarytmika, třída la | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 107.1 | C01B | ipratropium | p.o. | 30 | MG | 53,77 | | | | | | | | | | | | 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,39 | | | 23113 | TACHMALCOR | drg 50x25mg | VAD | D | | | | | 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 19,36 | | | 70549 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 1000x0.2gm | MVM | CZ | | | | | 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,27 | | | | | | | | | | | | 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 38,61 | | | | | | | | | | | | 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,37 | | | | | | | | | | | | 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,08 | | | 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | SVP | D | | | | | 108 | C01BA | antiarytmika, třída la | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 108.1 | C01B | ipratropium | parent. | 3 | MG | 782,94 | O | | | | | | | | | | | 108.2 | C01BA02 | prokainamid | parent. | 3 | GM | 251,87 | O | | | | | | | | | | | 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 251,87 | O | | | | | | | | | | | 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 251,87 | O | | 99356 | GILURYTMAL 10 I.V. | inj 5x10ml/50mg | GIU | D | | | | | 109 | C01BB | antiarytmika, třída Ib | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 9,68 | | | 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK | | | | | 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,22 | | | 110 | C01BB | antiarytmika, třída Ib | parent. | O/INT,KAR | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT,KAR | | | | | | | | | | | 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT,KAR | | | | | | | | | | | 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT,KAR | | 111 | C01BC | antiarytmika, třída lc | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 111.1 | C01BC03 | propafenon (100 mg a více v jedné tabletě) | p.o. | 0.3 | GM | 7,61 | | | 12188 | PROFENORM 150 MG | tbl obd 50x150mg | PMP | CZ | | | | | 53536 | PROPAFENON AL 150 | tbl. obd. 100x150mg | APA | D | | | | | 53534 | PROPAFENON AL 150 | tbl. obd.20x150mg | APA | D | | | | | 111.2 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,55 | | | 76761 | RYTMONORM 10MG | tbl obd 500x10mg | KNO | D | | | | | 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 112.1 | C01BC03 | Propafenon | parent. | 0.3 | GM | 165,41 | O/INT,KAR | | 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO | | | | | 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT,KAR | | 113 | C01BD | antiarytmika, třída III | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,20 | | | 59655 | AMIOCORDIN | tbl 60x200 mg | KRK | SLO | | | | | 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,94 | O/INT,KAR | | 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A | | | | | 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT,KAR | | | | | | | | | | | 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 728,30 | O/INT,KAR | | 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F | | | | | 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 76,00 | O | | 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | | | 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 109,39 | O | | 04380 | TENSAMIN | inj 10x5ml | LEX | CZ | | | | | 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 116.1 | C01CA02 | isoprenalin | parent. | 90 | MG | 15620,16 | H | | | | | | | | | | | 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 23,76 | H | | | | | | | | | | | 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 350,71 | H | | 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF | | | | | 92483 | DOBUDAMIN LACHEMA 250 | inj sic 1x250 mg | LCM | CZ | | | | | 01639 | DOBUTAMIN GIULINI | inj sic 10x250mg | WAU | D | | | | | 59267 | DOBUTAMIN LACHEMA 250 | inj sic 10x250mg | LCM | CZ | | | | | 84361 | DOBUTAMIN GIULINI | inj sic 1x250mg | WAU | D | | | | | 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 191,26 | H | | | | | | | | | | | 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 40,91 | H | | | | | | | | | | | 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 101,67 | H | | | | | | | | | | | 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 83,44 | H | | | | | | | | | | | 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 684,31 | P |

Léčivý přípravek obsahující epinefrin v lékových formách autoinjektoru předepisuje alergolog a klinický imunolog u pacientů s anamnézou anafylaktického šoku vyvolaného alergií na hmyz.

| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O | | | 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | | | | 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H | | | 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4250,80 | X | | | 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | | | | | | 117.2 | C01CE02 | milrinon | parent. | 50 | MG | 3980,00 | X | | | 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,00 | | | | | | | | | | | | | | 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,00 | | | | | | | | | | | | | | 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | | | | 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H | | | | | | 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | | | | | | | | | | | | | | 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | | | | 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | | | | | | 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,50 | | | | | | | | | | | | | | 118.7 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | | | | 6402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | | | | | | 6401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | | | | | | 6190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ | | | | | | 45821 | MONOSAN 20MG | tbl 500x20mg | PMP | CZ | | | | | | 61467 | ISMN AL 20 | tbl 100x20mg | APA | D | | | | | | 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | | | | | | 118.8 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,25 | | | | | | | | | | | | | | 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | | | | 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | | | | | | 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D | | | | | | 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D | | | | | | 61469 | ISMN AL 40 | tbl 100x40 mg | APA | D | | | | | | 45822 | MONOSAN 40MG | tbl 500x40mg | PMP | CZ | | | | | | 96191 | MONOSAN 40MG | tbl 30x40mg | PMP | CZ | | | | | | 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,59 | H | | | 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D | | | | | | 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H | | | 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,59 | | | | 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | | | | | | 31407 | NITROMINT | aer dos 1x10 g | EGY | H | | | | | | 53139 | NITRILEX | aer 1x14gm/205davek | GNO | CZ | | | | | | 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | | | | 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | | | | | | | 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 6,11 | | | | 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | | | | | | 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | | | | 122 | C01DX | ostatní vazodilatancia | p.o. | | | | | | | 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | | | | | | | | | | | | | | 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,46 | | | | | | | | | | | | | | 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 2,72 | | | | | | | | | | | | | | 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | | | | 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D | | | | | | 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D | | | | | | 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D | | | | | | 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 7,23 | L/INT, KAR | | | 123 | C01DX | ostatní vazodilatancia | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H | | | | | | | | | | | | | 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H | | | 87732 | CORVATON | inj 10x1ml/2mg | HOE | D | | | | | | 124 | C01EA | prostaglandiny | parent. | X | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3365,32 | X | | | 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | | | | | | 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ | | | | | | 61219 | PROSTIN VR | inj 1x1 ml/0.5mg | UPJ | B | | | | | | 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 661,58 | X | | | 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | | | | | | 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 7,28 | | | | 01328 | DOPEGYT | tbl 50x250mg | EGI | H | | | | | | 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 9,14 | | | | | | | | | | | | | | 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 9,14 | | | | | | | | | | | | | | 125.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.3 | MG | 9,14 | | | | | | | | | | | | | | 125.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.3 | MG | 8,68 | | | | | | | | | | | | | | 125.6 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,56 | | | | 02629 | CRYSTEPIN | drg 30 | LEX | CZ | | | | | | 125.7 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | | | | | | | | | | | | | | 125.8 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,42 | | | | | | | | | | | | | | 125.9 | C02AC06 | rilmenidin | p.o. | 1 | MG | 8,68 | | | | 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H | | | 92074 | CATAPRESAN | inj 5x1ml/0.15mg | BOE | D | | | | | | 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | | | | | | | | | | | | | | 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 12,59 | | | | 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ | | | | | | 58259 | DEPRAZOLIN MITE | tbl 15x1mg | LEX | CZ | | | | | | 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 2,99 | | | | 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | | | | | | 127.4 | C02CA06 | Urapidil | p.o. | 50 | MG | 6,89 | | | | | | | | | | | | | | 127.5 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 20,33 | L/URN | | | | | | | | | | | | | 127.6 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 11,00 | L/URN | | | | | | | | | | | | | 127.7 | C02CA04 | doxazosin - neretardované formy | p.o. | 4 | MG | 18,10 | L/URN | | | 45214 | ZOXON 2 | tbl 30x2mg | LEX | CZ | | | | | | 45215 | ZOXON 4 | tbl 30x4mg | LEX | CZ | | | | | | 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 225,87 | O | | | 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | | | | | | 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | | | | | | 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | | | | 00110 | DIHYDRALAZIN SLOVAKOFARMA | tbl 50x25mg | SLO | SK | | | | | | 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | | | | | | | | | | | | | | 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR | | | 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H | | | | | | | | | | | | | 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,40 | H | | | 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH | | | | | | 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 273,97 | H | | | 131 | C03AA | thiazidová diuretika | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,90 | | | | 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ | | | | | | 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | | | | 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ | | | | | | 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,59 | | | | 83551 | URANDIL | tbl 30x50mg(blistr.) | LEX | CZ | | | | | | 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | | | | | | | | | | | | | | 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | | | | 96696 | INDAP | cps 30x2.5mg | PMP | CZ | | | | | | 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | | | | | | | | | | | | | | 132.6 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | | | | 133 | C03CA | kličková diuretika | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | | | | 98219 | FURON | tbl 50x40mg | MCK | D | | | | | | 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | | | | 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | | | | | | 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40 mg | SLO | SK | | | | | | 97935 | FURSEMID | tbl 100x40mg | BLU | CHO | | | | | | 96328 | FURSEMID | tbl 12x40mg | BLU | CHO | | | | | | 76031 | FURSEMID | tbl 48x40mg | BLU | CHO | | | | | | 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | | | | 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | | | | 56815 | FURORESE 500 | tbl 100x500mg | FST | D | | | | | | 56814 | FURORESE 500 | tbl 50x500mg | FST | D | | | | | | 56812 | FURORESE 250 | tbl 100x250mg | FST | D | | | | | | 56807 | FURORESE 125 | tbl 30x125mg | FST | D | | | | | | 56808 | FURORESE 125 | tbl 50x125mg | FST | D | | | | | | 56809 | FURORESE 125 | tbl 100x125mg | FST | D | | | | | | 56810 | FURORESE 250 | tbl 20x250mg | FST | D | | | | | | 56811 | FURORESE 250 | tbl 50x250mg | FST | D | | | | | | 68632 | FURORESE 500 | tbl 20x500mg | FST | D | | | | | | 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | | | | | | | | | | | | | | 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | | | | 134 | C03CA | kličková diuretika | parent. | O | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 16,28 | O | | | 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | BTA | SK | | | | | | 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,28 | O | | | 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | | | | | | 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O | | | | | | | | | | | | | 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O | | | | | | | | | | | | | 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O | | | 135 | C03D | kalium šetřící diuretika | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | | | | 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH | | | | | | 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH | | | | | | 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | | | | 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | | | | | | 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | | | | 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,17 | | | | 88518 | AMICLOTON | tbl 30 | SLO | SK | | | | | | 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | | | | 83717 | AMILORID HCT AL | tbl 50 | APA | D | | | | | | 83718 | AMILORID HCT AL | tbl 100 | APA | D | | | | | | 76380 | RHEFLUIN | tbl 30 | LEX | CZ | | | | | | 89125 | LORADUR MITE | tbl 50x2.5mg/25mg | MCK | A | | | | | | 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | | | | 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O | | | | | | | | | | | | | 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 83,14 | O | | | 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ | | | | | | 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,44 | | | | | | | | | | | | | | 138.2 | C04AD | etophyllin | p.o. | 0.3 | GM | 1,65 | | | | 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | | | | | | 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 4,57 | | | | | | | | | | | | | | 138.4 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,57 | | | | | | | | | | | | | | 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,90 | | | | 97702 | PENTOMER RETARD 600MG | tbl obd 20x600mg | MCK | D | | | | | | 96180 | AGAPURIN 600 RETARD | tbl obd 20x600mg | SLO | SK | | | | | | 138.6 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 7,10 | | | | 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 30x400mg | APA | D | | | | | | 87661 | AGAPURIN RETARD | tbl obd 20x400mg | SLO | SK | | | | | | 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D | | | | | | 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | | | | | | 92352 | AGAPURIN RETARD | tbl obd 50x400mg | SLO | SK | | | | | | 92353 | AGAPURIN RETARD | tbl obd 100x400mg | SLO | SK | | | | | | 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 139.1 | C04AC | olamini nicotinas | parent. | 0.9 | GM | 20,04 | | | | | | | | | | | | | | 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | | | | 00541 | OXYPHYLLIN | inj 5x2ml | HBS | SK | | | | | | 57351 | OXANTIL | inj 5x2 mg | HBS | SK | | | | | | 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | | | | | | | | | | | | | | 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | | | | 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | | | | | | 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO | | | | | | 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | | | | | | 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,00 | | | | 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ | | | | | | 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | | | | | | | | | | | | | | 140.3 | C04AE51 | hydrogenované ergotové alkaloidy, kombinace | p.o. | 2 | ML | 1,71 | | | | 88088 | ERSILAN | gtt 50ml | GNO | CZ | | | | | | 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 | | | | 00432 | DH-ERGOTOXIN LECIVA | inj 5x1 ml/0.3mg | LEX | CZ | | | | | | 142 | C04AX | jiná periferní vasodilatancia | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,72 | | | | | | | | | | | | | | 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | | | | | | | | | | | | | | 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,72 | | | | | | | | | | | | | | 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,72 | | | | | | | | | | | | | | 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,72 | | | | 97026 | ENELBIN 100 RETARD | tbl ret 50x100mg | LEX | CZ | | | | | | 66015 | ENELBIN 100 RETARD | tbl ret 100x100mg | LEX | CZ | | | | | | 143 | C04AX | jiná periferní vasodilatancia | parent. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | | | | | | | | | | | | | | 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | | | | 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 51,52 | | | | 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | | | | | | 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | | | 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | | | | | | | | | | | 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | | | 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | | | | | | | | | | | 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | | DF | 0,98 | | | | | | | | | | | | | | 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | 00832 | AVIRIL H | ung 1x30gm | LEX | CZ | | | | | | 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 145.1 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | 01966 | KETAZON H | ung 1x20gm 5% | LEX | CZ | | | | | | 145.2 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 146.1 | C05BA | heparin nebo heparinoidy k zevnímu použití | lok. | 1 | GM | 0,83 | | | | | | | | | | | | | | 146.2 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,83 | | | | 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ | | | | | | 146.3 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,83 | | | | 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | | | | | | 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | | | | | | 72931 | THROMBAREDUCT 60000 | ung 1x200gm | AZU | D | | | | | | 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 147.1 | C05CA | bioflavonoidy (hydroxyethylrutosid) | p.o. | 0.9 | GM | 4,50 | | | | | | | | | | | | | | 147.2 | C05CA | bioflavonoidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,37 | | | | 96303 | ASCORUTIN | tbl obd 50 | SLO | SK | | | | | | 147.3 | C05CA | bioflavonoidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | | | | 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ | | | | | | 147.4 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 4,50 | | | | | | | | | | | | | | 147.5 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 6,52 | | | | | | | | | | | | | | 147.6 | C05CA | standardizovaný extrakt gingko biloba v kombinaci | p.o. | 2 | DF | 4,50 | | | | 148 | C05 | jiné kapiláry stabilizující látky | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 148.1 | C05CX | jiné kapiláry stabilizující látky (dobesilat vápenatý) | p.o. | 0.75 | GM | 6,52 | | | | | | | | | | | | | | 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,52 | | | | 94327 | YELLON | cps 30x20mg | SLO | SK | | | | | | 148.3 | C05CX01 | tribenosid | p.o. | 0.6 | GM | 4,50 | | | | 149 | C05 | jiné kapiláry stabilizující látky | parent. | H | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H | | | | | | | | | | | | | 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,71 | O | | | 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | | | | | | 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D | | | | | | 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,91 | O | | | 20034 | AETHOXYSKLEROL 1 % | inj 1x30ml 1% | KRS | D | | | | | | 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D | | | | | | 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,87 | O | | | 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D | | | | | | 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D | | | | | | 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 20,38 | O | | | 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D | | | | | | 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 5,12 | L/KAR,INT | | | 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D | | | | | | 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | | | | | | | | | | | | | | 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,75 | | | | 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK | | | | | | 151.3 | C07AA | | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | | | 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK | | | | | | 151.4 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,74 | | | | | | | | | | | | | | 151.5 | C07AA03 | pindolol | p.o. | 15 | MG | 2,74 | | | | | | | | | | | | | | 151.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,74 | | | | | | | | | | | | | | 151.7 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,74 | | | | | | | | | | | | | | 151.8 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,74 | | | | | | | | | | | | | | 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,30 | | | | 96998 | SANDONORM | tbl 30x1mg | LEX | CZ | | | | | | 151.10 | C07AA23 | Penbutolol | p.o. | 40 | MG | 2,74 | | | | | | | | | | | | | | 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | | | | 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 152.1 | C07AA | metipranolol | parent. | 10 | MG | 68,63 | O | | | 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | | | | | | 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O | | | | | | | | | | | | | 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O | | | | | | | | | | | | | 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O | | | | | | | | | | | | | 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O | | | 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 153.1 | C07AB02 | metoprolol (do 0,05 GM včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | | | | 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | | | | | | 50080 | VASOCARDIN 50 | tbl 50x50mg - blistr | SLO | SK | | | | | | 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | | | | 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | | | | 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H | | | | | | 59893 | EGILOK 100MG | tbl 60x100mg | EGI | H | | | | | | 62491 | METOPROLOL DH 50MG DIAG HUMAN | tbl 100x50mg | GNS | GB | | | | | | 153.2 | C07AB02 | metoprolol (nad 0,05 GM v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | | | | 45555 | BETALOC 100MG | tbl 100x100mg | APN | S | | | | | | 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | | | | | | 62493 | METOPROLOL DH 100MG DIAG HUMAN | tbl 100x100mg | GNS | GB | | | | | | 74958 | METOPROLOL 100 STADA | tbl 20x100mg | STD | D | | | | | | 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | | | | 46980 | BETALOC SR 200 MG | tbl ret 100x200 mg | APN | S | | | | | | 46981 | BETALOC SR 200 MG | tbl ret 30x200 mg | APN | S | | | | | | 153.4 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75 | MG | 3,35 | | | | 62856 | ATENOBENE 50MG | tbl obd 20x50mg | MCK | D | | | | | | 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | | | | | | 72987 | CATENOL 50 | tbl 100x50mg | CAD | IND | | | | | | 83640 | ATEHEXAL 25 | tbl obd 100x25mg | HEX | D | | | | | | 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | | | | | | 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D | | | | | | 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | | | | | | 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | | | | | | 153.5 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75 | MG | 3,10 | | | | 72988 | CATENOL 100 | tbl 100x100mg | CAD | IND | | | | | | 80438 | BETASYN 100 | tbl obd 100x100mg | TRM | D | | | | | | 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D | | | | | | 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | | | | | | 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D | | | | | | 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | | | | | | 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | | | | | | 89769 | BETASYN 100 | tbl obd 30x100mg | TRM | D | | | | | | 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH | | | | | | 62860 | ATENOBENE 100MG | tbl obd 50x100mg | MCK | D | | | | | | 153.6 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,12 | | | | 75939 | ACECOR 400 | tbl obd 30x400mg | SPA | I | | | | | | 153.7 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,12 | | | | | | | | | | | | | | 153.8 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,12 | | | | | | | | | | | | | | 153.9 | C07AB08 | Celiprolol | p.o. | 0.2 | GM | 5,12 | | | | | | | | | | | | | | 153.10 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,12 | | | | 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | O | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O | | | | | | | | | | | | | 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1904,42 | O | | | 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | | | | | | 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O | | | | | | | | | | | | | 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4836,19 | H | | | 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- |

Karvediol je ordinován internistou nebo kardiologem k léčbě srdečního selhání, zejména pokročilých stadií. Karvediol v dávce 6,25 mg je určen pouze k zavedení léčby na dobu nezbytně nutnou a je možno jej předepsat maximálně v množtví 3 balení na pacienta. Cílová dávka karvediolu v této indikaci je 25-50 mg denně. V indikaci léčby hypertense nelze hradit z prostředků zdravotního pojištění.

| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT | | 87669 | TRANDATE | tbl 250x200mg | GLA | GB | | | | | 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 46,00 | P | | | | | | | | | | | 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 21,00 | P | | 156 | C07AG | alfa, beta-blokátory | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1012,92 | H | | 87508 | TRANDATE | inj 5x20ml/100mg | GLA | GB | | | | | 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,40 | | | | | | | | | | | | 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,40 | | | | | | | | | | | | 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,73 | | | 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ | | | | | 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | | | 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 8,50 | | | 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | | | | | 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | | | | | 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 6,50 | | | | | | | | | | | | 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | | | | | | | | | | | | 158.4 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 6,50 | | | | | | | | | | | | 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,56 | | | | | | | | | | | | 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | | | 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO | | | | | 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D | | | | | 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D | | | | | 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | | | | | 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | | | 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D | | | | | 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D | | | | | 65383 | NIFEHEXAL 40 RETARD | tbl obd 30x40mg | HEX | D | | | | | 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,91 | | | | | | | | | | | | 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X | | 94189 | DILCEREN | tbl obd 50x30mg | SLO | SK | | | | | 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 9,09 | | | | | | | | | | | | 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 6,50 | | | 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | | | | | 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | | | | | 69306 | UNIPRES 20 | tbl 20x20mg | KRK | SLO | | | | | 69305 | UNIPRES 10 | tbl 20x10mg | KRK | SLO | | | | | 83082 | LUSOPRESS | tbl 28x20mg | LUS | I | | | | | 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 6,50 | | | | | | | | | | | | 158.13 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR | | 159 | C08CA | antagoniste vápníku dihydropyridinové řady | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3074,59 | H | | 96533 | LOMIR I.V. | inj 5x10ml 0.1 mg/ml | SAN | CH | | | | | 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H | | | | | | | | | | | 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3438,25 | X | | 88858 | NIMOTOP S | inf 1x50ml/10mg | BAY | D | | | | | 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D | | | | | 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 160.1 | C08DA01 | verapamil | p.o. | 0.24 | GM | 5,13 | | | 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | | | 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | | | 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | | | 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | | | 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | | | 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | | | | | 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | | | 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | | | | | 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | | | | | 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | | | | | 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | | | | | 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | | | | | 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | | | | | 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | | | 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | | | 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg) | p.o. | 0.24 | GM | 5,91 | | | 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ | | | | | 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | | | | | 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | | | | | 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | | | 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | | | | | 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,13 | | | 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 317,03 | H | | 09210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO | | | | | 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | | | 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ | | | | | 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ | | | | | 94314 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ | | | | | 93711 | DIACORDIN 90 RETARD | tbl 30x90mg | LEX | CZ | | | | | 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,77 | | | 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ | | | | | 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H | | 99136 | DILZEM PARENTERAL | inj sic 5x100mg+sol | GOD | D | | | | | 93135 | DILZEM PARENTERAL | inj sic 5x25mg+5ml | GOD | D | | | | | 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,52 | | | 31385 | TENSIOMIN 12.5MG | tbl 30x12.5mg | EGI | H | | | | | 47282 | TENSIOMIN 12.5MG | tbl 200x12.5mg | EGI | H | | | | | 49564 | TENSIOMIN 12.5MG | tbl 90x12.5mg | EGI | H | | | | | 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | | | 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | | | | | 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,25 | | | 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H | | | | | 47283 | TENSIOMIN 25MG | tbl 200x25mg | EGI | H | | | | | 49562 | TENSIOMIN 25MG | tbl 90x25mg | EGI | H | | | | | 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND | | | | | 90975 | KATOPIL | tbl 40x25mg | GLN | YU | | | | | 164.3 | C09AA02 | enalapril (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,62 | | | 45273 | ENAP 5 MG | tbl 30x5 mg | KRK | SLO | | | | | 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5 mg | LCM | CZ | | | | | 59916 | ENALAPRIL LACHEMA 5 | tbl 60x5 mg | LCM | CZ | | | | | 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5 mg | LCM | CZ | | | | | 83508 | EDNYT 5 MG | tbl 100x5 mg | GED | H | | | | | 83503 | APO-ENALAPRIL 5 MG | tbl 100x5 mg | APQ | MEX | | | | | 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H | | | | | 83507 | EDNYT 5MG | tbl 28x5mg | GED | H | | | | | 84514 | ACETENSIL 5MG | tbl 10x5mg | ANO | E | | | | | 84515 | ACETENSIL 5MG | tbl 60x5mg | ANO | E | | | | | 164.4 | C09AA02 | enalapril (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,32 | | | 83510 | EDNYT 10 MG | tbl 100x 10 mg | GED | H | | | | | 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | | | 59917 | ENALAPRIL LACHEMA 10 | tbl 60x10mg | LCM | CZ | | | | | 83509 | EDNYT 10MG | tbl 28x10mg | GED | H | | | | | 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ | | | | | 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO | | | | | 45274 | ENAP 10MG | tbl 30x10mg | KRK | SLO | | | | | 164.5 | C09AA02 | enalapril (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 3,40 | | | 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ | | | | | 84516 | ACETENSIL 20MG | tbl 28x20mg | ANO | E | | | | | 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ | | | | | 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | | | | | 45275 | ENAP 20MG | tbl 30x20mg | KRK | SLO | | | | | 59641 | ENAP 20MG | tbl 100x20 | KRK | SLO | | | | | 164.6 | C09AA03 | lisinopril | p.o. | 10 | MG | 7,00 | | | 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY | | | | | 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY | | | | | 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY | | | | | 164.7 | C09AA04 | perindopril | p.o. | 4 | MG | 7,25 | | | | | | | | | | | | 164.8 | C09AA05 | ramipril | p.o. | 2.5 | MG | 7,25 | | | | | | | | | | | | 164.9 | C09AA06 | quinapril | p.o. | 15 | MG | 7,25 | | | | | | | | | | | | 164.10 | C09AA07 | benazepril | p.o. | 7.5 | MG | 7,25 | | | | | | | | | | | | 164.11 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 7,25 | | | | | | | | | | | | 164.12 | C09AA09 | fosinopril | p.o. | 1 | DF | 7,25 | | | | | | | | | | | | 164.13 | C09AA10 | trandolapril | p.o. | 2 | MG | 7,25 | | | | | | | | | | | | 164.14 | C09AA11 | spirapril | p.o. | 6 | MG | 7,25 | | | | | | | | | | | | 164.15 | C09AA12 | delapril | p.o. | 30 | MG | 7,25 | | | | | | | | | | | | 164.16 | C09AA13 | moexipril | p.o. | 15 | MG | 7,25 | | | | | | | | | | | | 164.17 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,00 | | | 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H | | | | | 47284 | TENSIOMIN 50MG | tbl 200x50mg | EGI | H | | | | | 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | | | 90976 | KATOPIL | tbl 40x50mg | GLN | YU | | | | | 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 27,76 | H | | 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | | | | | 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | | | 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 5,22 | | | 55429 | ENAP-HL | tbl 30 | KRK | SLO | | | | | 66506 | ENAP-H | tbl 30 | KRK | SLO | | | | | 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 5,28 | | | | | | | | | | | | 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 5,06 | | | | | | | | | | | | 166.5 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 10,50 | | | | | | | | | | | | 166.6 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 11,10 | | | 167 | C09CA | antagonisté angiotensinu II | p.o. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 22,00 | Z | | | | | | | | | | | 167.2 | C09CA02 | eprosartan | p.o. | 600 | MG | 22,00 | Z | | | | | | | | | | | 167.3 | C09CA03 | valsartan | p.o. | 80 | MG | 22,00 | Z | | 56240 | DIOVAN 160 | cps 28x160mg | NPA | CH | | | | | 167.4 | C09CA04 | irbesartan | p.o. | 150 | MG | 22,00 | Z | | 53657 | APROVEL 300MG | tbl 28x300mg | SWI | F | | | | | 167.5 | C09CA06 | kandesartan | p.o. | 8 | MG | 22,00 | Z | | 53389 | ATACAND 16 MG | tbl 28x16mg | APN | S | | | | | 167.6 | C09CA07 | telmisartan | p.o. | 40 | MG | 22,00 | Z | | | | | | | | | | | 167.7 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 22,40 | Z | | 168 | C10AA | hypolipidemika ze skupiny statinů | po. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:

a) léčba pacientů s familiární hypercholesterolemií,

b) léčba pacientů s manifestní atherosklerózou s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,

c) léčba pacientů s kumulací rizikových faktorů s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,

d) u ostatních pacientů pouze po předchozím schválení revizním lékařem.

| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 18,85 | P | | 59727 | SIMGAL 10MG | tbl obd 28x10mg | GNO | CZ | | | | | 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | | | | | 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 15 | MG | 18,85 | P | | 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | | | | | 59728 | SIMGAL 20MG | tbl obd 28x20mg | GNO | CZ | | | | | 168.3 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě) | p.o. | 15 | MG | 18,85 | P | | 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | | | 59729 | SIMGAL 40MG | tbl obd 28x40mg | GNO | CZ | | | | | 168.4 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 30 | MG | 18,85 | P | | 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | | | | | 45184 | HOLETAR | tbl 20x20mg | KRK | SLO | | | | | 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | | | 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | | | | | 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | | | | | 59800 | LOVACARD 20 | tbl 28x20mg | LEX | CZ | | | | | 168.5 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě) | p.o. | 30 | MG | 17,34 | P | | 59799 | LOVACARD 40 | tbl 28x40mg | LEX | CZ | | | | | 168.6 | C10AA03 p | ravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 20 | MG | 32,33 | P | | | | | | | | | | | 168.7 | C10AA03 p | ravastatin (nad 10 mg v jedné tabletě) | 0.0. | 20 | MG | 26,94 | P | | | | | | | | | | | 168.8 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 40 | MG | 27,26 | P | | | | | | | | | | | 168.9 | C10AA04 f | luvastatin (nad 20 mg v jedné tabletě) | p.o. | 40 | MG | 22,56 | P | | | | | | | | | | | 168.1C | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 10 | MG | 30,48 | P | | | | | | | | | | | 168.11 | C10AA05 | atorvastatin (nad 10 MG v jedné tabletě) | p.o. | 10 | MG | 18,37 | P | | | | | | | | | | | 168.12 | C10AA06 | cerivastatin (do 0,10 MG včetně v jedné tabletě) | p.o. | 0,2 | MG | 32,33 | P | | | | | | | | | | | 168.1: | C10AA06 | cerivastatin (nad 0,10 do 0,20 MG včetně v jedné tabletě) | p.o. | 0,2 | MG | 26,94 | P | | | | | | | | | | | 168.14 | C10AA06 | cerivastatin (nad 0,20 MG v jedné tabletě) | p.o. | 0,2 | MG | 22,79 | P | | 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 4,79 | | | 49609 | DUOLIP FORTE | tbl 100x500mg | MCK | A | | | | | 49608 | DUOLIP FORTE | tbl 30x500mg | MCK | A | | | | | 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 9,34 | | | 21569 | REGADRIN B | drg 50x200mg | BCE | D | | | | | 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 9,34 | | | 53941 | INNOGEM 300MG | cps 100x300mg | EGI | H | | | | | 96574 | GEVILON | tbl obd 30x450mg | LEX | CZ | | | | | 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 8,41 | | | 85813 | LIPANTHYL | cps 50x100mg | FFR | F | | | | | 97669 | LIPANTHYL 100 | cps 50x100mg | LCM | CZ | | | | | 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 11,00 | | | 45295 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | ETP | F | | | | | 45296 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | PLF | H | | | | | 76502 | LIPANTHYL 200 M | cps 30x200mg | FFR | F | | | | | 92327 | LIPANTHYL 200 M | cps 30x200mg | LCM | CZ | | | | | 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 9,34 | | | | | | | | | | | | 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | | | 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:

a) léčba pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,

b) léčba pacientů s pruritem při biliární cirhóze.

| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,77 | P | | 94031 | VASOSAN P | plv 1x400gm | FOP | D | | | | | 94033 | VASOSAN S | plv 1x400gm | FOP | D | | | | | 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P | | 94764 | COLESTID | plv 50x5gm | UPJ | B | | | | | 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,54 | | | 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | | | | | 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | | | 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 172.1 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1 | GM | 1,96 | | | 86262 | CANESTEN | crm 1x20gm | LEX | CZ | | | | | 65484 | CLOTRIMAZOL AL 1 % | crm 1x20gm 1% | APA | D | | | | | 93483 | CLOTRIMAZOLUM POLFA | crm 20gm 1% | POL | PL | | | | | 172.2 | D01AC01 | klotrimazol nad 20 g | lok. | 1 | GM | 1,65 | | | | | | | | | | | | 172.3 | D01AC02 | mikonazol | lok. | | GM | 1,96 | | | | | | | | | | | | 172.4 | D01AC03 | ekonazol lékové formy krému | lok. | | GM | 1,96 | | | | | | | | | | | | 172.5 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1 | GM | 3,52 | | | | | | | | | | | | 172.6 | D01AC05 | isokonazol | lok. | | ML | 1,96 | | | | | | | | | | | | 172.7 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.8 | D01AC10 | bifonazol | lok. | | GM | 2,49 | | | | | | | | | | | | 172.9 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | | | 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ | | | | | 172.10 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.11 | D01AC16 | flutrimazol | lok. | | GM | 5,88 | | | | | | | | | | | | 172.12 | D01AC20 | kombinace | lok. | | GM | 1,96 | | | | | | | | | | | | 172.13 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.14 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 29,33 | P |

Léčbu ordinuje dermatolog u onychomykóz, doložených kultivačním vyšetřením a dokladovanou kontraindikací k použití systémové antimykotické terapie.

172.15	D01AC14	sertakonazol	lok.	1	GM	2,49
172.16	D01AC01	klotrimazol tekuté lékové formy	lok.	1	GM	2,54
173	D01AE	antimykotika pro lokální podání ostatních skupin	lok.
---	---	---	---	---	---	---	---
173.1	D01AE	jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat)	lok.	1	ML	0,83
00799	NITROFUNGIN	liq 1x25ml	GNO	CZ
02772	MYCO-DECIDIN	liq 25ml	GNO	CZ
173.2	D01AE04	kyselina undecylenová	lok.	1	GM	0,93
00871	MYKOSEPTIN	ung 1x30gm	LEX	CZ
173.3	D01AE14	ciclopirox	lok.	1	GM	3,91
06291	BATRAFEN ROZTOK	sol 1x20ml 1%	HOE	D
76150	BATRAFEN	crm 1x20gm	HBS	SK
76152	BATRAFEN	liq 1x20ml	HBS	SK
173.4	D01AE15	terbinafin	lok.	1	GM	3,91

173.5	D01AE16	amorolfin	lok.		GM	3,91

173.6	D01AE18	tolnaftat	lok.	1	GM	1,96

173.7	D01AE19	tolciklát	lok.		GM	1,96

173.8	D01AE20	kombinace antimykotik (tolnaftat/cetrimid)	lok.	1	GM	1,96

173.9	D01AE20	kombinace antimykotik (ostatní kombinace)	lok.		GM	0,64

173.10	D01AE	naftini hydrochlorid	lok.	1	GM	2,93
174	D01BA	antimykotika pro celkové podání	p.o.	P
---	---	---	---	---	---	---	---

Léčbu terbinafinem ordinuje dermatolog:

a) těžké formy dermatomykóz vyvonalých dermatofyty na základě kultivačního nebo mikroskopického vyšetření

b) těžké formy nehtových mykóz, platí-li alespoň jedna z následujících podmínek:

• postižení celé nehtové ploténky

• postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem

• postižení nehtu palce dolní končetiny

Podmínkou zahájení léčby ad b) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.

| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 9,97 | | | 94717 | GRISOVIN | tbl obd 100x125mg | GLA | GB | | | | | 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 66,00 | P | | 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,78 | | | 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ | | | | | 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 176.1 | D02AC91 | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1 | ML | 0,59 | L/DER,PDD | | | | | | | | | | | 176.2 | D02AC91 | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1 | ML | 0,65 | L/DER,PDD | | | | | | | | | | | 176.3 | D02AC91 | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1 | ML | 0,43 | L/DER,PDD | | | | | | | | | | | 176.4 | D02AC91 | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1 | ML | 0,47 | L/DER,PDD | | | | | | | | | | | 176.5 | D02AC91 | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1 | GM | 0,59 | L/DER,PDD | | | | | | | | | | | 176.6 | D02AC91 | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1 | GM | 0,43 | L/DER,PDD | | | | | | | | | | | 176.7 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny -tekuté lékové formy | lok. | 1 | ML | 0,50 | L/DER,PDD | | 97152 | EXCIPIAL U LIPOLOTIO | lot 1x200ml | SEG | CH | | | | | 97153 | EXCIPIAL U HYDROLOTIO | lot 1x200ml | SEG | CH | | | | | 177 | D02AX | jiná emolliencia a protektiva | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,71 | | | 00891 | POLYSAN | pst 1x50gm | SLO | SK | | | | | 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,64 | | | 04192 | POLYSAN | pst 1x650gm | SLO | SK | | | | | 88603 | POLYSAN CUM OLEUM HELIANTI GLO | ung 1x900gm | GAO | CZ | | | | | 177.3 | D03AX92 | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,49 | | | | | | | | | | | | 177.4 | D03AX02 | dextranomer | lok. | 1 | GM | 3,91 | | | | | | | | | | | | 177.5 | D03AX91 | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1 | GM | 15,40 | | | 93561 | SYSTOGEN | plv.ads.1x20GM | IHO | CZ | | | | | 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1 | GM | 1,42 | | | | | | | | | | | | 177.7 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1 | ML | 3,91 | | | 178 | D03BA | proteolytické enzymy | lok. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje chirurg, ortoped, gynekolog, otorhinolaryngolog nebo dermatolog:

a) léčba bércových vředů,

b) léčba nekrotických poúrazových nebo pooperačních ran,

c) ošetřování nekrotických ran a dekubitů.

178.1	D03BA	proteolytické enzymy (chymotrypsin)	lok.	1	GM	79,28	P
178.2	D03BA	proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně)	lok.	1	GM	18,57	P

178.3	D03BA	proteolytické enzymy (plasmin/deoxiribonukleáza)	lok.	1	GM	13,69	P
42261	FIBROLAN	ung 1x100gm	PDA	D
42262	FIBROLAN	ung 1x25gm	PDA	D
62518	FIBROLAN	ung 1x50gm	PDA	D
178.4	D03BA	proteolytické enzymy (trypsin/chymotrypsin)	lok.	1	GM	28,84	P

178.5	D03BA	proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení)	lok.	1	GM	16,62	P

178.6	D04AB01	lidokain (lékové formy spreje, koncentrace 10%)	lok.	1	GM	2,10	O
179	D05AA	antipsoriatika ze skupiny dehtů a derivátů vitaminu D	lok.
---	---	---	---	---	---	---	---

Léčbu deriváty vitaminu D v lokálních lékových formách ordinuje dermatolog:

a) léčba torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.

b) v ostatních případech pouze po schválení revizním lékařem zdravotní pojišťovny.

179.1	D05AA	dehty (odbarvený dehet)	lok.	1	GM	1,17
179.2	D05AA	dehty	lok.	1	GM	0,73
00889	PITYOL	ung 1x30gm	LEX	CZ
66262	SALOXYL	ung 1x30gm	HEO	CZ
66502	ICHTOXYL	ung 1x30gm	HEO	CZ
85950	SUSPENSIO VISNEVSKI+PICE LIQUID	sus 1x1000gm	HEO	CZ
179.3	D05AD02	methoxalen (0,15 % koncentrace)	lok.	1	ML	4,30
90618	OXSORALEN	liq 1x50ml 0.15%	GER	A
179.4	D05AC01	dithranol	lok.	1	GM	3,91

179.5	D05AX02	kalcipotriol	lok.	1	GM	11,00	P

179.6	D05AX04	tacalcitol	lok.	1	GM	18,00	P
180	D05BB	retinoidy pro celkové podání	p.o.	P
---	---	---	---	---	---	---	---

Léčbu ordinuje dermatolog:

a) léčba těžkých generalizovaných forem psoriázy nereagujících na jinou léčbu,

b) ostatní těžké formy poruchy keratinizace nereagující na jinou léčbu pouze po předchozím schválení revizním lékařem

c) kožní T-lymfomy

180.1	D05BB01	etretinát	p.o.	35	MG	81,14	P
180.2	D05BB02	acitretin	p.o.	35	MG	81,14	P

180.3	D05BA02	methoxalen	p.o.	10	MG	4,06	L/DER
03733	OXSORALEN	cps 50x10mg	GER	A
181	D06AX	antibiotika k zevnímu použití	lok.
---	---	---	---	---	---	---	---
181.1	D06AA	tetracyklin a deriváty	lok.	1	GM	2,93

181.2	D06AX	neomycin/bacitracin (k přípravě roztoku)	lok.	1	ML	3,91
55759	PAMYCON NA PRIPRAVU KAPEK	plv 1x1lahv	BTA	SK
181.3	D06AX	neomycin/bacitracin (zásyp do 2 g včetně)	lok.	1	GM	13,69
01062	FRAMYKOIN	plv ads 1x2gm	IHO	CZ
181.4	D06AX	neomycin/bacitracin (zásyp nad 2 do 5 g v jednom balení včetně)	lok.	1	GM	7,63
44894	FRAMYKOIN	plv ads 1x5gm	IHO	CZ
181.5	D06AX	neomycin/bacitracin (mast)	lok.	1	GM	2,93
01066	FRAMYKOIN	ung 1x10gm	LEX	CZ
181.6	D06AX	primycin	lok.	1	GM	2,44

181.7	D06AX02	chloramfenikol	lok.		GM	2,88

181.8	D06AX09	mupirocin (do 5 g v jednom balení včetně)	lok.	1	GM	8,31

181.9	D06AX09	mupirocin (nad 5 g v jednom balení)	lok.		GM	5,18

181.10	D06AX	neomycin/bacitracin (zásyp nad 5 g v jednom balení)	lok.	1	GM	2,44
01063	FRAMYKOIN	plv ads 1x20gm	IHO	CZ
182	D06BA	sulfonamidy s obsahem stříbrných solí k lokálnímu podání	lok.	L/DER,CHI
---	---	---	---	---	---	---	---
182.1	D06BA	sulfathiazin stříbrný (do 50 g v jednom balení včetně)	lok.	1	GM	1,08	L/DER,CH1

182.2	D06BA	sulfathiazin stříbrný (nad 50 g v jednom balení)	lok.	1	GM	0,98	L/DER,CHI

182.3	D06BA01	sulfadiazin stříbrný (do 50 g v jednom balení včetně)	lok.	1	GM	1,32	L/DER,CHI
62229	DERMAZIN	crm 1x50gm 1%	LEK	SLO
182.4	D06BA01	sulfadiazin stříbrný (nad 50 g v jednom balení)	lok.	1	GM	1,12	L/DER,CHI

182.5	D06BA02	sulfathiazol	lok.	1	GM	1,03
00899	SULFATHIAZOL NEO-SLOVAKOFARMA	ung 1x20gm 5%	SLO	SK
182.6	D06BA03	mafenid	lok.	1	GM	0,98	L/DER,CHI

182.7	D06BA51	sulfadiazin stříbrný v kombinaci (léková forma náplasti) lok.	100	CM2	13,49	L/DER,CHI

182.8	D06BA51	sulfadiazin stříbrný v kombinaci (léková forma krému)	lok.	1	GM	2,25	L/DER,CHI
183	D07AA	kortikosteroidy třídy I, slabě účinné	lok.
---	---	---	---	---	---	---	---
183.1	D07AA02	hydrokortison	lok.	1	GM	3,16
00858	HYDROCORTISON LECIVA	ung 1x10gm 1%	LEX	CZ
183.2	D07AA03	Prednisolon	lok.	1	GM	3,32
184	D07AB	kortikosteroidy třídy II, středně účinné	lok.
---	---	---	---	---	---	---	---
184.1	D07AB01	klobetazon	lok.	1	GM	3,32

184.2	D07AB02	hydrokortison butyrát	lok.	1	GM	3,32
09310	LOCOID 0.1%	ung 1x30gm 0.1%	YEU	NL
09305	LOCOID 0.1%	crm 1x30gm 0.1%	YEU	NL
09307	LOCOID 0.1% LOTION	lot 1x30ml	YEU	NL
62047	LOCOID LIPOCREAM	crm 1x30gm 0.1%	YEU	NL
184.3	D07AB03	flumetason	lok.	1	GM	3,32

184.4	D07AB07	flupredniden	lok.	1	GM	3,32

184.5	D07AB09	triamcinolon (lékové formy mastí a krémů)	lok.	1	GM	2,44
02828	TRIAMCINOLON LECIVA	crm 1x10gm 0.1%	LEX	CZ
02829	TRIAMCINOLON LECIVA	ung 1x10gm 0.1%	LEX	CZ
184.6	D07AB09	triamcinolon (lékové formy lotia)	lok.	1	ML	2,83
02826	TRIAMCINOLON	lot 1x15gm	GNO	CZ
66167	TRIAMCINOLON-GALENA	lot 1x30gm	GNO	CZ
184.7	D07AB09	triamcinolon (lékové formy spreje)	lok.	1	GM	0,73

184.8	D07AB09	triamcinolon (lékové formy tinktury)	lok.	1	ML	0,98

184.9	D07AB19	dexamethason acetát	lok.	1	GM	3,09
02415	DEXAMETHAZON LECIVA	crm 10gm 0.01%	LEX	CZ
01965	DEXAMETHAZON LECIVA	ung 1x10gm 0.025%	LEX	CZ
185	D07AC	kortikosteroidy třídy III, účinné (fluorované)	lok.
185.1	D07AC01	betamethason dipropionát	lok.	1	GM	2,49
80204	BELODERM	ung 1x30gm 0.05%	BLU	CHO
80206	BELODERM	crm 1x30gm 0.05%	BLU	CHO
88489	KUTERID	crm 20gm	LEK	SLO
88495	KUTERID	ung 20gm	LEK	SLO
98032	DIPROSONE	ung 1x30gm	SCH	B
98034	DIPROSONE	crm 1x30gm	SCH	B
185.2	D07AC01	betamethason valerát	lok.	1	GM	3,32

185.3	D07AC02	fluklorolon	lok.	1	GM	3,32

185.4	D07AC04	fluocinolon gel	lok.	1	GM	2,44
04156	GELARGIN	gel 1x25gm	LEX	CZ
185.5	D07AC04	fluocinolon mast a krém (koncentrace do 0,025% včetně)	lok.	1	GM	2,93
92285	GELARGIN	ung 1x20gm/5mg	LEX	CZ
185.6	D07AC04	fluocinolon mast a krém (koncentrace nad 0,025%)	lok.	1	GM	3,91
92286	GELARGIN FORTE UNG	ung 1x20gm/40mg	LEX	CZ
185.7	D07AC04	fluocinolon lotio (koncentrace do 0,025% včetně)	lok.	1	GM	2,93

185.8	D07AC04	fluocinolon lotio (koncentrace nad 0,025%)	lok.	1	GM	3,91
44743	GELARGIN FORTE LOT	lot1x50GM/100MG	LEX	CZ
185.9	D07AC06	diflukortolon	lok.	1	GM	3,42

185.10	D07AC08	fluocinonid	lok.	1	GM	2,93

185.11	D07AC12	halometason	lok.	1	GM	3,27

185.12	D07AC17	flutikason	lok.	1	GM	3,42
186	D07AC	kortikosteroidy třídy III, účinné (nefluorované)	lok.	L/DER,ALG,PDD
---	---	---	---	---	---	---	---
186.1	D07AC09	budesonid	lok.	1	GM	3,18

186.2	D07AC13	mometazon do 10g v 1 balení včetně	lok.	1	GM	6,70	L/DER,ALG, PDD

186.3	D07AC13	mometazon nad 10g v jednom balení	lok.	1	GM	5,00	L/DER,ALG, PDD

186.4	D07AC14	methylprednisoni aceponas	lok.	1	GM	5,87	L/DER,ALG, PDD

186.5	D07AC18	prednikarbat (do 10 g v 1 balení včetně)	lok.	1	GM	6,70	L/DER,ALG, PDD
83154	DERMATOP	crm 1x10gm 2.5mg/gm	HBS	SK
83156	DERMATOP	ung 1x10gm 2.5mg/gm	HBS	SK
186.6	D07AC18	prednikarbat (nad 10 g v 1 balení)	lok.	1	GM	5,87	L/DER,ALG, PDD
187	D07AD	kortikosteroidy třídy IV, vysoce účinné	lok.	L/DER
---	---	---	---	---	---	---	---
187.1	D07AD01	klobetasol	lok.	1	GM	4,40	L/DER

187.2	D07AD02	halcinonid	lok.	1	ML	4,64	L/DER
97019	BETACORTON	liq 1x25ml	SEG	CH
97020	BETACORTON	liq 1x100ml	SEG	CH
188	D07BB	kortikosteroidy, středně účinné, kombinace s antiseptiky	lok.
---	---	---	---	---	---	---	---
188.1	D07BA01	prednisolon/cloroxin	lok.	1	GM	1,96

188.2	D07BB01	flumetason a antiseptika	lok.	1	GM	3,32
03405	LORINDEN C	ung 15gm	POL	PL
188.3	D07BB03	triamcinolon a antiseptika (lékové formy pěny)	lok.	1	GM	1,42
02975	TRIAMCINOLON	spm 40gm	GNO	CZ
188.4	D07BB03	triamcinolon a antiseptika (lékové formy spreje)	lok.	1	GM	0,59

188.5	D07BB03	triamcinolon a antiseptika (lékové formy tinktury)	lok.	1	ML	1,47
02827	TRIAMCINOLON	tct 1x10ml	GNO	CZ
188.6	D07BB03	triamcinolon a antiseptika (lékové formy mastí a krémů)	lok.	1	GM	1,81
04178	TRIAMCINOLON E LECIVA	ung 1x20gm	LEX	CZ
188.7	D07BA01	prednisolon/hexamidin diisothionát	lok.	1	GM	1,96

188.8	D07CC01	betamethason a gentamycin	lok.	1	GM	2,50	L/DER
189	D07X	kortikosteroidy, jiné kombinace	lok.
---	---	---	---	---	---	---	---
189.1	D07XA01	hydrokortison	lok.	1	ML	1,96

189.2	D07XA02	prednisolon/kyselina salicylová	lok.	1	ML	1,32

189.3	D07XB01	flumetason/dehet	lok.	1	GM	4,40
09297	LOCACORTEN TAR	ung 1x60gm	CGC	CH
189.4	D07XB01	flumethason pivalat/kyselina salicylová	lok.	1	GM	2,93

189.5	D07XB02	triamcinolon	lok.	1	GM	1,81
04160	TRIAMCINOLON S LECIVA	ung 1x30gm	LEX	CZ
189.6	D07XC	diflucortolon/isoconasol	lok.	1	GM	2,69

189.7	D07XC01	betamethason (lékové formy mastí a krémů)	lok.	1	GM	2,69
85864	BELOSALIC	ung 1x30gm	BLU	CHO
189.8	D07XC01	betamethason (lékové formy tinktur)	lok.	1	ML	2,69

189.9	D07XD	halcinonid/kyselina salicylová	lok.	1	ML	3,57

189.10	D07XD	halcinonid/močovina	lok.	1	GM	3,57

189.11	D07CA01	hydrocortison a antibiotika (lékové formy mastí a krémů)	lok.	1	GM	1,96

189.12	D07CA01	hydrocortison a antibiotika (tekuté lékové formy)	lok.	1	ML	1,96
190	D08A	antiseptika a desinficiencia	lok.
---	---	---	---	---	---	---	---
190.1	D08AC02	chlorhexidin	lok.	1000	ML	178,70

190.2	D08AD	kyselina boritá (lékové formy mastí)	lok.	1	GM	0,68

190.3	D08AD	kyselina boritá (lékové formy roztoků)	lok.	10	GM	1,32

190.4	D08AG02	polyvidon-jód (do 200 ml včetně roztoku v jednom balení)	lok.	1	ML	0,98
62318	BETADINE (CHIRURG.)	liq 1x120ml	EGI	H
02981	JODISOL ROZTOK	liq 1x80gm	LDN	CZ
96605	JODISOL SPRAY S MECH.ROZPRASOV.	spr 1x75gm	LDN	CZ
46054	BRAUNOL 2000	liq 1x100ml	BMB	CH
190.5	D08AG02	polyvidon-jód (nad 200 ml roztoku v jednom balení)	lok.	1	ML	0,49
02983	JODISOL ROZTOK	liq 1x760gm	LDN	CZ
80553	BRAUNOL 2000	liq 1x1000ml	BMB	CH
46056	BRAUNOL 2000	liq 1x500ml	BMB	CH
62319	BETADINE (CHIRURG.)	liq 1x1000ml	EGI	H
62317	BETADINE	liq 1x1000ml	EGI	H
190.6	D08AG02	polyvidon-jód (do 200 g masti v jednom balení včetně)	lok.	1	GM	1,96
84421	BRAUNOVIDON MAST	ung 100gm (pe tuba)	BMB	CH
190.7	D08AG02	polyvidon-jód nad 200 g masti v jednom balení)	lok.	1	GM	0,98
46052	BRAUNOVIDON MAST	ung 250gm (pe nad.)	BMB	CH
84422	BRAUNOVIDON MAST	ung 250gm (pe tuba)	BMB	CH
190.8	D08AH	kloroxin	lok.	1	GM	0,78
03008	ENDIARON	pst 1 x30gm 5%	LEX	CZ
190.9	D08AJ	bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně)	lok.	1	ML	0,29
00739	AJATIN TINCTURA	tct 1x50ml 1%	SLO	SK
190.10	D08AJ	bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení)	lok.	1	ML	0,29	H

190.11	D08AJ	chlorid karbetopendecinia (tinktura 50 ml v jednom balení včetně)	lok.	1	ML	0,29
191	D08AX	jiná antiseptika a desinficiencia	lok.	H
---	---	---	---	---	---	---	---
191.1	D08AX	hexamidin/chlorhexidin	lok.	1	ML	121,37	H

191.2	D08AX	noxytiolin	lok.	2.5	GM	492,11	H

191.3	D08AX	noxytiolin/tetrakain	lok.	2.5	GM	492,11	H

191.4	D08AX	taurolidin	lok.	1	GM	94,48	H
93242	TAUROLIN	gel 1x50gm/1.75gm	GSO	CH
192	D10A	lokálně podávaná léčiva k léčbě akne	lok.
---	---	---	---	---	---	---	---
192.1	D10AD01	tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně)	lok.	1	GM	3,96
98205	LOCACID	crm 1x30gm 0.05%	PFB	F
97573	RETIN A	crm 1x30gm 0.025%	CIL	CH
03740	RETIN A	crm 1x30gm 0.05%	CIL	CH
192.2	D10AD01	tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%)	lok.	1	GM	4,40

192.3	D10AD01	tretinoin (lékové formy roztoků do koncentrace 0,05% včetně)	lok.	1	ML	4,11

192.4	D10AD01	tretinoin (lékové formy roztoků koncentrace nad 0,05%)	lok.	1 ML	4,40

192.5	D10AE01	benzoyl peroxid (lékové formy krémů a gelů)	lok.	1	GM	1,42
86754	ANTOPAR	gel 30gm 5%	LEK	SLO
192.6	D10AE01	benzoyl peroxid (lékové formy roztoků a lotií)	lok.	1	ML	0,39
91816	INOXITAN	lot 100ml 50mg/ml	GNO	CZ
192.7	D10AE01	benzoyl peroxid (koncentrace 20%)	lok.	1	ML	2,54

192.8	D10AF01	klindamycin	lok.	1	ML	1,96

192.9	D10AF02	erythromycin (lékové formy krémů a mastí)	lok.	1	GM	2,93

192.10	D10AF02	erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení	lok.	1	ML	2,25
98204	ERYFLUID	sol 1x30ml	PFB	F
192.11	D10AF52	erythromycin v kombinaci	lok.	1	ML	2,93

192.12	D10AX03	kyselina azelaová	lok.	1	GM	1,96

192.13	D10AF02	erythromycin (lékové formy roztoků) nad 60 ml v jednom balení	lok.	1	ML	1,81
75285	ERYFLUID	sol 1x100ml	PFB	F
193	D10B	celkově podávaná léčiva k léčbě akné	p.o.	X
---	---	---	---	---	---	---	---
193.1	D10BA01	isotretinoin (do 10 MG včetně v jedné kapsli )	p.o.	30	MG	92,82	X
11685	ROACCUTANE ROCHE	cps 30x10mg	HLR	CH
193.2	D10BA01	isotretinoin (nad 10 MG v jedné kapsli)	p.o.	30	MG	83,77	X
194	D11AX	jiná dermatologika	lok.	L/DER
---	---	---	---	---	---	---	---
194.1	D11AX	celulóza (lékové formy zásypů)	lok.	1	GM	9,78	L/DER

194.2	D11AX	fluorouracil (lékové formy roztoků)	lok.	1	ML	17,25	L/DER
60890	VERRUMAL	liq 1x13ml	HEM	D
194.3	D11AX	fluorouracil (lékové formy mastí)	lok.	1	GM	13,15	L/DER,ONK
195	G01AA	vaginálně podávaná antimykotika a antibiotika	vag.
---	---	---	---	---	---	---	---

Léčbu vaginálním clindamycinem ordinuje gynekolog:

a) léčba bakteriální vaginózy v těhotenství,

b) vaginitis s průkazem citlivosti bakteriálních kmenů na clindamycin.

195.1	G01AA01	nystatin	vag.	100	KU	0,98
195.2	G01AA02	natamycin (lékové formy s obsahem méně než 100 mg)	vag.	25	MG	4,11

195.3	G01AA02	natamycin (lékové formy s obsahem 100 mg)	vag.	25	MG	7,14
78213	PIMAFUCIN	glo vag 3x100mg	YEU	NL
195.4	G01AA10	klindamycin (lékové formy krémů)	vag.	1	GM	11,00	P

195.5	G01AA	neomycin/polymyxin/nystatin	vag.	1	DF	10,90
196	G01AF	vaginálně podávané imidazolové deriváty	vag.
---	---	---	---	---	---	---	---
196.1	G01AF	deriváty imidazolu	vag.	0.1	GM	6,35

196.2	G01AF01	metronidazol	vag.	0.5	GM	3,71
02430	ENTIZOL	tbl vag 10x500mg	POL	PL
66787	MEDAZOL	tbl vag 10	BLU	CHO
196.3	G01AF02	klotrimazol (lékové formy vaginálních tablet)	vag.	0.1	GM	8,70
62862	CANDIBENE 100MG	tbl vag 6x100mg	MCK	D
62863	CANDIBENE 200MG	tbl vag 3x200mg	MCK	D
65483	CLOTRIMAZOL AL 100	tbl vag 6x100mg+apl	HHC	D
66549	CLOTRIMAZOL AL 200	tbl vag 3x200mg+apl	HHC	D
93484	CLOTRIMAZOLUM POLFA	tbl vag 6x100mg	POL	PL
196.4	G01AF02	klotrimazol (lékové formy vaginálních krémů)	vag.	0.1	GM	13,39
68917	JENAMAZOL 2%	crm vag 20gm+aplik.	VJP	D
196.5	G01AF04	mikonazol	vag.	0.1	GM	8,70

196.6	G01AF05	ekonazol (lékové formy vaginálních krémů)	vag.	0.1	GM	13,39

196.7	G01AF05	ekonazol (lékové formy vaginálních tablet, globuli a čípků)	vag.	0.1	GM	31,58
06095	GYNO-PEVARYL 50	glo vag 15x50mg	CIL	CH
196.8	G01AF11	ketoconazol	vag.	0.4	GM	13,44

196.9	G01AF12	fenticonazol	vag.	0.1	GM	13,44

196.10	G01AF17	oxikonazol	vag.	0.6	GM	109,90
99250	GYNO-MYFUNGAR	tbl vag 1x600mg	LEX	CZ
196.11	G01AG02	terkonazol (lékové formy vaginálních krémů)	vag.	80	MG	13,49

196.12	G01AG02	terkonazol (lékové formy vaginálních tablet)	vag.	80	MG	31,28
197	G01AX	vaginálně podávaná jiná antiinfektiva a antiseptika	vag.
---	---	---	---	---	---	---	---
197.1	G01AX	laktobacillus	vag.	1	DF	10,26

197.2	G01AX	nifuratel/nystatin (lékové formy vaginálních čípků)	vag.	1	DF	17,60

197.3	G01AX	nifuratel/nystatin (lékové formy vaginálních krémů)	vag.	5	GM	35,19

197.4	G01AX	nitrofurantoin	vag.	0.2	GM	2,64
03629	FURANTOIN LECIVA	tbl vag 30x100mg	LEX	CZ
197.5	G01AX	polykresol	vag.	1	GM	1,42
41965	VAGOTHYL	sol 1x50gm	POL	PL
197.6	G01AX05	nifuratel	p.o.	0.6	GM	15,64	L/GYN,URN

197.7	G01AX11	polyvidon-jód (vaginální čípky)	vag.	0.2	GM	8,94
62321	BETADINE	sup vag 14	EGI	H
197.8	G01AX11	polyvidon-jód (vaginální gel)	vag.	0.2	GM	6,16

197.9	G01AX12	ciklopirox (vaginální krém - do 40 GM včetně v jednom balení)	vag.	1	GM	4,69

197.10	G01AX	sulfathiazol	vag.	1	DF	6,60

197.11	G01AX	jiná antiinfektiva a antiseptika (tetraboritan sodný)	vag.	1	DF	6,40

197.12	G01AX12	ciclopirox (vaginální roztok)	vag.	1	DF	17,60

197.13	G01AX12	ciclopirox (vaginální čípky)	vag.	1	DF	31,28

197.14	G01AX12	ciklopirox (vaginální krém - nad 40 GM v jednom balení)	vag.	1	GM	3,11

197.15	G01AX14	laktobacilus a estriol - vaginální tablety	vag.	1	DF	16,13

197.16	G02CC03	benzydamin hydrochlorid	vag.	1	DF	8,00
198	G02AB	uterotonika ze skupiny námelových alkaloidů	p.o.
---	---	---	---	---	---	---	---
198.1	G02AB02	ergotové alkaloidy	p.o.	0.2	MG	1,12

198.2	G02AB03	ergometrin	p.o.	0.2	MG	1,12
199	G02AB	uterotonika ze skupiny námelových alkaloidů	parent.
---	---	---	---	---	---	---	---
199.1	G02AB01	methylergometrin	parent.	0.2	MG	17,21
00509	METHYLERGOMETRIN SPOFA	inj 5x1 ml/0.2mg	SPX	CZ
199.2	G02AB03	ergometrin	parent.	0.2	MG	9,38
200	G02AD	uterotonika ze skupiny prostaglandinů	p.o.	H
---	---	---	---	---	---	---	---
200.1	G02AD02	dinoproston	p.o.	0.5	MG	95,31	H
86287	PROSTIN E2	tbl 10x0.5mg	UPJ	GB
201	G02AD	uterotonika ze skupiny prostaglandinů	vag.	K/P
---	---	---	---	---	---	---	---

Léčbu ordinuje gynekolog:

a) preindukce porodu při ukončení těhotenství,

b) indukce potratu do 24 týdne těhotenství z genetických důvodů,

c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,

d) v poporodním období při závažné metrorhagii.

| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 974,55 | K/P | | 91643 | PREPIDIL | gel vag 3gm/0.5mg | UPJ | B | | | | | 201.2 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 416,94 | K/P | | | | | | | | | | | 201.3 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P | | 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje gynekolog:

a) preindukce porodu při ukončení těhotenství,

b) indukce potratu do 24 týdne těhotenství z genetických důvodů,

c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,

d) v poporodním období při závažné metrorhagii.

202.1	G02AD01	dinoprost	parent.	25	MG	651,85	K/P
202.2	G02AD02	dinoproston	parent.	0.5	MG	389,86	K/P
67188	PROSTIN E2 SS 1MG/ML	inj 1x0.75ml	UPJ	B
67189	PROSTIN E2 SS 10MG/ML	inj 1x0.5ml	UPJ	B
202.3	G02AD04	karboprost	parent.	0.25	MG	675,61	K/P

202.4	G02AD05	sulproston	parent.	0.5	MG	651,85	K/P
203	G02CA	tokotytika ze skupiny beta-sympatomimetik	p.o.	P
---	---	---	---	---	---	---	---

Léčbu ordinuje gynekolog:

pouze jako pokračování parenterální aplikace tokolytik.

| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,80 | P | | 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | | | | | 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,66 | P | | | | | | | | | | | 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,66 | P | | 21391 | PARTUSISTEN | tbl 50x5mg | BOE | D | | | | | 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje gynekolog:

a) zahájení tokolytické léčby po 20. týdnu těhotenství,

b) léčba porodní dystokie,

c) intrapartální akutní tokolýza.

| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P | | 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | | | 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A | | | | | 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | | | | | 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P | | | | | | | | | | | 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P | | 205 | G02CB | inhibitory prolaktinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 205.1 | G02CB | tergurid | p.o. | 1 | MG | 5,46 | | | 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | | | | | 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 14,22 | | | 67512 | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY | | | | | 67514 | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY | | | | | 97673 | SEROCRYPTIN | tbl 30x2.5mg | SRO | I | | | | | 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | | | | | | | | | | | | 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,08 | Z | | | | | | | | | | | 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,08 | Z | | 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK, GYN, SEX,URN | | | | | | | | | | | 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK, GYN, SEX,URN | | 09591 | PROVIRON 25 | tbl 20x25mg | SAG | D | | | | | 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D | | | | | 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK, GYN, SEX,URN | | 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK | | | | | 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Estradiol, léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:

a) substituční léčba žen po předčasné menopauze,

b) léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.

Estriol, léčbu ordinuje gynekolog, urolog, sexuolog nebo endokrinolog:

léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.

208.1	G03CA	přirozené a semisyntetické estrogeny prosté, mestranol	p.o.	0.15	MG	3,76	P
208.2	G03CA57	přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce)	p.o.	625	RG	6,00	P
42200	PREMARIN 0.625MG	tbl obd 1x28	WYM	IRL
53298	PREMARIN 0.625MG	tbl obd 3x28	WYM	IRL
83387	OESTROFEMINAL 0.6	cps 21x0.6mg	MAC	D
208.3	G03CA03	estradiol (do 1 mg v jedné tabletě včetně)	p.o.	2	MG	9,00	P

208.4	G03CA03	estradiol (nad 1 mg do 2 mg v jedné tabletě včetně)	p.o.	2	MG	6,00	P

208.5	G03CA03	estradiol (nad 2 mg v jedné tabletě)	p.o.	2	MG	4,40	P

208.6	G03CA03	estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu)	transd.	50	RG	4,40	P

208.7	G03CA03	estradiol (s uvolněním od 50 do 99 RG včetně /den, v rámci 28. denního cyklu)	transd.	50	RG	6,00	P

208.8	G03CA03	estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu)	transd.	50	RG	9,00	P

208.9	G03CA03	estradiol (lékové formy gelů)	transd.	1,5	MG	5,87	P
76922	OESTROGEL	gel 1x80gm	LBE	F
208.10	G03CA03	estradiol	vag.	25	RG	5,87	P

208.11	G03CA04	estriol	p.o.	2	MG	6,00	P
31315	OVESTIN	tbl 30x2mg	ORG	NL
208.12	G03CA04	estriol (lékové formy vaginálních krémů)	vag.	0.2	MG	3,08	P
97170	OVESTIN	crm 15gm+aplikator	ORG	NL
98182	OVESTIN	crm vag 1x 15gm+aplikator	ORG	IRL
208.13	G03CA04	estriol (lékové formy vaginálních tablet, do 0,5 mg včetně)	vag.	0.2	MG	5,87	P

208.14	G03CA04	estriol (lékové formy vaginálních tablet, nad 0,5 mg)	vag.	0.2	MG	1,22	P
53300	PREMARIN 1.25MG	tbl obd 3x28	WYM	IRL
208.15	G03CA57	přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce)	p.o.	625	RG	4,34	P
09467	OESTROFEMINAL 1.25	cps 21x1.25mg	MAC	D
208.16	G03CA03	estradiol (lékové formy vaginálních krémů)	vag.	0.2	MG	3,08	P
209	G03CA	přirozené a semisyntetické estrogeny	parent.
---	---	---	---	---	---	---	---
209.1	G03CA03	estradiol	parent.	1	MG	4,35
00364	AGOFOLLIN	inj 5x1ml/5mg	BTA	SK
00365	AGOFOLLIN-DEPOT	inj 1x2ml/10mg	BTA	SK
56188	AGOFOLLIN DEPOT	inj 5x2ml/10mg	BTA	SK
209.2	G03CA03	estradiol valerat	parent.	1	MG	2,40
00529	NEOFOLLIN	inj 5x1ml/5mg	BTA	SK
209.3	G03CA03	estradiol implantát	parent.	1	DF	1095,00

209.4	G03CA04	estriol	parent.	2	MG	4,30
210	G03D	progestiny	p.o.	L/GYN,URN,END,INT, SEX
---	---	---	---	---	---	---	---
210.1	G03DA02	medroxyprogesteron	p.o.	5	MG	3,62	L/GYN,URN, END, INT,SEX

210.2	G03DA04	progesteron	p.o.	0.3	GM	17,40	L/GYN,URN, END, INT,SEX

210.3	G03DB01	dydrogesteron	p.o.	10	MG	3,81	L/GYN,URN, END, INT,SEX

210.4	G03DC02	norethisteron	p.o.	5	MG	2,88	L/GYN,URN, END, INT,SEX
01939	NORETHISTERON SLOVAKOFARMA	tbl 30x5mg	SLO	SK
210.5	G03DC03	lynestrenol	p.o.	5	MG	2,88	L/GYN,URN, END, INT,SEX

210.6	G03DC05	tibolon	p.o.	2.5	MG	18,00	P

Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.

211	G03D	progestiny	parent.	L/GYN,URN,SEX
211.1	G03DA03	hydroxyprogesteron	parent.	10	MG	1,76	L/GYN,URN, SEX
00531	NEOLUTIN FORTE	inj 5x1 ml/125mg	SPX	CZ
211.2	G03DA04	progesteron (depotní lékové formy)	parent.	5	MG	4,01	L/GYN,URN, SEX
00367	AGOLUTIN-DEPOT	inj 1x2ml/50mg	BTA	SK
211.3	G03DA04	progesteron	parent.	5	MG	1,08	L/GYN,URN, SEX
02094	AGOLUTIN	inj 5x2ml/60mg	BTA	SK
212	G03E	androgeny a ženské pohlavní hormony	parent.	L/GYN,END,SEX
---	---	---	---	---	---	---	---
212.1	G03EA02	testosteron a estrogen	parent.	1	DF	22,34	L/GYN,END, SEX
00464	FOLIVIRIN	inj 5x2ml	BTA	SK
212.2	G03EA03	prasteron enantat/estradiol valerat	parent.	1	DF	73,32	L/GYN,END, SEX
213	G03F	progestiny a estrogeny	p.o.	P
---	---	---	---	---	---	---	---

Léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:

léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.

213.1	G03FA01	norethisteron a estrogen, fixní kombinace s obsahem 2 MG estradiolu v jedné tabletě	p.o.	1	DF	6,84	P
213.2	G03FA01	norethisteron a estrogen, fixní kombinace s obsahem 1 MG estradiolu v jedné tabletě	p.o.	1	DF	5,50	P

213.3	G03FA01	norethisteron a estrogen, fixní kombinace	transd.	50	RG	6,84	P

213.4	G03FA12	medroxyprogesteron a estrogen, fixní kombinace	p.o.	1	DF	6,84	P
53690	PREMELLA 2.5	tbl obd 1x28	WYM	IRL
53691	PREMELLA 2.5	tbl obd 3x28	WYM	IRL
53692	PREMELLA 5	tbl obd 1x28	WYM	IRL
53693	PREMELLA 5	tbl obd 3x28	WYM	IRL
213.5	G03FB	gestageny a estrogeny, sekvenční přípravky	p.o.	0.75	DF	5,08	P
67425	CYCLO-MENORETTE	tbl obd 3x21 (=63)	WYE	D
84582	CYCLOOSTROGYNAL	drg 21	ASH	D
84583	CYCLOOSTROGYNAL	drg 3x21 (=63)	ASH	D
213.6	G03FB05	norethisteron a estrogen, sekvenční přípravky	p.o.	1	DF	6,84	P

213.7	G03FB05	norethisteron a estrogen, sekvenční přípravky	transd.	50	RG	6,84	P

213.8	G03FB06	medroxyprogesteron a estrogen, sekvenční přípravky	p.o.	0.75	DF	5,08	P
54310	DIVINA	tbl 3x21 (=63)	ORN	DK
54309	DIVINA	tbl 1x21	ORN	DK
45182	CYCLO-PREMELLA	tbl obd 1x28	WYM	IRL
45183	CYCLO-PREMELLA	tbl obd 3x28	WYM	IRL
213.9	G03FB09	levonorgestrel a estradiol, sekvenční přípravky	transd.	1	DF	6,84	P

213.10	G03HB01	cyproteron/estradiol	p.o.	0.75	DF	5,08	P
214	G03GA	gonadotrofin (choriový)	parent.	L/GYN,END,PDD,SEX
---	---	---	---	---	---	---	---
214.1	G03GA01	choriový gonadotrofin (do 500 U v 1 ampuli včetně)	parent.	250	U	24,59	L/GYN,END, PDD, SEX
10809	PREGNYL	inj 3x500ut+solv.	ORG	NL
214.2	G03GA01	choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně)	parent.	250	U	15,45	L/GYN,END, PDD, SEX
11951	PREGNYL	inj 3x1500ut+solv.	ORG	NL
214.3	G03GA01	choriový gonadotrofin (nad 1500 U v 1 ampuli)	parent.	250	U	11,05	L/GYN,END, PDD, SEX
96314	PREGNYL	inj 3x5000ut+solv.	ORG	NL
99905	PROFASI 5000	inj sic 1x5ku+solv.	SRO	I
99906	PROFASI 5000	inj 1x5ku+1x1ml	SRO	CH
09571	PROFASI 5000	inj sic 3x5ku+solv.	SRO	I
97855	PROFASI 5000	inj sic 3x5ku+solv.	SRO	CH
99316	PREGNYL	inj 50x5000ut+solv.	ORG	NL
215	G03GA	gonadotrofin (lidský)	parent.	Z
---	---	---	---	---	---	---	---
215.1	G03GA02	gonadotrofin lidský	parent.	75	U	329,64	Z
12979	MENOGON	inj sic 10+10xsolv.	FEI	D
43727	MERIONAL 75 M.J.	inj sic 1x75ut+solv	IBS	CH
12979	MENOGON	inj sic 10+10xsolv.	FEI	D
215.2	G03GA04	urofollitrofin	parent.	75	U	400,81	Z
99629	METRODIN 75	inj sic 1x75ut+solv	LSE	CH
56473	METRODIN 75	inj sic 1x75ut+solv	SRO	I
94394	METRODIN 75	inj sic 10x75ut+sol	LSE	CH
56474	METRODIN 75	inj sic 10x75ut+sol	SRO	I
43723	FOSTIMON 75 M.J.	inj sic 1x75ut+solv	IBS	CH
43724	FOSTIMON 75 M.J	inj sic 10x75ut+sol	IBS	CH
215.3	G03GA06	folitrofin beta	parent.	75	U	733,19	Z

215.4	G03GA04	urofollitrofin vysoce čištěný	parent.	75	U	488,79	Z

215.5	G03GA05	folitrofin alfa	parent.	75	U	733,19	Z
216	G03GB	syntetické stimulátory ovulace	p.o.	L/GYN,END,SEX
---	---	---	---	---	---	---	---
216.1	G03GB02	klomifen	p.o.	9	MG	1,32	L/GYN,END, SEX, URN
83672	CLOMHEXAL 50	tbl 10x50mg	HEX	D
217	G03HA	antiandrogeny	p.o.	L/PSY,END,URN,GYN, SEX
---	---	---	---	---	---	---	---
217.1	G03HA01	cyproteron (do 10 mg v jedné tabletě včetně)	p.o.	0.1	GM	195,52	L/PSY,END, URN GYN,SEX
77006	ANDROCUR 10MG	tbl 15x10mg	SAG	D
217.2	G03HA01	cyproteron (nad 10 mg v jedné tabletě)	p.o.	0.1	GM	71,51	L/PSY,END, URN GYN,SEX
97862	ANDROCUR	tbl 20x50mg	SAG	D
03783	ANDROCUR	tbl 50x50mg	SAG	D
218	G03HA	antiandrogeny	parent	L/PSY,SEX
---	---	---	---	---	---	---	---
218.1	G03HA01	cyproteron	parent.	0.1	GM	128,06	L/PSY,SEX, URN
23342	ANDROCUR-DEPOT	inj 3x3ml/300mg	SAG	D
219	G03XA	antigonadotrofiny a podobná léčiva	p.o.	L/GYN,END,HEM,ALG, SEX
---	---	---	---	---	---	---	---
219.1	G03XA01	danazol	p.o.	0.6	GM	83,68	L/GYN,END, HEM,ALG,SEX
67525	ANARGIL 100MG	cps 100x100mg	MOE	CY
67526	ANARGIL 100MG	cps 200x100mg	MOE	CY
67527	ANARGIL 100MG	cps 500x100mg	MOE	CY
67528	ANARGIL 200MG	cps 100x200mg	MOE	CY
67529	ANARGIL 200MG	cps 200x200mg	MOE	CY
67530	ANARGIL 200MG	cps 500x200mg	MOE	CY
219.2	G03XA02	gestrinon	p.o.	0.7	MG	47,36	L/GYN,END, HEM,ALG,SEX

G03XC01 – raloxifen:

Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:

a) denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina u žen v postmenopauze

b) ženy s osteoporotickou zlomeninou, u kterých nelze z objektivních důvodů použít substituční hormonální terapii.

Výše uvedená léčba může být dlouhodbá. Léčba delší než jeden rok pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.

| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 41,00 | P | | 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | | | | | | | | | | | | 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | | | | | | | | | | | | 220.3 | G04AB04 | kyselina oxolinová | p.o. | 1 | GM | 8,55 | | | 91101 | DESUROL | tbl 50x250mg | LEX | CZ | | | | | 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 221.1 | G04AC01 | nitrofurantoin | p.o. | 0.2 | GM | 2,44 | | | 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | | | | | 221.2 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,44 | | | 222 | G04BC | rozpouštědla močových kamenů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 5,97 | | | 02150 | ALKALIT | gra 1x200gm | IHO | CZ | | | | | 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | | | 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 13,69 | L/URN,GYN, SEX,GER | | | | | | | | | | | 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 13,69 | L/URN,GYN, SEX,GER | | 66791 | DITROPAN | tbl 30x5mg | MDD | F | | | | | 59104 | UROXAL 5MG | tbl 60x5mg | FFR | F | | | | | 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,32 | L/URN,GYN, SEX PDD,GER | | 66819 | MICTONETTEN | drg 50x5mg | APG | D | | | | | 92255 | MICTONETTEN | drg 30x5mg | APG | D | | | | | 66820 | MICTONETTEN | drg 100x5mg | APG | D | | | | | 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN, SEX,GER | | 92254 | MICTONORM | drg 30x15mg | APG | D | | | | | 66817 | MICTONORM | drg 50x15mg | APG | D | | | | | 66818 | MICTONORM | drg 100x15mg | APG | D | | | | | 223.5 | G04BD07 | tolterodin | p.o. | 4 | MG | 30,00 | L/URN,GYN, SEX,GER | | 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 21,50 | L/URN | | | | | | | | | | | 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 21,50 | L/URN | | | | | | | | | | | 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 21,50 | L/URN | | | | | | | | | | | 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 18,10 | L/URN | | | | | | | | | | | 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 21,50 | L/URN | | 65988 | PENESTER | tbl obd 30x5mg | LEX | CZ | | | | | 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 17,50 | L/URN | | 42212 | TADENAN 50MG | cps 30 | DEB | F | | | | | 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací | p.o. | 320 | MG | 17,50 | L/URN | | 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | | | | | 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | | | | | 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | | | | | 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | | | | | 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D | | | | | 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D | | | | | 07428 | PROSTAKAN MONO | cps 120x160mg | SCE | D | | | | | 224.8 | G04CX03 | mepartricin | p.o. | 150 | KU | 21,50 | L/URN | | | | | | | | | | | 224.9 | G04CX91 | extrakt Pyg. africanum v kombinaci. | p.o. | 2 | DF | 17,50 | L/URN | | 225 | H01A | hormony předního laloku hypofýzy | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END | | | | | | | | | | | 225.2 | H01AC01 | somatropin | parent. | 2 | U | 765,20 | L/J5 | | 56362 | ZOMACTON 12 | inj sic 5x12ut+solv | FEI | D | | | | | 96132 | NORDITROPIN PENSET 12UT | inj sic 1x12ut+solv | NOO | DK | | | | | 96133 | NORDITROPIN PENSET 24UT | inj sic 1x24ut+solv | NOO | DK | | | | | 56033 | NORDITROPIN12I.U. | inj sic 1x12ut+solv | NOO | DK | | | | | 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH | | | | | 91584 | SAIZEN | inj sic 1x4ut+1ml | SRO | CH | | | | | 226 | H01BA | vasopresin a jeho deriváty | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | H | | 04070 | ADIURETIN | inj 5x1ml/4rg | FRL | CZ | | | | | 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 301,88 | H | | 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ | | | | | 03648 | REMESTYP 0.2 | inj 5x2ml/0.2mg | FRL | CZ | | | | | 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H | | | | | | | | | | | 226.4 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H | | 227 | H01BA | vasopresin a jeho deriváty | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 20,63 | | | 02634 | ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ | | | | | 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 20,63 | | | | | | | | | | | | 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 20,63 | | | 228 | H01BB | oxytocin a jeho deriváty | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 44,28 | H | | 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | | | | | 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 19,80 | H | | 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | | | | | 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z | | 86238 | KRYPTOCUR | inh sol 1x10gm+pump | HOE | D | | | | | 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z | | 45481 | SYNAREL | spr nas 1x4ml | SEA | POR | | | | | 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z | | 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | | | | | 230 | H01CB | somatostatin a jeho deriváty | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 8052,52 | X | | 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B | | | | | 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | | | | | 97824 | STILAMIN | inj sic 1x3mg | SRO | CH | | | | | 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5050,76 | X | | 93864 | SANDOSTATIN | inj 5x1ml/0.05mg | SAN | CH | | | | | 93865 | SANDOSTATIN | inj 5x1 ml/0.1 mg | SAN | CH | | | | | 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH | | | | | 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH | | | | | 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 MG | parent. | 0,35 7 | MG | 1434,00 | X | | | | | | | | | | | 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 MG | parent. | 0,71 4 | MG | 1912,00 | X | | | | | | | | | | | 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 MG | parent. | 1,07 2 | MG | 2390,00 | X | | | | | | | | | | | 230.6 | H01CB03 | lantreotid | parent. | 2,14 | MG | 2206,74 | X | | 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | | | | | 231 | H02AA | mineralokortikoidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | | | 23865 | FLUDROCORTISON | tbl 100x0.1 mg | SQH | D | | | | | 232 | H02AB | glukokortikoidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | | | | | | | | | | | | 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | | | 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | | | | | 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | | | 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | | | | | 70508 | DEXONA | tbl 100x0.5mg | CAD | IND | | | | | 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | | | | | | | | | | | | 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | | | 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B | | | | | 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B | | | | | 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,52 | | | 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | | | | | 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | | | | | 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | | | 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ | | | | | 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | | | 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | | | | | 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | | | | | | | | | | | | 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | | | 84001 | RECTODELT | sup 6x10mg | TRM | D | | | | | 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | | | | | | | | | | | | 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | | | 233 | H02AB | glukokortikoidy | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O | | 02125 | DEPERSOLON | inj 3x1ml/30mg | GED | H | | | | | 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 4,01 | O | | 89870 | DIPROPHOS | inj 1x1ml | SCH | B | | | | | 78257 | DIPROPHOS | inj 5x1ml | SCH | F | | | | | 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 26,54 | O | | 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | | | | | 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O | | 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | | | | | 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND | | | | | 96109 | DEXONA | inj 8x6x2ml | CAD | IND | | | | | 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | | | | | 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 36.20 | O | | 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | | | | | 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O | | | | | | | | | | | 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,44 | O | | 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | | | | | 233.8 | H02AB06 | Prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O | | 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | | | | | 233.9 | H02AB06 | Prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O | | 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | | | | | 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O | | 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ | | | | | 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ | | | | | 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O | | 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B | | | | | 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ | | | | | 234 | H03AA | hormony štítné žlázy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | | | 61161 | JODTHYROX | tbl 100 | MEC | D | | | | | 61160 | JODTHYROX | tbl 50 | MEC | D | | | | | 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | | | 47141 | LETROX 50 | tbl 100x50rg | BCE | D | | | | | 96142 | L-THYROXINE 50 HENNING | tbl 100x50rg | HNB | D | | | | | 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | | | | | 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | | | 47144 | LETROX 100 | tbl 100x100rg | BCE | D | | | | | 96146 | L-THYROXINE 100 HENNING | tbl 100x100rg | HNB | D | | | | | 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | | | | | 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | | | 96150 | L-THYROXINE 150 HENNING | tbl 100x150rg | HNB | D | | | | | 47133 | LETROX 150 | tbl 100x150rg | BCE | D | | | | | 47133 | LETROX 150 | tbl 100x150rg | BCE | D | | | | | 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | | | 09805 | TERTROXIN | tbl 100x0.02mg | GLA | GB | | | | | 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | | | 03875 | THYREOTOM | tbl 60x50rg | BCE | D | | | | | 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | | | 61158 | JODID 100 | tbl 100 | MEC | D | | | | | 61159 | JODID 200 | tbl 100 | MEC | D | | | | | 235 | H03B | thyreostatika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,76 | | | 09577 | PROPYCIL 50 | tbl 100x50mg | KCH | D | | | | | 09576 | PROPYCIL 50 | tbl 20x50mg | SVP | D | | | | | 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | | | 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | | | | | 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | | | | | | | | | | | | 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | | | 236 | H03B | thyreostatika | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H | | 20617 | FAVISTAN | inj 10x1ml/40mg | ASD | D | | | | | 237 | H04AA | giukagon a jeho deriváty | parent. | L/DIA | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 237.1 | H04AA01 | giukagon | parent. | 1 | MG | 404,62 | L/DIA | | | | | | | | | | | 237.2 | H04AA01 | giukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA | | 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | DK | | | | | | 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 115,70 | L/INT,ORT, END | | 64662 | TONOCALCIN 100I.U.NOSNI | spr nas 1x3.5ml | MCI | CZ | | | | | 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 93,73 | L/INT,ORT, END | | 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END | | 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | | | | | 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END | | 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END | | 240 | J01AA | tetracyklinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | | | 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | | | | | 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | | | | | 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | | | | | 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | | | | | 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | | | 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | | | | | | | | | | | | 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | | | | | | | | | | | | 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | | | | | | | | | | | | 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | | | | | | | | | | | | 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 7,00 | | | 241 | J01AA | tetracyklinová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K | | 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | | | | | 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | | | | | 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K | | 242 | J01BA | amfenikolová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | | | 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | | | | | 243 | J01BA | amfenikolová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 241,12 | K | | 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | | | | | 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K | | 244 | J01CA | aminopenicilinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | | | | | | | | | | | | 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | | | | | | | | | | | | 244.3 | J01CA04 | amoxicillin (pevné lékové formy) do 0,5 GM v 1tabletě včetně | p.o. | 1 | GM | 10,12 | | | 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | | | | | 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | | | 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | | | 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | | | 53682 | AMOXICILLIN 500-SLOVA KOFARMA | cps 30x500mg | SLO | SK | | | | | 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 GM v 1tabletě | p.o. | 1 | GM | 9,06 | | | 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | | | | | 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | | | | | 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HCC | D | | | | | 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HCC | D | | | | | 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | | | 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | | | 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | | | | | 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | | | | | 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | | | | | 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,00 | | | | | | | | | | | | 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | | | 245 | J01CA | aminopenicilinová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K | | 60248 | PENTREXYL | inj sic 50x250mg | BMS | I | | | | | 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB | | 04035 | SECUROPEN | inj sic 5x2gm+20ml | BAY | D | | | | | 46974 | SECUROPEN 2GM | inj sic 5x2gm | BAY | D | | | | | 97002 | SECUROPEN | inf 5x5gm | BAY | D | | | | | 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB | | 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR | | | | | 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB | | 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | | | 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-blistr | SLO | SK | | | | | 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | | | | | 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | | | | | 49513 | PENBENE | tbl obd 30x1mu | MCK | D | | | | | 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | | | | | 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | | | 65356 | PENBENE | tbl obd 12x1mu | MCK | D | | | | | 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | | | | | 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | | | | | 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | | | 84626 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-lekov. | SLO | SK | | | | | 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | | | 247.3 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | | | 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | | | | | 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14,52 | | | 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | | | | | 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | | | 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | | | | | 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | | | | | 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | | | | | | | | | | | | 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | | | 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K | | 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | | | | | 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | | | | | 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K | | 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | | | | | 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K | | | | | | | | | | | 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 32,94 | K | | 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A | | | | | 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K | | | | | | | | | | | 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K | | 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | | | | | 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K | | 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | | | | | 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | | | | | | | | | | 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | | | | | | | | | | 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | | | | | 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | | | | | 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K | | 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | | | | | 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 251.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | | | | | | | | | | | | 251.2 | J01CR01 | ampicilin a inhibitor beta-laktamázy (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | | | | | | | | | | | | 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | | | | | | | | | | | | 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | | | | | | | | | | | | 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | | | | | | | | | | | | 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | | | 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | | | | | 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | | | 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 1,5 | GM | 121,63 | U/ATB | | | | | | | | | | | 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 106,50 | U/ATB | | 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | | | | | 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB | | | | | | | | | | | 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB | | | | | | | | | | | 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U | | | | | | | | | | | 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB | | 253 | J01DA | cefalosporinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | | | 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | | | | | 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D | | | | | 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D | | | | | 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D | | | | | 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D | | | | | 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | | | 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | | | 06158 | ORACEF | cps 16x500mg | KRK | SLO | | | | | 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | | | | | 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | | | 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | | | | | 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | | | | | 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | | | | | | | | | | | | 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | | | | | | | | | | | | 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 72,88 | | | 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND | | | | | 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) p.o. | 1.5 GM | 103,11 | | | | | | | | | | | | | | 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | | | 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND | | | | | 253.8 | J01DA09 | Cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 44,00 | | | 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | | | | | 44799 | BIODROXIL | cps 12x500mg | BCA | A | | | | | 253.9 | J01DA09 | Cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 68,00 | | | 44807 | BIODROXIL 250MG/5ML | plv sus 1x60ml/3gm | BCA | A | | | | | 253.10 | J01DA23 | Cefixim | p.o. | 0.4 | GM | 107,35 | ATB | | | | | | | | | | | 253.11 | J01DA26 | Cefetamet | p.o. | 1 | GM | 107,53 | ATB | | | | | | | | | | | 253.12 | J01DA33 | Cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB | | | | | | | | | | | 253.13 | J01DA39 | Ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB | | | | | | | | | | | 253.14 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | | | 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND | | | | | 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | | | | | | | | | | | | 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | | | 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:

a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,

b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),

c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).

| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U | | 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | | | | | 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 162,06 | U | | 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | | | 58092 | CEFAZOLIN BIOCHEMIE 1GM | inj sic 10x1gm | BCA | A | | | | | 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND | | | | | 99867 | ORIZOLIN | inj sic 1x500mg | CAD | IND | | | | | 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | | | | | 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK | | | | | 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK | | | | | 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB | | | | | | | | | | | 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 497,69 | U/ATB | | 76360 | ZINACEF AD INJ. | inj sic 1x1.5gm | GLA | I | | | | | 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 663,29 | U/ATB | | 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | | | | | 254.7 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB | | | | | | | | | | | 254.8 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.9 | J01DA13 | ceftriaxon | parent. | 2 | GM | 654,12 | ambulantně: K/P ústavně: U/ATB | | 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | | | | | 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO | | | | | 254.10 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U | | | | | | | | | | | 254.12 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB | | | | | | | | | | | 254.13 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB | | 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | | | | | 254.14 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB | | | | | | | | | | | 254.15 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 593,68 | U/ATB | | 94177 | CEFOTAXIME | inj 1x2gm | LEK | SLO | | | | | 254.16 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB | | 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1694,73 | U/ATB | | 86412 | AZACTAM | inj sic 1x1gm | BMS | I | | | | | 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB | | 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB | | | | | 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB | | 257 | J01EB | krátkodobé působící sulfonamidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | | | 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | | | | | 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | | | | | 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | | | 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | | | | | 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | | | | | 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | | | 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | | | | | | | | | | | | 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | | | 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND | | | | | 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND | | | | | 06264 | SUMETROLIM | tbl 20x480mg | EGI | H | | | | | 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | | | | | 12917 | BISMORAL 480 | tbl 20x480mg | SLO | SK | | | | | 258.3 | J01EE01 | Sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | | | 97867 | ORIPRIM PRO INFANT. | sus 100ml 240mg/5ml | CAD | IND | | | | | 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 113,40 | K | | 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | | | | | 260 | J01FA | makrolidová antibiotika | p.o | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | | | | | | | | | | | | 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | | | 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | | | | | 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | | | | | 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | | | | | 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | | | | | 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | | | | | | | | | | | | 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | | | | | | | | | | | | 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | | | | | | | | | | | | 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | | | | | | | | | | | | 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | | | | | | | | | | | | 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | | | | | | | | | | | | 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | | | | | | | | | | | | 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | | | | | | | | | | | | 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | | | | | | | | | | | | 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | | | | | | | | | | | | 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | | | | | | | | | | | | 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | | | | | | | | | | | | 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | | | 261 | J01FA | makrolidová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 261.1 | J01FA01 | erythromycin | parent. | 1,2 | GM | 861,00 | K | | 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB | | | | | 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K | | 78174 | ROVAMYCINE 1.5MU | inj sic 1x1.5mu | SPC | F | | | | | 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K | | 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | | | 03365 | DALACIN C | cps 16x150mg | UPJ | B | | | | | 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | | | | | 83458 | DALACIN C | cps 16x300mg | UPJ | B | | | | | 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | | | | | 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | | | | | | | | | | | | 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB | | 91997 | NELOREN | cps 16x500mg | LEK | SLO | | | | | 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB | | 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB | | | | | | | | | | | 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB | | | | | | | | | | | 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB | | 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY | | | | | 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY | | | | | 264 | J01GA | streptomycin a jeho deriváty | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 119,10 | | | 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D | | | | | 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U | | | | | | | | | | | 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U | | | | | | | | | | | 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U | | 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO | | | | | 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U | | 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO | | | | | 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB | | | | | | | | | | | 265.6 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB | | | | | | | | | | | 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB | | | | | | | | | | | 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB | | 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR | | | | | 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB | | 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR | | | | | 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB | | | | | | | | | | | 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB | | | | | | | | | | | 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB | | | | | | | | | | | 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB | | 266 | J01MA | fluorované chinolony | p o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

K léčbě sparfloxacinem a trovafloxacinem je třeba konzultace a schválení antibiotického střediska.

| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 29,33 | | | 54391 | TAROFLOX 200 | tbl obd 10x200mg | HBS | SK | | | | | 55636 | OFLOXIN 200 | tbl obd 10x200mg | LEX | CZ | | | | | 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 29,33 | | | 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | | | 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | | | | | 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | | | 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | | | 53201 | CIPHIN¨250 | tbl obd 10x250mg | SLO | SK | | | | | 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | | | 53203 | CIPHIN 750 | tbl obd 10x750mg | SLO | SK | | | | | 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | | | 64698 | QUINTOR 250MG | tbl obd 10x250mg | TRT | IND | | | | | 64699 | QUINTOR 500MG | tbl obd 10x500mg | TRT | IND | | | | | 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | | | 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | | | 80539 | QUINTOR 250MG | tbl obd 50x250mg | TRT | IND | | | | | 80540 | QUINTOR 500MG | tbl obd 20x500mg | TRT | IND | | | | | 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | | | 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | | | 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | | | 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | | | 266.3 | J01MA03 | Pefloxacin | p.o. | 0.8 | GM | 29,33 | | | 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | | | | | 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 22,48 | | | | | | | | | | | | 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 22,48 | | | 44087 | GYRABLOCK 400 | tbl obd 30x400mg | MOE | CY | | | | | 44089 | GYRABLOCK 400 | tbl obd 100x400mg | MOE | CY | | | | | 44090 | GYRABLOCK 400 | tbl obd 500x400mg | MOE | CY | | | | | 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY | | | | | 67015 | GYRABLOCK 400 | tbl obd 14x400mg | MOE | CY | | | | | 93465 | NOLICIN | tbl 20x400mg | KRK | SLO | | | | | 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 29,33 | | | | | | | | | | | | 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 29,33 | | | | | | | | | | | | 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 29,33 | P | | | | | | | | | | | 266.9 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 29,33 | P | | 267 | J01MA | fluorované chinolony | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | | | | | | | | | | 267.2 | J01MA02 | ciprofloxacin - infúze | parent. | 0.5 | GM | 212,23 | U/ATB | | | | | | | | | | | 267.3 | J01MA02 | ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB | | | | | | | | | | | 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB | | 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | | | | | 267.5 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | | | | | | | | | | 267.6 | J01MA | trovafloxacin | parent. | 0,2 | GM | 212,23 | U/ATB | | 268 | J01XA | ostatní antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1375,38 | U/ATB | | 92289 | EDICIN 0,5GM | inj.sicc.1x500mg | LEK | SLO | | | | | 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO | | | | | 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB | | | | | | | | | | | 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 116,92 | U/ATB | | 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F | | | | | 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB | | 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB | | 86794 | COLIMYCINE | tbl 50x1.5mu | RRO | F | | | | | 270 | J01XD | imidazolová chemoterapeutika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U | | 11692 | METRONIDAZOL 500MG BRAUN | inf 10x100ml/500mg | BMM | D | | | | | 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U | | 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ | | | | | 271 | J02AA | antimykotická antibiotika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 292,49 | U | | 1969 | AMPHOTERICIN B | inj sic 1x50mg | SQH | D | | | | | 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F | | | | | 272 | J02AB | imidazolová antimykotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 27,37 | | | 91739 | ORONAZOL | tbl 20x200mg | KRK | SLO | | | | | 273 | J02AB | imidazolová antimykotika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 469,63 | U | | 274 | J02AC | triazolová antimykotika | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

1. Krátkodobou léčbu ordinuje gynekolog nebo dermatolog na základě kultivačního nebo mikroskopického vyšetření:

a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika

b) recidivy vaginálních mykóz

1. Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog:

a) systémové mykózy u imunokompromitovaných pacientů

b) těžké formy slizničních a kožních mykóz vyvolaných kandidami nebo dermatofyty na základě kultivačního nebo mikroskopického vyšetření

c) těžké formy nehtových mykóz (itrakonazol), platí-li alespoň jedna z následujících podmínek:

• postižení celé nehtové ploténky

• postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem

• postižení nehtu palce dolní končetiny

Podmínkou zahájení léčby ad c) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.

d) profylakticky u imunokompromitovaných pacientů nebo u pacientů před provedením transplantace

e) itrakonazol tekuté lékové formy - léčba orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů

| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P | | 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | | | 274.2 | J02AC01 | flukonazol - ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P | | 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | | | 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK | | | | | 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | | | 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | | | 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | | | 274.3 | J02AC01 | flukonazol - tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P | | | | | | | | | | | 274.4 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P | | | | | | | | | | | 274.5 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P | | | | | | | | | | | 274.6 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 117,52 | P | | 94897 | SPORANOX | cps 15x100mg | JAN | B | | | | | 274.7 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 101,93 | P | | | | | | | | | | | 274.8 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P | | | | | | | | | | | 274.9 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 402,81 | P | | 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN | | | | | | 275 | J02AC | triazolová antimykotika | parent. | U/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Terapeuticky: těžké, život ohrožující systémové mykózy.

Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.

| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 904,23 | U/P | | 46979 | FLUCONAZOL-SLOVAKOFARMA PRO INF | inf 1x100ml/200mg | SLO | SK | | | | | 65989 | MYCOMAX INF. | inf 1x100ml/200mg | LEX | CZ | | | | | 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P | | 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.

| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | | | 96735 | ARFICIN | cps 100x150mg | BLU | CHO | | | | | 96780 | ARFICIN | cps 100x300mg | BLU | CHO | | | | | 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P | | 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | | | | | | | | | | | | 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | | | 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,00 | | | 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ | | | | | 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,85 | | | 75508 | TISAMID | tbl 100x500mg | ORN | SF | | | | | 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,42 | | | 03023 | SURAL | tbl 100x400mg | CHN | H | | | | | 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | | | 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F | | | | | 281 | J05A | antivirotika | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:

a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,

b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),

c) léčba herpes zoster při lokalizaci v obličeji,

d) profylaxe po alogenní transplantaci kostní dřeně.

Léčbu acyklovirem u pacientů s herpes zoster při lokalizaci v obličeji indikuje ošetřující lékař též odbornosti praktický lékař pro dospělé a praktický lékař pro děti a dorost.

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir, lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.

Léčbu lamivudinem dále indikuje ošetřující lékař u chronické virové hepatitidy typu B.

Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,

b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,

c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.

281.1	J05AB	brivudin	p.o.	0.5	GM	458,88	P

281.2	J05AB01	acyklovir do 200 mg včetně	p.o.	4	GM	330,00	P
54031	PROVIRSAN	tbl 30x200mg	PMP	CZ
281.3	J05AB01	acyklovir nad 200 mg	p.o.	4	GM	265,00	P
54216	RANVIR 400	tbl 25x400mg	RXG	IND
281.4	J05AB06	gancyklovir	p.o.	3	GM	2002,96	P
53102	CYMEVENE 250MG	cps 84x250mg	SYN	POR
281.5	J05AB09	famcyklovir	p.o.	0.75	GM	458,88	P

281.6	J05AB11	valacyklovir	p.o.	3	GM	440,00	P

281.7	J05AE01	saquinavir	p.o.	1,8	GM	504,14	P

281.8	J05AE02	indinavir	p.o.	2,4	GM	504,14	P

281.9	J05AE03	ritonavir	p.o.	1,2	GM	504,14	P

281.10	J05AE04	nelfinavir	p.o.	2,25	GM	504,14	P

281.11	J05AF01	zidovudin	p.o.	1.5	GM	685,28	P
96179	AZITIDIN 100	tbl 50x100mg	LCM	CZ
281.12	J05AF02	didanosin	p.o.	0.4	GM	236,43	P

281.13	J05AF03	zalcitabin	p.o.	2.25	MG	241,76	P
66734	HIVID 0.75MG	tbl obd 100x0.75mg	HLR	CH
281.14	J05AF04	stavudin	p.o.	80	MG	302,07	P
53210	ZERIT 40MG	cps 60x40mg	BMS	F
53209	ZERIT 40MG	cps 56x40mg	BMS	F
281.15	J05AF05	lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně	p.o.	0,3	GM	327,60	P
02086	ZEFFIX 100 MG	tbl obd 84x100mg	GOW	GB
02085	ZEFFIX 100 MG	tbl obd 28x100mg	GOW	GB
281.16	J05AF05	lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru	p.o.	0,3	GM	248,01	P

281.17	J05AF06	abacavir	p.o.	600	MG	360,00	P

281.18	J05AF30	kombinace antiretrovirových virostatik	p.o.	2	DF	522,13	P
281.19	J05AG01	nevirapin	p.o.	0,4	GM	353,49	P
57777	VIRAMUNE	tbl 60x200mg	UUI	P
281.20	J05AG03	efavirenz	p.o.	0,6	GM	423,29	P

281.21	J05AH01	zanamivir	inhal.	20	MG	130,00	P

Zanamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:

1. děti starší 12 let s cystickou fibrózou, děti s onkologickým onemocněním na imunosupresivní léčbě

1. dospělí se závažným chronickým plicním či kardiálním onemocněním na trvalé medikaci

1. pacienti se závažným imunodeficitem, kde je po očkování nepravděpodobnost protilátkové odpovědi.

Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Zanamivir u výše uvedených skupin ordinuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené hlavním hygienikem.

281.22	J05AX	palivizumab do 50 mg v jedné ampuli včetně	parent.	1	DF	27.645,00	Z
281.23	J05AX	palivizumab nad 50 mg v jedné ampuli	parent.	1	DF	45.568,00	Z

281.24	J05AX05	inosin pranobex	p.o.	1	GM	30,55	P
88174	ISOPRINOSINE	tbl 5x10(=50)x500mg	EWO	CH
282	J05AB	antivirotika ze skupiny nukloeosidů	parent.	U/P
---	---	---	---	---	---	---	---

a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,

b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),

c) léčba herpes zoster při lokalizaci v obličeji,

d) profylaxe po alogenní transplantaci kostní dřeně.

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir a lamivudin) indikuje infekcionista pracující v AIDS centrech.

Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,

b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,

c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.

| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1551,47 | U/P | | 93260 | HERPESIN 250 | inj sic 10x250mg | LCM | CZ | | | | | 282.2 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 1960,83 | U/P | | | | | | | | | | | 282.3 | J05AB12 | cidofovir | parent. | 375 | MG | 33556,50 | U/P | | 44745 | VISTIDE | inf 1x5ml 75mg/ml | PAU | B | | | | | 282.4 | J05AD01 | foskarnet | parent. | 6.5 | GM | 3006,25 | U/P | | | | | | | | | | | 282.5 | J05AF01 | zidovudin | parent. | 1 | GM | 2748,47 | U/P | | 283 | J06AA | imunitní séra | parent. | K/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Sérum proti stafylokokovým infekcím ordinuje lékař ke komplexní léčbě těžkých stafylokokových infekcí.

Sérum proti záškrtu ordinuje infekcionista nebo pediatr ke komplexní léčbě záškrtu.

Sérum proti hadímu jedu ordinuje lékař k léčbě uštknutí zmijí obecnou.

Sérum proti botulismu ordinuje lékař ke komplexní léčbě botulismu.

Sérum proti plynaté sněti ordinuje infekcionista nebo specialista chirurgických oborů k profylaxi a terapii klostridiových infekcí.

Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.

283.1	J06AA	sérum proti stafylokokovým infekcím	parent.			plně	K/P
283.2	J06AA01	sérum proti záškrtu	parent.			plně	K/P

283.3	J06AA03	sérum proti hadímu jedu	parent.			plně	K/P
83330	IPSER EUROPE PASTEUR	inj. 1x5ml	PMX	F
283.4	J06AA04	sérum proti botulinu	parent.			plné	K/P
01190	BOSEA SEVAC	inj. 1x35ml	SEV	CZ
283.5	J06AA05	sérum proti plynaté sněti	parent.			plně	K/P
01195	GASEA SEVAC	inj. 1x20ml/25ku	SEV	CZ
283.6	J06AA06	sérum proti vzteklině	parent.			plně	K/P
94015	SERUM ANTIRAB.1000 U.I.PASTEUR	inj 1x5ml 200ut/ml	PMX	F
284	J06BA	imunoglobuliny, normální lidské	parent.
---	---	---	---	---	---	---	---
284.1	J06BA01	imunoglobuliny, norm. lidské, k extravasální aplikaci do velikosti méně než 5 ml v jedné ampuli	parent.	1	DF	175,50	O
01263	NORGA I.M.SEVAC	inj 10x1.9ml	SEV	CZ
01262	NORGA I.M.SEVAC	inj 1x1.9ml	SEV	CZ
57669	PASTEUR. HUM.IMMUNOGL.GRIFOLS 16	inj 1x2ml	GFO	E
87736	HISTAGLOBIN	inj sic 3x12mg+sol.	BBL	CH
284.2	J06BA01	imunoglobuliny, norm. lidské, k extravasální aplikaci 5 ml a více v jedné ampuli	parent.	1	DF	438,75	O

284.3	J06BA02	imunoglobuliny normální lidské pro i.v. aplikaci (z tuzemské plazmy zakázkovou frakcionací)	parent.	1	GM	991,90	B

284.4	J06BA02	imunoglobuliny normální lidské pro i.v. aplikaci	parent.	1 GM	991,90	B
62553	INTRAGLOBIN F PRO INFUS.	inf 1x50ml	BTP	D
62554	INTRAGLOBIN F PRO INFUS.	inf 1x100ml	BTP	D
62555	INTRAGLOBIN F PRO INFUS.	inf 1x200ml	BTP	D
284.5	J06BA02	imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM)	parent.	1	GM	1955,16	U
45372	OCTAGAM	inj 1x20ml	OPU	A
12691	OCTAGAM	inj 1x50ml	OPU	A
12693	OCTAGAM	inj 1x200ml	OPU	A
12692	OCTAGAM	inj 1x100ml	OPU	A
285	J06BB	specifické imunoglobuliny	parent.	K
---	---	---	---	---	---	---	---

Léčbu imunoglobuliny proti neštovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:

a) neočkované těhotné ženy,

b) novorozenec po kontaktu s varicellou,

c) imunokomprimovaný pacient po kontaktu s varicellou,

d) varicelózní primární pneumonitis.

Léčbu imunoglobulinem proti cytomegalovirové infekci ordinuje infekcionista, onkolog, hematolog nebo pediatr:

a) novorozenec s prokázanou cytomegalovirovou infekcí,

b) generalizovaná cytomegalovirová infekce u imunokomprimovaných pacientů,

c) profylaxe cytomegalovirových infekcí u transplantovaných pacientů při pozitivitě dárce nebo příjemce. Imunoglobulin proti cytomegalovirové infekci je hrazen dle symbolu U. Imunoglobulin proti tetanu je hrazen dle symbolu B.

| 285.1 | J06BB | protiencefalický globulin | parent. | 1 | ML | 300,65 | K | | 95082 | FSME-BULIN I.M. | inj 1x1ml | IMM | A | | | | | 95083 | FSME-BULIN I.M. | inj 1x2ml | IMM | A | | | | | 95084 | FSME-BULIN I.M. | inj 1x5ml | IMM | A | | | | | 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 RG v jedné ampuli včetně) | parent. | 250 | RG | 1407,96 | K | | 93505 | RHEGA I.M.SEVAC | inj 1x1.75ml/100rg | SEV | CZ | | | | | 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 RG v jedné ampuli) | parent. | 250 | RG | 1320,40 | K | | 02445 | RHEGA I.M.SEVAC | inj 1x2.5ml/250rg | SEV | CZ | | | | | 91307 | PARTOBULIN-INJECT I.M. | inj 1x1ml/250rg | OIH | A | | | | | 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B | | 44668 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x250ut+2ml | GFO | E | | | | | 44669 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x500ut+2ml | GFO | E | | | | | 83607 | TETABULIN | inj 250ut/ml | IMM | A | | | | | 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 33322,57 | K/P | | 97895 | VARITECT(R) | inj 1x20ml | BTP | D | | | | | 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K | | 97897 | HEPATECT (R) | inj. | 1x2ml | BTP | D | | | | 97898 | HEPATECT (R) | inj. | 1x10ml | BTP | D | | | | 285.7 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 4956,87 | U/P | | 94864 | CYTOTECT | inf 1x50ml 100mg/ml | BTP | D | | | | | 286 | J07AM | očkovací látky proti tetanu | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 286.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K | | 83622 | ALTEANA SEVAC | inj 10x0.5ml | SEV | CZ | | | | | 83443 | TETAVAX | inj 1x0.5ml-strik. | PMX | F | | | | | 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | | | | | 83445 | TETAVAX | inj 1x10ml | PMX | F | | | | | 83447 | TETAVAX | inj 10x20ml | PMX | F | | | | | 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | | | | | 83526 | TETAVAX | inj 10x10ml | PMX | F | | | | | 287 | J07AN | očkovací látky proti tuberkulóze | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 254,86 | H | | 76027 | LYOPHILIZED B.C.G.VACCINE | lyo 10x10davek+sol. | PMX | F | | | | | 76028 | LYOPHILIZED B.C.G.VACCINE | lyo 10x20davek+sol. | PMX | F | | | | | 76189 | BCG-VACCINE 500 BEHRING | inj sic 50x0.1ml+so | CBG | D | | | | | 288 | J07AX | jiné bakteriální očkovací látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | | | plně | K | | 94269 | POLYSTAFANA SEVAC | inj 10x0.5ml | SEV | CZ | | | | | 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,15 | K | | | | | | | | | | | 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1 | DF | 206,02 | O | | | | | | | | | | | 288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 280,47 | O | | 289 | J07BG | očkovací látky proti vzteklině | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | | | plně | K | | 75379 | RABIPUR(PCEC RABIES VACCINE) | inj sic 1x2.5ut+1ml | BEH | D | | | | | 90996 | RABIPUR(PCEC RABIES VACCINE) | inj sic 5x2.5ut+1ml | BEH | D | | | | | 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | | | | | 290 | L01AA | alkylační cytostatika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,72 | | | 94174 | CYCLOPHOSPHAMID | tbl 50x50mg | FAO | SF | | | | | 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,50 | | | 01842 | LEUKERAN 2MG | tbl obd 25x2mg | BWE | GB | | | | | 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,72 | | | 01843 | LEUKERAN 5MG | tbl obd 25x5mg | BWE | GB | | | | | 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,30 | | | 02050 | ALKERAN | tbl obd 25x2mg | BWE | GB | | | | | 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,88 | | | 02051 | ALKERAN | tbl obd 25x5mg | BWE | GB | | | | | 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,62 | | | | | | | | | | | | 290.7 | L01AX03 | temozolomid | p. o. | 370 | MG | 15998,00 | X | | 291 | L01AA | alkylační cytostatika | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,52 | B | | 70442 | CYTOXAN | inj sic 12x500mg | BMS | USA | | | | | 70441 | CYTOXAN | inj sic 12x200mg | BMS | USA | | | | | 70443 | CYTOXAN | inj sic 6x1gm | BMS | USA | | | | | 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,61 | B/ONK,HEM | | 75182 | ALKERAN | inj 1x50mg+10mlsolv | BWE | GB | | | | | 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 34,22 | B/ONK,HEM | | | | | | | | | | | 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,42 | B/ONK,HEM | | | | | | | | | | | 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,32 | B/ONK,HEM | | | | | | | | | | | 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,31 | B/ONK,HEM | | | | | | | | | | | 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7,92 | B/ONK,HEM | | 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | | | | | 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | | | 292 | L01AB | alkylsulfaty | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 14,86 | L/ONK,HEM | | | | | | | | | | | 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 4,89 | L/ONK,HEM | | 21157 | MYLERAN | tbl 100x2mg | BWE | GB | | | | | 293 | L01AD | nitrosomočoviny | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,72 | L/ONK,HEM | | 60270 | CEENU LOMUSTINE (CCNU) | cps 20x10mg | BMS | USA | | | | | 293.2 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,45 | L/ONK,HEM | | 60272 | CEENU LOMUSTINE (CCNU) | cps 20x100mg | BMS | USA | | | | | 293.3 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 6,01 | L/ONK,HEM | | 03735 | LOMUSTINE | cps 6 | BMS | USA | | | | | 64653 | CEENU LOMUSTINE (CCNU) 100MG | cps 20x100mg | BMS | I | | | | | 294 | L01AD | nitrosomočoviny | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 9,92 | B/ONK,HEM | | 83482 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | USA | | | | | 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 14,81 | B/ONK,HEM | | | | | | | | | | | 294.3 | L01AD05 | fotemustin | parent. | 1 | MG | 94,48 | B/P |

Fotemustin - léčba generalizovaného maligního melanomu. Léčbu ordinuje onkolog pouze na pracovištích se speciálním smluvním vztahem se zdravotními pojišťovnami.

295	L01BA	antimetabolity ze skupiny analog kyseliny listové	p.o.
295.1	L01BA01	metotrexát	p.o.	1	MG	1,52
91065	METHOTREXAT LACHEMA 2.5	tbl 100x2.5mg	LCM	CZ
91922	METHOTREXAT LACHEMA 10	tbl 100x10mg	LCM	CZ
296	L01BA	antimetabolity ze skupiny analog kyseliny listové	parent.	B
---	---	---	---	---	---	---	---
296.1	L01BA01	metotrexát (do 5 mg v jedné ampuli včetně)	parent.	1	MG	9,09	B
91025	METHOTREXAT LACHEMA 5	inj 10x2ml/5mg	LCM	CZ
12787	METHOTREXATE-TEVA 2.5MG/ML	inj 5x2ml/5mg	AIC	IL
296.2	L01BA01	metotrexát (nad 500 mg v jedné ampuli)	parent.	10	MG	4,89	B
93965	METHOTREXAT LACHEMA 1000	inj 10x20ml/1000mg	LCM	CZ
296.3	L01BA01	metotrexát (nad 5 do 500 mg v jedné ampuli včetně)	parent.	1	MG	3,23	B
12788	METHOTREXATE-TEVA 25MG/ML	inj 1x2ml/50mg	AIC	IL
12789	METHOTREXATE-TEVA 25MG/ML	inj 1x4ml/100mg	AIC	IL
12790	METHOTREXATE-TEVA 25MG/ML	inj 1x8ml/200mg	AIC	IL
12791	METHOTREXATE-TEVA 25MG/ML	inj 1x20ml/500mg	AIC	IL
12792	METHOTREXATE-TEVA 25MG/ML	inj 5x2ml/50mg	AIC	IL
64784	METHOTREXAT EBEWE	inf 1x5ml/500mg	EBW	A
83484	METHOTREXAT LEDERLE	inf 1x20ml/500mg	LED	D
87564	METHOTREXAT LACHEMA 50	inj sic 10x50mg	LCM	CZ
87761	METHOTREXAT LACHEMA 500	inj sic 10x500mg	LCM	CZ
93963	METHOTREXAT LACHEMA 20	inj 10x2ml/20mg	LCM	CZ
93964	METHOTREXAT LACHEMA 50	inj 10x5ml/50mg	LCM	CZ
296.4	L01BA03	raltitrexed	parent.	1	DF	7498,00	X
297	L01BB	antimetabolity ze skupiny analog purinů	p.o.	L/ONK,HEM
---	---	---	---	---	---	---	---
297.1	L01BB02	merkaptopurin	p.o.	10	MG	6,21	L/ONK,HEM
94241	PURI-NETHOL	tbl 25x50mg	BWE	GB
297.2	L01BB03	tioguanin	p.o.	10	MG	9,34	L/ONK,HEM
298	L01BB	antimetabolity ze skupiny analog purinů	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
298.1	L01BB04	cladribin	parent.	1	MG	884,61	B/ONK,HEM

298.2	L01BB05	fludarabin	parent.	1	MG	130,26	B/ONK,HEM
77008	FLUDARA I.V.	inj sic 5x50mg	SAG	D
59058	FLUDARA	inj sic 5x50mg	SHI	I
299	L01BC	antimetabolity ze skupiny analog pyrimidinu	p.o.	L/ONK,HEM
---	---	---	---	---	---	---	---
299.1	L01BC	azaribin	p.o.	1	MG	8,50	L/ONK,HEM

299.2	L01BC03	tegafur	p.o.	10	MG	1,47	L/ONK,HEM
10407	FTORAFUR	cps 100x400mg	GRX	LT
299.3	L01BC02	fluorouracil	p.o.	10	MG	1,47	L/ONK,HEM
300	L01BC	antimetabolity ze skupiny analog pyrimidinu	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
300.1	L01BC01	cytarabin (do 100 mg v jedné ampuli včetně)	parent.	1	MG	1,27	B/ONK,HEM
99483	ALEXAN (LAHVICKY)	inj 10x5ml/100mg	MAC	D
99484	ALEXAN (LAHVICKY)	inj 30x2ml/40mg	MAC	D
300.2	L01BC01	cytarabin (nad 100 mg v jedné ampuli)	parent.	1	MG	1,03	B/ONK,HEM
96990	ALEXAN (LAHVICKY)	inj 1x20ml/1000mg	MAC	D
300.3	L01BC03	tegafur	parent.	10	MG	2,83	B/ONK,HEM

300.4	L01BC02	fluorouracil	parent.	10	MG	2,72	B/ONK,HEM
12665	5-FLUOROURACIL EBEWE	inj 1x10ml/500mg	EBW	A
12666	5-FLUOROURACIL EBEWE	inj 1x20ml/1000mg	EBW	A
12667	5-FLUOROURACIL EBEWE	inj 1x100ml/5000mg	EBW	A
56055	5-FLUOROURACIL EBEWE	inj 1x5ml/250mg	EBW	A
57650	LA-FU 500	inj 1x10ml/500mg	LCM	CZ
300.5	L01BC05	gemcitabin	parent.	1	MG	5,87	X
301	L01CA	vinka alkaloidy a jejich deriváty	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
301.1	L01CA01	vinblastin	parent.	1	MG	26,54	B/ONK,HEM

301.2	L01CA02	vinkristin	parent.	1	MG	219,20	B/ONK,HEM
12772	VINCRISTINE-TEVA	inj sic 1x1mg+solv.	AIC	IL
12773	VINCRISTINE TEVA	inj 1x1ml/1mg	AIC	IL
47220	VINCRISTINE TEVA	inj 1x2ml/2mg	AIC	IL
47221	VINCRISTINE TEVA	inj 1x5ml/5mg	AIC	IL
74990	CITOMID 1MG	inj sic 1x1mg+10ml	LMR	MEX
301.3	L01CA04	vinorelbin	parent.	1	MG	108,27	X
302	L01CB	podofylotoxinové deriváty	p.o.	L/ONK,HEM
---	---	---	---	---	---	---	---
302.1	L01CB01	etoposid	p.o.	1	MG	3,39	L/ONK,HEM
86416	VEPESID	cps 20x50mg	BMS	D
86417	VEPESID	cps 10x100mg	BMS	D
303	L01CB	podofylotoxinové deriváty	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
303.1	L01CB01	etoposid	parent.	1	MG	3,36	B/ONK,HEM
12671	ETOPOSID EBEWE	inf 1x20ml/400mg	EBW	A
86418	VEPESID	inj 10x5ml/100mg	BMS	D
87191	ETOPOSIDE DELTA WEST	inj 10x5ml/100mg	DWP	AUS
87192	ETOPOSIDE DELTA WEST	inj 1x5ml/100mg	DWP	AUS
303.2	L01CB02	teniposid	parent.	1	MG	6,06	B/ONK,HEM
304	L01CD	taxany	parent.	X
---	---	---	---	---	---	---	---
304.1	L01CD01	paclitaxel	parent.	1	MG	140,25	X
45154	PAXENE	inj 1x5ml/30mg	GNO	CZ
304.2	L01CD02	docetaxel	parent.	1	MG	245,83	X
305	L01DA	aktinomyciny	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
305.1	L01DA01	daktinomycin	parent.	1	MG	664,85	B/ONK,HEM
21055	LYOVAC COSMEGEN	inj sic 1x0.5mg	MSD	USA
306	L01DB	antracykliny a jejich deriváty	p.o.	X
---	---	---	---	---	---	---	---
306.1	L01DB06	idarubicin	p.o.	1	MG	274,70	X
78812	ZAVEDOS 5MG	cps 1x5mg	FAR	I
78813	ZAVEDOS 10MG	cps 1x10mg	FAR	I
78814	ZAVEDOS 25MG	cps 1x25mg	FAR	I
307	L01DB	antracykliny a jejich deriváty	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
307.1	L01DB01	doxorubicin (do 40 mg včetně v jedné ampuli)	parent.	1	MG	34,22	B/ONK,HEM
12663	DOXORUBICIN EBEWE 10MG	inj 1x5ml/10mg	EBW	A
94567	RASTOCIN	inj 10x10mg	PLI	CHO
307.2	L01DB01	doxorubicin (nad 40 mg v jedné ampuli)	parent.	1	MG	32,80	B/ONK,HEM
12664	DOXORUBICIN EBEWE 50MG	inj 1x25ml/50mg	EBW	A
307.3	L01DB02	daunorubicin	parent.	1	MG	19,21	B/ONK,HEM

307.4	L01DB03	epirubicin	parent.	1	MG	40,08	B/ONK,HEM

307.5	L01DB04	aklarubicin	parent.	1	MG	19,21	B/ONK,HEM

307.6	L01DB05	zorubicin	parent.	1	MG	19,21	B/ONK,HEM

307.7	L01DB06	idarubicin	parent.	1	MG	753,57	B/ONK,HEM

307.8	L01DB07	mitoxantron	parent.	1	MG	53,96	B/ONK,HEM
54033	REFADOR 2MG/ML	inj 1x15ml/30mg	LCM	CZ
308	L01DC	ostatní cytotoxická antibiotika	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
308.1	L01DC01	bleomycin	parent.	1	MG	61,74	B/ONK,HEM
03404	BLEOCIN	inj 1x15mg	NKU	J
308.2	L01DC03	mitomycin (do 2 mg v jedné ampuli včetně)	parent.	1	MG	76,25	B/ONK,HEM

308.3	L01DC03	mitomycin (nad 2 mg v jedné ampuli)	parent.	1	MG	69,31	B/ONK,HEM
83440	MITOMYCIN C KYOWA	inj sic 5x20mg	KYA	J
309	L01XA	platinová cytostatika	parent.	B/ONK,HEM
---	---	---	---	---	---	---	---
309.1	L01XA01	cisplatina	parent.	1	MG	8,21	B/ONK,HEM
96453	PLATIDIAM	inj 10x10mg/20ml	LCM	CZ
96454	PLATIDIAM	inj 5x25mg/50ml	LCM	CZ
96455	PLATIDIAM	inj 1x50mg/100ml	LCM	CZ
92302	CISPLATIN EBEWE	inf 1x100ml/50mg	EBW	A
309.2	L01XA02	karboplatina (do 50 mg v jedné ampuli včetně)	parent.	1	MG	6,70	B/ONK,HEM
90777	CYCLOPLATIN 50	inj sic 10x50mg	LCM	CZ
75010	CYCLOPLATIN	inj sic 1x5ml/50mg	LCM	CZ
309.3	L01XA02	karboplatina (nad 50 mg v jedné ampuli)	parent.	1	MG	3,86	B/ONK,HEM
93665	CYCLOPLATIN 200	inj sic 5x200mg	LCM	CZ
60924	CYCLOPLATIN	inj 1x60ml/600mg	LCM	CZ
310	L01XB	methylhydrazinová cytostatika	p.o.	L/ONK,HEM
---	---	---	---	---	---	---	---
310.1	L01XB01	prokarbazin	p.o.	10	MG	2,44	L/ONK,HEM
311	L01XX	ostatní cytostatika	p.o.	L/ONK,HEM,URN
---	---	---	---	---	---	---	---
311.1	L01XX05	hydroxymočovina	p.o.	0.1	GM	2,30	L/ONK,HEM, URN
95122	LITALIR	cps 100x500mg	BMS	D
57345	LITALIR	cps 100x500mg	BMS	I
311.2	L01XX11	estramustin	p.o.	10	MG	3,91	L/ONK,HEM, URN
08921	ESTRACYT	cps 100x140mg	KBP	S
311.3	L01XX14	tretinoin	p.o.	10	MG	104,85	L/ONK,HEM, URN
84009	VESANOID	cps 100x10mg	HLR	CH
312	L01XX	ostatní cytostatika	parent	B/ONK,HEM
---	---	---	---	---	---	---	---

Léčbu L-asparaginázou ordinuje onkolog nebo hematolog. Revizní lékař pojišťovny může na základě žádosti lékaře povolit plnou úhradu ekonomicky náročnějších přípravků obsahujících L-asparaginázu v případě, že se jedná o podání dětem do 18 let věku, nebo že se jedná o opakované podání starším osobám, případně u pacientů s alergickou anamnézou.

312.1	L01XX01	amsakrin	parent.	1	MG	26,15	B/ONK,HEM
312.2	L01XX02	asparagináza	parent.	1	MG	2784,54	B/P
92117	KIDROLASE	inj sic 10x10ku	RBE	F
312.3	L01XX11	estramustin	parent.	1	MG	1,03	B/ONK,HEM, UR N

312.4	L01XX17	topotekan	parent.	1	MG	3066,38	X

312.5	L01XX19	irinotekan	parent.	1	MG	77,33	X

312.6	L01XX09	miltefosin	lok.	60	MG	9,78

312.7	L01XX21	rituximab	parent.	10	MG	1365,48	Z
46130	MABTHERA 500 MG	inf 1x50ml/500mg	HLR	D
59839	MABTHERA 100 MG	inf 2x10ml/100mg	HLR	D
313	L02AA	estrogeny	p.o.	L/ONK,HEM,URN,GYN, SEX
---	---	---	---	---	---	---	---
313.1	L02AA01	diethylstilbestrol	p.o.	10	MG	3,32	L/ONK,HEM, URN GYN,SEX

313.2	L02AA03	ethinylestradiol	p.o.	1	MG	4,06	L/ONK,HEM, URN GYN,SEX

313.3	L02AA04	fosfestrol	p.o.	0.1	GM	3,32	L/ONK,HEM, URN GYN,SEX
314	L02AA	estrogeny	parent.	B/ONK,HEM,URN,SEX
---	---	---	---	---	---	---	---
314.1	L02AA02	polyestradiol fosfát	parent.	1	MG	3,18	B/ONK,HEM, URN,SEX
88381	ESTRADURIN	inj sic 10x80mg+2ml	KBP	S
314.2	L02AA01	diethylstilbestrol	parent.	10	MG	6,55	B/ONK,HEM, URN,SEX

314.3	L02AA04	fosfestrol	parent.	0.1	GM	4,79	B/ONK,HEM, URN,SEX
315	L02AB	progestiny	p.o.	L/ONK,HEM,URN,GYN, SEX
---	---	---	---	---	---	---	---
315.1	L02AB01	megestrol (pevné lékové formy)	p.o.	160	MG	52,13	L/ONK,HEM, URN GYN,SEX
86059	MEGACE	tbl 100x160mg	BMS	D
86211	MEGACE	tbl 100x40mg	BMS	D
315.2	L02AB02	medroxyprogesteron	p.o.	1	GM	175,96	L/ONK,HEM, URN GYN,SEX
91618	PROVERA	tbl 20x500mg	UPJ	GB
90793	PROVERA 100MG	tbl 100x100mg	UPJ	GB
315.3	L02AB01	megestrol (tekuté lékové formy)	p.o.	160	MG	73,07	Z
53145	MEGACE 40MG/ML	sus por 1x240ml	BMS	USA
53146	MEGACE 40MG/ML	sus por 1x240ml	BMS	POR
316	L02AB	progestiny	parent.	L/ONK,GYN,SEX
---	---	---	---	---	---	---	---
316.1	L02AB02	medroxyprogesteron	parent.	1	GM	784,67	L/ONK,GYN, SEX
87805	DEPO-PROVERA 150MG/ML	inj 1x1ml/150mg	UPJ	B
316.2	L02AB03	gestonoron	parent.	1	MG	1,12	L/ONK,GYN, SEX
317	L02AE	hormon uvolňující gonadotrofin a jeho deriváty	inhal.	Z
---	---	---	---	---	---	---	---
317.1	L02AE01	buserelin	inhal.	1	MG	236,87	Z
90966	SUPREFACT NASAL	sol nas 4x10gm/10mg	HOE	D
318	L02AE	hormon uvolňující gonadotrofin a jeho deriváty	parent.	K/P
---	---	---	---	---	---	---	---

Léčbu ordinuje onkolog, urolog, endokrinolog, dětský endokrinolog nebo gynekolog:

a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.

b) léčba karcinomu prostaty,

c) léčba myomatózy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu,

d) léčba těžkých, jinak konzervativně nereagujících forem endometriózy,

e) pubertas precox,

f) indukce ovulace při in vitro fertilizad pouze na základě předchozího schválení revizním lékařem.

318.1	L02AE01	buserelin	parent.	1	MG	267,51	K/P
318.2	L02AE01	buserelin (depotní lékové formy)	parent.	1	MG	1866,31	K/P

318.3	L02AE02	leuprorelin	parent.	1	MG	267,51	K/P

318.4	L02AE02	leuprorelin (depotní lékové formy)	parent.	1	MG	1642,36	K/P

318.5	L02AE03	goserelin (depotní lékové formy)	parent.	1	MG	1710,80	K/P

318.6	L02AE04	triptorelin	parent.	1	MG	267,51	K/P

318.7	L02AE04	triptorelin (depotní lékové formy)	parent.	1	MG	1642,36	K/P
57567	DECAPEPTYL DEPOT	inj sic 3.75mg+solv	FEI	S
96107	DECAPEPTYL DEPOT	inj sic 3.75mg+2ml	FEI	D
319	L02BA	antiestrogeny	p.o.
---	---	---	---	---	---	---	---
319.1	L02BA01	tamoxifen (do 20 mg v 1 tabletě včetně)	p.o.	20	MG	6,00
67039	TAMIFEN 10	tbl 30x10mg	MOE	CY
44056	TAMOXIFEN EBEWE 10	tbl 30x10mg	EBW	A
44057	TAMOXIFEN EBEWE 20	tbl 30x20mg	EBW	A
88392	TAMOXIFEN LACHEMA 10	tbl 100x10mg	LCM	CZ
319.2	L02BA01	tamoxifen (nad 20 mg v 1 tabletě)	p.o.	20	MG	4,40
44058	TAMOXIFEN EBEWE 30	tbl 30x30mg	EBW	A
44059	TAMOXIFEN EBEWE 40	tbl 30x40mg	EBW	A
320	L02BB	antiandrogeny	p.o.	L/ONK,URN,SEX
---	---	---	---	---	---	---	---
320.1	L02BB01	flutamid	p.o.	10	MG	1,19	L/ONK,URN, SEX
83392	FLUCINOM	tbl 100x250mg	SCH	B
320.2	L02BB02	nilutamid	p.o.	1	MG	0,61	L/ONK,URN, SEX

320.3	L02BB03	bicalutamid	p.o.	50	MG	107,14	L/ONK,URN, SEX
321	L02BG	inhibitory tvorby steroidních hormonů	p.o.	L/ONK,END
---	---	---	---	---	---	---	---
321.1	L02BG01	aminogluthetimid	p.o.	1	GM	63,54	L/ONK,END
07510	ORIMETEN	tbl 100x250mg	CGC	CH
321.2	L02BG03	anastrozol	p.o.	1	MG	165,45	X
76468	ARIMIDEX	tbl obd 28x1mg	ZNC	USA
321.3	L02BG04	letrozol	p.o.	2,5	MG	165,45	X
322	L02BG	inhibitory tvorby steroidních hormonů	parent.	X
---	---	---	---	---	---	---	---
322.1	L02BG02	formestan	parent.	18	MG	259,74	X
92361	LENTARON DEPOT 250MG I.M.	inj sic 1x250mg+2ml	CGC	CH
323	L03AA	cytokiny	parent.	X
---	---	---	---	---	---	---	---
323.1	L03AA02	filgrastim	parent.	1	MG	12255,29	X
98297	NEUPOGEN	inj 5x1.6ml	HLR	CH
69026	NEUPOGEN	inj 5x1ml	HLR	CH
57863	NEUPOGEN	inj 5x1ml	AMG	POR
57864	NEUPOGEN	inj 5x1.6ml	AMG	POR
323.2	L03AA03	molgramostim (do 0,3 MG včetně v jedné ampuli)	parent.	1	MG	14034,30	X
96865	LEUCOMAX	inj sic 0.15mg+1ml	SAN	CH
72549	LEUCOMAX	inj sic 0.3mg+1ml	SAN	CH
323.3	L03AA03	molgramostim (nad 0,3 MG v jedné ampuli)	parent.	1	MG	12209,97	X
96866	LEUCOMAX	inj sic 0.4mg+1ml	SAN	CH
323.4	L03AA10	lenograstim	parent.	1	MG	13981,84	X

323.5	L03AB01	interferon alfa přirozený humánní	parent.	1	MU	239,51	X

323.6	L03AB03	interferon gamma	parent.	1	MU	1531,33	X

323.7	L03AB05	interferon alfa	parent.	1	MU	239,51	X
89225	ROFERON A	inj 1x3ml/18mu	HLR	CH
91640	INTRON A	inj 1x5mu	SCH	IRL
89224	ROFERON A	inj 1x1ml/3mu	HLR	CH
59222	INTRON A 10 MIL.M.J.	inj sic 1x10mu+solv	SCH	IRL
83393	INTRON A 3 MIL.M.J.	inj sic 1x3mu+solv	SCH	IRL
83394	INTRON A 5 MIL.M.J.	inj sic 1x5mu+solv	SCH	IRL
54372	INTRON A 3 MIL.M.J./0.5 ML	inj 1x0.5ml-lahv.	SCH	IRL
54374	INTRON A 5 MIL.M.J./0.5 ML	inj 1x0.5ml-lahv.	SCH	IRL
54375	INTRON A 5 MIL.M.J./0.5 ML	inj 1x1ml-lahv.	SCH	IRL
54472	INTRON A REDIPEN 3MIL.M.J.	inj 1x1.2ml/18mu	SCH	IRL
54473	INTRON A REDIPEN 5 MIL.M.J.	inj 1x1.2ml/30mu	SCH	IRL
54474	INTRON A REDIPEN 10MIL.M.J.	inj 1x1.2ml/60mu	SCH	IRL
54560	INTRON A 5 MIL.M.J./0.5 ML	inj 1x0.5ml+soupr.	SCH	IRL
54561	INTRON A 5 MIL.M.J./0.5 ML	inj 1x1ml+soupr.	SCH	IRL
54563	INTRON A 3 MIL.M.J./0.5 ML	inj 1x0.5ml+soupr.	SCH	IRL
323.8	L03AB07	interferon beta 1a	parent.	1	MU	430,33	X

323.9	L03AB07	interferon beta 1 a (výhradně pro intramuskulární užití)	parent.	1	DF	9036,55	X
57913	AVONEX	inj.sic. 4x30rg + solv.	BGI	NL
45187	AVONEX	inj.sic. 4x30rg + solv.	SVD	NL
323.10	L03AB08	interferon beta 1b	parent.	1	MU	322,75	X
87312	BETAFERON	inj sic 15+15x2ml	SAG	D
323.11	L03AC90	interleukin 2	parent.	1	MG	7739,31	X
86786	PROLEUKIN	inj sic 1x1mg	CNC	NL
324	L03AX	ostatní imunostimulační léčiva	lok., p.o.	L/ALG
---	---	---	---	---	---	---	---
324.1	L03AX92	směs bakteriálních lyzátů	p.o.	1	BA	60%

324.2	L03AX92	směs bakteriálních lyzátů	lok.	1	BA	60%	L/ALG,ORL

324.3	L03AX93	dialyzát vepřových leukocytů	p.o.	1	BA	60%	L/ALG,IMU

324.4	L03AX96	vaccin. staphyl. phagolys.	lok.	1	ML	36,51	L/ALG,ORL
94631	STAVA-NASAL	gtt 10x5ml	BIU	CZ
325	L03AX	ostatní imunostimulační léčiva	parent.	O
---	---	---	---	---	---	---	---
325.1	L03AX03	BCG vakcína	parent.	1	MG	43,36	O/ONK,URN

325.2	L03AX90	dialyzát lidských leukocytů	parent.	1	DF	988,38	O/ALG,IMU
56930	IMMODIN SEVAC	inj sic 1x2ml+solv.	SEV	CZ
97146	IMMODIN SEVAC	inj sic 5x2ml+solv.	SEV	CZ
325.3	L03AX91	thymostimulin (do 10 mg včetně v jedné ampuli)	parent.	1	MG	64,86	Z

325.4	L03AX91	thymostimulin (nad 10 mg v jedné ampuli)	parent.	1	MG	45,31	Z

325.5	L03AX94	bac. propionibacterii acnes	parent.	1	MG	72,83	O/ONK

325.6	L03AX95	laktobacillus acidophilus	parent.	3	DF	612,65	O/GYN
86711	SOLCOTRICHOVAC	inj 3x0.5ml	SOC	CH
325.7	L03AX96	vaccin. staphyl. phagolys.	parent.	1	DF	72,98	O
326	L04AA	selektivní imunosupresivní léčiva	p.o.	P
---	---	---	---	---	---	---	---

Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, urolog revmatolog a alergolog a klinický imunolog:

a) prevence reakce štěpu proti hostiteli po transplantacích,

b) léčba myelodysplastického syndromu nereagující na standardní léčbu,

c) léčba aplastické anemie nereagující na standardní léčbu,

d) léčba autoimunní hemolytické anemie a autoimunní trombocytopenické purpury nereagující na standardní léčbu,

e) léčba nefrotického syndromu nereagující na standardní léčbu,

f) těžké formy revmatoidní artritidy dospělých a dětí se středně těžkým a těžkým průběhem kloubního postižení nebo se současným postižením jiných orgánů (zvláště plic),

g) těžké generalizované formy psoriázy (psoriasis vulgaris, arthropatica, pustulosa) nereagující na standardní léčbu,

h) systémový lupus erythematodes nereagující na standardní léčbu,

i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu,

j) v indikaci plicní fibrózy ordinuje též lékař s nástavbovou specializací v oboru tuberkulózy a respiračních nemocí Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).

k) u myasthenia gravis předepisuje neurolog

Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy. I) těžké generalizované formy atopické dermatitidy se syndromem hyper-IgE.

326.1	L04AA01	cyklosporin	p.o.	250	MG	275,00	P
326.2	L04AA01	cyklosporin (mikroemul gované formy)	p.o.	250	MG	275,00	P

326.3	L04AA06	mophetil mycophenolát	p.o.	10	MG	2,50	P
55681	CELLCEPT	cps 100x250mg	HLR	CH
44077	CELLCEPT 500MG	tbl obd 50x500mg	HLR	CH
327	L04AA	selektivní imunosupresivní léčiva	parent.	U/J10
---	---	---	---	---	---	---	---
327.1	L04AA09	basiliximab	parent.	20	MG	53004,39	H

327.2	L04AA01	cyklosporin	parent.	1	MG	2,64	U/J10
88514	SANDIMMUN KONZENTRAT	inf 10x5ml 50mg/1ml	SAN	CH
327.3	L04AA02	muromonab-CD3	parent.	1	MG	2225,85	U/J10
96997	CEDETRIN-T(MONOK.PROTIL.A1-CD3)	inj 10x3.2ml	EXB	CZ
327.4	L04AA03	antilymfocytár ní IG	parent.	10	MG	103,87	U/J10

327.5	L04AA04	antithymocy tární IG	parent.	1	MG	121,46	U/J10
44491	ATG-FRESENIUS S	inj 1x5ml/100mg	FRE	D
44492	ATG-FRESENIUS S	inj 10x5ml/100mg	FRE	D
327.6	L04AA05	tacrolimus	parent.	5	MG	376,26	P

Tacrolimus je ordinován ošetřujícím lékařem nemocným po transplantaci orgánů v následujících případech:

a) imunosuprese u hypersensibilisovaných nemocných s PRA více než 80%

b) u opakovaných transplantovaných

c) jako záchranná léčba u pacientů s rejekcí rezistentní na antirejekční léčbu

| 327.7 | L04AA12 | infliximab | parent. | 400 | MG | 112.732,00 | X | | 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,56 | | | 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | | | 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,12 | | | 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | | | 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 9,82 | U/J10 | | 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | | | 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 330.1 | M01AA | butylpyrazolidi ny | p.o. | 3 | DF | 3,32 | | | 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,32 | | | 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 331.1 | M01AA | butylpyrazolidi ny | parent. | 1 | DF | 6,89 | | | 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | | | | | 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,76 | | | | | | | | | | | | 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,18 | | | 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | | | 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | | | 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | | | | | 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | | | | | 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 4,69 | | | | | | | | | | | | 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 4,69 | | | | | | | | | | | | 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 4,29 | | | 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | | | 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | | | 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | | | 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | | | 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | | | 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | | | 58426 | DOLMINA 25 | tbl obd 30x25mg | LEX | CZ | | | | | 58425 | DOLMINA 50 | tbl obd 30x50mg | LEX | CZ | | | | | 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | | | 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | | | 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | | | 332.6 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (do 100 MG v jedné tabletě včetně) | p.o. | 0.1 | GM | 4,52 | | | | | | | | | | | | 332.7 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (nad 100 MG v jedné tabletě) | p.o. | 0.1 | GM | 4,20 | | | | | | | | | | | | 332.8 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 4,29 | | | | | | | | | | | | 332.9 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 4,29 | | | | | | | | | | | | 332.10 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 4,29 | | | | | | | | | | | | 332.11 | M01AB55 | diklofenak/ misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 29,33 | Z | | 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,27 | | | 02789 | INDOMETACINUM | sup 5x100mg | CHN | H | | | | | 96329 | INDOMETACIN | sup 10x100mg | BLU | CHO | | | | | 93724 | INDOMETACIN 100 BERLIN-CHEMIE | sup 10x100mg | BCE | D | | | | | 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,56 | | | | | | | | | | | | 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,56 | | | 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | | | | | 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | | | | | 87206 | VERAL 100MG | sup 10x100 | SLO | SK | | | | | 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,56 | | | 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 12,66 | | | | | | | | | | | | 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 12,90 | | | 54539 | DOLMINA INJ. | inj 5x3ml/75mg | LEX | CZ | | | | | 67547 | ALMIRAL | inj 10x3ml/75mg | MOE | CY | | | | | 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY | | | | | 76727 | DICLO 75 VON CT | inj 5x2ml/75mg | CTA | D | | | | | 98109 | NAKLOFEN | inj 5x3ml/75mg | KRK | SLO | | | | | 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,49 | | | 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | | | 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | | | 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | | | 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | | | 84717 | HOTEMIN 20MG | cps 20x20mg | EGI | H | | | | | 31245 | HOTEMIN 10MG | cps 20x10mg | EGI | H | | | | | 53744 | PRO-ROXIKAM 10MG | tbl 20x10mg | PMP | CZ | | | | | 53745 | PRO-ROXIKAM 20MG | tbl 20x20mg | PMP | CZ | | | | | 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | | | 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | | | 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | | | 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,49 | | | | | | | | | | | | 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 14,32 | L/ORT,REV, NEU | | | | | | | | | | | 335.4 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 4,52 | | | 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 10,75 | | | 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | | | 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 10,75 | | | | | | | | | | | | 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 14,32 | L/ORT,REV, NEU | | 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 337.1 | M01AC01 | piroxìkam | parent. | 20 | MG | 11,73 | | | 68649 | HOTEMIN | inj 5x1ml/20mg | EGI | H | | | | | 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 11,73 | | | 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,57 | | | 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | | | 93651 | IBUPROFEN 400 LECIVA | tbl obd 30x400mg | LEX | CZ | | | | | 56035 | IBUPROFEN 600 LECIVA | tbl obd 30x600mg | LEX | CZ | | | | | 46983 | IBUPROFEN 400 LECIVA | tbl obd 100x400mg | LEX | CZ | | | | | 58250 | IBUPROFEN 600 LECIVA | tbl obd 100x600mg | LEX | CZ | | | | | 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 19,55 | | | | | | | | | | | | 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 4,29 | | | | | | | | | | | | 338.4 | M01AE02 | naproxen (tekuté lékové formy), | p.o. | 0.5 | GM | 13,15 | | | | | | | | | | | | 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 4,29 | | | | | | | | | | | | 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 4,29 | | | | | | | | | | | | 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 4,29 | | | | | | | | | | | | 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 4,29 | | | | | | | | | | | | 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 4,29 | | | | | | | | | | | | 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 6,70 | | | | | | | | | | | | 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 4,29 | | | 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 9,38 | | | | | | | | | | | | 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 10,75 | | | | | | | | | | | | 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8,75 | | | 06171 | PROFENID 100MG | sup 12 | SPC | F | | | | | 67639 | KETOPROFEN VON CT | sup 10x100mg | CTA | D | | | | | 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 10,75 | | | 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 13,73 | | | | | | | | | | | | 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 13,73 | | | 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 13,73 | | | 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | | | 59443 | KETONAL | inj 5x2ml/100mg | LEK | SLO | | | | | 340.4 | M01AG | etofenamat | parent. | 1 | GM | 13,73 | | | 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 15,60 | L/REV, ORT | | | | | | | | | | | 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 11,78 | | | 31023 | PROLIXAN 300 | cps 30x300mg | IDA | H | | | | | 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,44 | L/REV, ORT | | | | | | | | | | | 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 11,78 | | | | | | | | | | | | 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,32 | L/REV,ORT, NEU | | | | | | | | | | | 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 19,55 | L/REV,PDD, NEU | | | | | | | | | | | 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT, NEU | | | | | | | | | | | 341.8 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 30,00 | P | | | | | | | | | | | 341.9 | M01AH | rofecoxib (pevné i tekuté lékové formy) | p.o. | 1 | DF | 30,00 | P |

Léčiva skupiny specifických COX 2 inhibitorů jsou předepisována revmatologem nebo ortopedem osobám s níže uvedeným rizikem:

1) prodělaná vředová choroba žaludku či duodena, ověřená fibroskopicky, v předchozích 20 letech života nebo současně, nebo

2) současná dlouhodobá celková léčba kortikoidy (t.j. déle než 6 - 8 týdnů), nebo

3) současná léčba antikoagulačními léky warfarinového typu.

Osobám s výše uvedeným rizikem jsou tato léčiva předepisována u následujících diagnóz:

a) revmatoidní artritida dospělých ve všech stadiích onemocnění - celecoxib

b) osteoartróza nosných kloubů rentgenologicky III. - IV. stadia dle Kellgrena ve stadiu bolestivé dekompenzace či zánětlivé iritace -celecoxib i rofecoxib.

| 341.10 | M01AX21 | diacerein | p.o. | 100 | MG | 6,70 | L/REV, ORT | | 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,60 | L/REV | | 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | | | 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | | | 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou hyaluronovou ordinuje ortoped nebo revmatolog:

součást léčby primární osteoarthrózy kolenních klobů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.

| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 32,50 | | | 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 22,88 | | | | | | | | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 195,52 | P | | 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 14,66 | L/REV,ORT | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.3 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.4 | M02AA05 | benzydamin | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.5 | M02AA06 | etofenamát do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.6 | M02AA06 | etofenamát nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 01780 | REUMADOR | gel 1x100gm | SLO | SK | | | | | 344.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.11 | M02AA10 | ketoprofen spray (dle obsahu ketoprofenu) | lok. | 150 | MG | 5,50 | | | | | | | | | | | | 344.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | 67549 | ALMIRAL GEL | gel 1x25gm | MOE | CY | | | | | 344.15 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 65985 | VERAL GEL | gel 1x100gm 1% | SLO | SK | | | | | 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | | | 344.16 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,08 | | | | | | | | | | | | 344.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.18 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.19 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.20 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.21 | M02AA23 | indomethacin nad 50 g masti v jednom baleni | lok. | 1 | UM | 0,70 | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 0,85 | | | 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | | | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 0,85 | | | 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | | | | | 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1 kg | MVM | CZ | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,34 | | | 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | | | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 70,43 | H | | | | | | | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 55,82 | H | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 23,76 | H | | | | | | | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 63,84 | H | | | | | | | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 36,51 | H | | 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | | | | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 113,59 | H | | | | | | | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 43,11 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 113,59 | H | | | | | | | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 110,61 | H | | 86761 | TRACRIUM | inj 5x5ml/50mg | BWE | GB | | | | | 86760 | TRACRIUM | inj 5x2.5ml/25mg | BWE | GB | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 103,48 | H | | | | | | | | | | | 349.6 | M03AC10 | mivacuronium | parent. | 10 | MG | 129,58 | H | | | | | | | | | | | 349.7 | M03AC11 | cisatracurium | parent. | 10 | MG | 208,40 | H | | 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9580,28 | X | | 75241 | BOTOX | inj sic 1x100ut | ABL | IRL | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2443,95 | X | | 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 9,97 | | | | | | | | | | | | 351.2 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,31 | | | | | | | | | | | | 351.3 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 21,50 | L/NEU,ORT, REV | | | | | | | | | | | 351.4 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 15,84 | L/NEU,ORT, REV | | | | | | | | | | | 351.5 | M03BX04 | tolperison | p.o. | 200 | MG | 4,38 | | | 00208 | MYDOCALM | tbl obd 30x50mg | GED | H | | | | | 03788 | MYDOCALM 150 | tbl ent 30x150mg | GED | H | | | | | 57785 | MYDOCALM 50MG | tbl obd 30x50mg-le. | GED | H | | | | | 351.6 | M03BX04 | tolperison | parent. | 200 | MG | 9,58 | | | 02755 | MYDOCALM | inj 5x1ml/100mg | GED | H | | | | | 351.7 | M03BX05 | thiocolchicosid | p.o. | 12 | MG | 9,97 | | | | | | | | | | | | 351.8 | M03BX05 | thiocolchicosid | parent. | 12 | MG | 39,10 | | | | | | | | | | | | 351.9 | M03BX07 | tetrazepam | p.o. | 0.1 | GM | 15,84 | L/NEU,ORT, REV | | 56233 | MYOLASTAN | tbl obd 10x50mg | SWI | F | | | | | 351.10 | M03BC51 | orfenadrini citras a diklofenak | parent. | 1 | DF | 200,00 | H | | 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7156,08 | T | | 91583 | DANTROLEN | inj sic3x12x20mg+so | RHA | D | | | | | 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,28 | | | 96332 | ALOPURINOL BELUPO | tbl 100x100mg | BLU | CHO | | | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,08 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,86 | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,91 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

M05BA02 - kyselina klodronová, M05BA06 kyselina ibandronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped:

Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom. M05BA04 - kyselina alendronová:

Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:

a) Denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina.

b) Ženy o osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii.

Výše uvedená léčba kyselinou alendronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.

M05BA03 - kyselina pamidronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog:

a) Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázemi nebo bez nich; mnohočetný myelom.

b) Manifestní Pagetova choroba.

| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 225,58 | P | | 93985 | LODRONAT | cps 60x500mg | BOM | A | | | | | 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | | | 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 44,90 | P | | 357 | M05BA | bisfosfonáty | parent. | O/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

M05BA02 - kyselina klodronová, M05BA06 kyselina ibandronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped:

Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.

M05BA04 - kyselina alendronová:

Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:

a) Denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina.

b) Ženy o osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii.

M05BA03 - kyselina pamidronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog:

a) Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázemi nebo bez nich; mnohočetný myelom.

b) Manifestní Pagetova choroba.

| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2348,73 | O/P | | 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF | | | | | 93972 | LODRONAT | inj 5x10ml | BOM | A | | | | | 57452 | LODRONAT AMPULE | inj 5x10ml | BOM | D | | | | | 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3758,01 | O/P | | | | | | | | | | | 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9384,77 | O/P | | 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,45 | H | | 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H | | 75284 | NARCOTAN | liq 1x250ml | LEX | CZ | | | | | 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2290,62 | H | | | | | | | | | | | 359.3 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H | | 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H | | 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H | | 97388 | THIOPENTAL VUAB | inj sic 1x500mg | VUA | CZ | | | | | 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 34,95 | H | | 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ | | | | | 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 119,41 | O | | 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B | | | | | 60911 | FENTANYL | inj 5x10ml/0.5mg | JAN | B | | | | | 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 173,62 | O | | 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B | | | | | 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 48,29 | H | | 87721 | RAPIFEN | inj 5x2ml | JAN | B | | | | | 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1383,67 | H | | 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | | | | | 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 740,22 | H | | 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | | | | | 362.4 | N01AH03 | sufentanyl (nad 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1210,83 | H | | 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | | | 93703 | SUFENTA I.V. | inj 5x10ml/50rg | JAN | B | | | | | 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H | | | | | | | | | | | 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H | | 56741 | ULTIVA 5MG | inj sic 5x5mg | GWE | GB | | | | | 56740 | ULTIVA 2MG | inj sic 5x2mg | GWE | GB | | | | | 363 | N01AX | ostatní celková anestetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 363.1 | N01AX03 | ketamin (koncetrace do 1 % včetně) | parent. | 100 | ML | 240,19 | O | | 64824 | NARKAMON 1% INJ. | inj 10x10ml/100mg | SPX | CZ | | | | | 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 117,02 | O | | | | | | | | | | | 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,11 | O | | | | | | | | | | | 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O | | | | | | | | | | | 363.5 | N01AX10 | propofol | parent. | 10 | ML | 96,14 | O | | 53441 | PROPOFOL ABBOTT | inj 5x20ml/200mg-am | ABN | USA | | | | | 53442 | PROPOFOL ABBOTT | inj 5x20ml/200mg-la | ABN | USA | | | | | 53443 | PROPOFOL ABBOTT | inj 1x50ml/500mg | ABN | USA | | | | | 53444 | PROPOFOL ABBOTT | inj 1x100ml/1gm | ABN | USA | | | | | 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O | | | | | | | | | | | 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O | | 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | | | 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ | | | | | 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,54 | O | | 69669 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | | 69670 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | 69671 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | 69673 | INJECTIO | PROCAIN | CHLOR | .0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | 69674 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | 69676 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x250ml 1% | ARD | CZ | | 69677 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x500ml 1% | ARD | CZ | | 86437 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | | 86444 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | | 86445 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | | 86447 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | 86448 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | 86450 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 20x250ml 1% | ARD | CZ | | 86451 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 12x500ml 1% | ARD | CZ | | 89212 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | 89213 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | | 89214 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | | 89215 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | | 89216 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x200ml 1% | ARD | CZ | | 89217 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 20x200ml 1% | ARD | CZ | | 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,22 | O | | 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | | | 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 7,83 | O | | 62393 | INSTILLAGEL | gel 10x11ml(strik.) | FAP | D | | | | | 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O | | 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ | | | | | 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O | | 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | | | | | 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O | | 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | | | | | 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | | | 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1 x500ml 1 % | ARD | CZ | | | | | 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1 % | ARD | CZ | | | | | 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ | | | | | 86457 | INJECTIO TRIMECAIN.CHL. 1 % ARD. | inj 12x500ml 1% | ARD | CZ | | | | | 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O | | 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ | | | | | 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O | | | | | | | | | | | 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O | | | | | | | | | | | 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 49,66 | O | | 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S | | | | | 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O | | | | | | | | | | | 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O | | | | | | | | | | | 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O | | | | | | | | | | | 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,22 | O | | 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HOE | D | | | | | 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O | | | | | | | | | | | 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O | | | | | | | | | | | 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O | | 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ | | | | | 366.15 | N01BB09 | ropivacain | parent. | 1 | ML | 15,64 | O | | 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | S | | | | | 367 | N01BX | ostatní lokální anestetika | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O | | 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | | | 55939 | M-ESLON SR 10 | cps ret 50x10mg | ETP | F | | | | | 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | | | | | 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | | | | | 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F | | | | | 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | | | | | 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | | | 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | | | | | 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | | | | | 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F | | | | | 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | | | | | 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | | | | | 88835 | M-ESLON SR 30 | cps ret 20x30mg | ETP | F | | | | | 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | | | | | 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | | | 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | | | 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | | | | | 55945 | M-ESLON SR 100 | cps ret 50x100mg | ETP | F | | | | | 55946 | M-ESLON SR 100 | cps ret 100x100mg | ETP | F | | | | | 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | | | | | 88842 | M-ESLON SR 100 | cps ret 20x100mg | ETP | F | | | | | 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | | | 368.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | | | 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | | | 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | | | | | 55943 | M-ESLON SR 60 | cps ret 50x60mg | ETP | F | | | | | 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | | | 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | | | 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F | | | | | 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | | | 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | | | | | | | | | | | | 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | | | | | | | | | | | | 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | | | | | | | | | | | | 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | | | | | | | | | | | | 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | | | | | | | | | | | | 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | | | | | | | | | | | | 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 52,64 | | | | | | | | | | | | 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 48,74 | | | | | | | | | | | | 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 52,34 | | | 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB | | | | | 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | | | | | 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB | | | | | 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 44,58 | | | 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 14,88 | O | | 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | | | | | 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,00 | O | | 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | | | | | 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | | | | | | | | | | | | 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 241,46 | P | | | | | | | | | | | 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P | | | | | | | | | | | 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,20 | P | | | | | | | | | | | 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |

Lék je aplikován v případech, kdy pacient není schopen perorálního příjmu opioidů.

371	N02AB	analgetika ze skupiny fenylpiperidinových derivátů	parent.	O
371.1	N02AB02	pethidin (do 50 mg v jedné ampuli včetně)	parent.	0.4	GM	53,62	O
02715	DOLSIN	inj 10x1ml 5%	HBS	SK
371.2	N02AB02	pethidin (nad 50 mg v jedné ampuli)	parent.	0.4	GM	33,87	O
02716	DOLSIN	inj 10x2ml 5%	HBS	SK
371.3	N02AC03	piritramid	parent.	300	MG	94,43	O
372	N02AC	analgetika ze skupupiny difenylpropylaminových derivátů	p.o.
---	---	---	---	---	---	---	---	---
372.1	N02AC05	benzitramid	p.o.	10	MG	12,71
373	N02AD	analgetika ze skupiny benzomorfanových derivátů	p.o.
---	---	---	---	---	---	---	---	---
373.1	N02AD01	pentazocin	p.o.	0.2	GM	25,47
08968	FORTRAL	tbl 100x50mg	KRK	SLO
374	N02AD	anatgetika ze skupiny benzomorfanových derivátů	parent.	O
---	---	---	---	---	---	---	---	---
374.1	N02AD01	pentazocin	parent.	0.2	GM	99,22	O
08966	FORTRAL	inj 10x1ml/30mg	KRK	SLO
375	N02AX	analgetika ze skupiny ostatních opioidů	p.o., subling.
---	---	---	---	---	---	---	---	---
375.1	N02AE01	buprenorfin	sublng.	1.2	MG	95,80

375.2	N02AX01	tilidin	p.o.	0.2	GM	15,76
03558	VALORON	gtt 10ml 10%	GNO	CZ
375.3	N02AX02	tramadol (pevné lékové formy neretardované)	p.o.	0.3	GM	23,00
12826	TRAMADOL LANNACHER 50MG	tbl flm 30x50mg	LAR	A
53716	PROTRADON	cps 500x50mg	PMP	CZ
83094	TRAMAL	cps 20x50mg	LEX	CZ
84375	PROTRADON	cps 10x50mg	PMP	CZ
84376	PROTRADON	cps 20x50mg	PMP	CZ
375.4	N02AX02	tramadol (pevné lékové formy retardované)	p.o.	0.3	GM	32,75
43711	TRAMAL RETARD 100	tbl obd 10x100mg	LEX	CZ
43712	TRAMAL RETARD 100	tbl obd 30x100mg	LEX	CZ
53366	TRAMAL RETARD 150	tbl ret 10x150mg	LEX	CZ
53367	TRAMAL RETARD 150	tbl ret 30x150mg	LEX	CZ
53368	TRAMAL RETARD 200	tbl ret 10x200mg	LEX	CZ
53369	TRAMAL RETARD 200	tbl ret 30x200mg	LEX	CZ
375.5	N02AX02	tramadol (tekuté lékové formy)	p.o.	0.3	GM	36,07
12471	TRAMABENE KAPKY	gtt 1x10ml/1gm	MCK	D
12472	TRAMABENE KAPKY	gtt 1x30ml/3gm	MCK	D
12918	TRAMADOL-SLOVAKOFARMA	sol 1x10ml	SLO	SK
53555	PROTRADON KAPKY	gtt 1x10ml/1gm	PMP	CZ
56036	TRAMAL	gtt 1x96ml/9.6gm	LEX	CZ
64981	TRAMADOL LANNACHER 100MG/ML	gtt 1x10ml/1gm	LAR	A
83095	TRAMAL	gtt 1x10ml/1gm	LEX	CZ
84630	TRAMADOL-K	gtt 1x10ml/1gm	KRK	SLO
376	N02AX	analgetika ze skupiny ostatních opioidů	p.rect., parent.	O
---	---	---	---	---	---	---	---	---
376.1	N02AE01	buprenorfin	parent.	1.2	MG	200,40	O

376.2	N02AF01	butorfanol	parent.	12	MG	83,10	O
88739	BEFORAL	inj 5x1ml/2mg	LEX	CZ
376.3	N02AF02	nalbufin	parent.	80	MG	69,21	O
376.4	N02AX01	tilidin	parent.	0.2	GM	16,37	O

376.5	N02AX02	tramadol	p.rect.	0.3	GM	59,78
12822	TRAMADOL LANNACHER 100MG	sup 5x100mg	LAR	A
44713	TRAMADOL 100-SLOVAKOFARMA	sup 10x100mg	SLO	SK
83096	TRAMAL	sup 5x100mg	LEX	CZ
84632	TRAMADOL-K	sup 5x100mg	KRK	SLO
376.6	N02AX02	tramadol (do 50 mg v jedné ampuli včetně)	parent.	0.3	GM	115,21	O
53675	TRAMADOL-SLOVAKOFARMA 50MG/1ML	inj 5x1ml/50mg	SLO	SK
83097	TRAMAL 50	inj 5x1ml/50mg	LEX	CZ
84628	TRAMADOL-K 50MG/1ML	inj 5x1ml/50mg	KRK	SLO
92363	TRAMADOL LANNACHER 50MG/1ML	inj 5x1ml/50mg	LAR	A
376.7	N02AX02	tramadol (nad 50 mg v jedné ampuli)	parent.	0.3	GM	58,65	O
53678	TRAMADOL-SLOVAKOFARMA 100MG/2ML	inj 5x2ml/100mg	SLO	SK
67558	MABRON	inj 5x2ml/100mg	MOE	CY
67559	MABRON	inj 10x2ml/100mg	MOE	CY
67560	MABRON	inj 100x2ml/100mg	MOE	CY
83098	TRAMAL 100	inj 5x2ml/100mg	LEX	CZ
84629	TRAMADOL-K 100MG/2ML	inj 5x2ml/100mg	KRK	SLO
92364	TRAMADOL LANNACHER 100MG/2ML	inj 5x2ml/100mg	LAR	A
377	N02BA	analgetika ze skupiny kyseliny salicylové a jejich derivátů	p.o.
---	---	---	---	---	---	---	---	---
377.1	N02BA01	kyselina acetylsalicylová	p.o.	3	GM	6,45
00011	ACYLPYRIN	tbl 10x500mg	SLO	SK
377.2	N02BA02	aloxiprin	p.o.	3	GM	6,45

377.3	N02BA03	cholin salicylát	p.o.	3	GM	8,65

377.4	N02BA11	diflunisal	p.o.	0.75	GM	5,72

377.5	N02BA91	lysin acetylsalicylát (do 100 mg v jedné tabletě včetně)	p.o.	3	GM	8,65

377.6	N02BA91	lysin acetylsalicylát (nad 100 mg v jedné tabletě)	p.o.	3	GM	6,45

377.7	N02BA92	lysin acetylsalicylát v kombinaci s metoklopramidem	p.o.	1	DF	21,66
378	N02BA	analgetika ze skupiny kyseliny salicylové a jejich derivátů	parent.
---	---	---	---	---	---	---	---	---
378.1	N02BA	lysin salicylát	parent.	3	GM	41,79

378.2	N02BA04	salicylát sodný	parent.	3	GM	38,13
00527	NATRIUM SALICYLICUM BIOTIKA	inj 10x10ml 10%	HBS	SK
378.3	N02BA91	lysin acetylsalicylát	parent.	3	GM	40,37
379	N02BE	analgetika ze skupiny anilidů	p.o.
---	---	---	---	---	---	---	---	---
379.1	N02BE01	paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně)	p.o.	3	GM	8,26
97656	PARALEN 125	tbl 20x125mg	LEX	CZ
379.2	N02BE01	paracetamol (pevné lékové formy nad 125 mg v jedné tabletě)	p.o.	3	GM	4,94
03837	PARALEN 500	tbl 10x500mg	LEX	CZ
71997	PARACETAMOL K	tbl 10x500mg	KRK	SLO
83608	APO-ACETAMINOPHEN 500MG	tbl 100x500mg	APT	CND
84749	MEDIPYRIN 500	tbl 10x500mg	SLO	SK
98078	PARACETAMOL K	tbl 1000x500mg	KRK	SLO
99381	PARALEN 500	tbl (10x10)x500mg	LEX	CZ
379.3	N02BE01	paracetamol (tekuté lékové formy)	p.o.	3	GM	8,65
380	N02BE	analgetika ze skupiny anilidů	p.rect.
---	---	---	---	---	---	---	---	---
380.1	N02BE01	paracetamol (do 150 mg v jednom čípku včetně)	p.rect.	3	GM	90,96
67226	EFFERALGAN JEUNE ENFANT 150MG	sup 10x150mg	UPS	F
67230	EFFERALGAN NOURRISSON 80MG	sup 10x80mg	UPS	F
86009	BEN-U-RON 125MG	sup 5x125mg	BNC	D
86010	BEN-U-RON 125MG	sup 10x125mg	BNC	D
91249	PARALEN 100	sup 5x100mg	LEX	CZ
380.2	N02BE01	paracetamol (nad 150 mg v jednom čípku)	p.rect.	3	GM	26,98
04343	PARALEN 500	sup 5x500mg	LEX	CZ
53169	EFFERALGAN ADULTE 600MG	sup 10x600mg	UPS	F
53920	MEDIPYRIN 250	sup 10x250mg	DAB	CZ
67227	EFFERALGAN GRAND ENFANT 300MG	sup 10x300mg	UPS	F
86013	BEN-U-RON 500MG	sup 5x500mg	BNC	D
86014	BEN-U-RON 500MG	sup 10x500mg	BNC	D
86015	BEN-U-RON 1000MG	sup 10x1000mg	BNC	D
94982	MEXALEN	sup 6x1000mg	MCK	D
381	N02B	ostatní analgetika	parent.	O
---	---	---	---	---	---	---	---	---
381.1	N02BB02	metamizol sodný (nad 1 g v 1 ampuli)	parent.	3	GM	18,48	O
62813	NOVALGIN	inj 5x5ml/2500mg	HOE	D
381.2	N02BB02	metamizol sodný (do	1 g v 1 ampuli včetně)	parent.	3	GM	44,53	O
62437	NOVALGIN	inj 10x2ml/1000mg	HOE	D
381.3	N02BB	aminophenazon v kombinacích	parent.	1	DF	7,33	O
00457	EUNALGIT	inj 5x2ml	LEX	CZ
381.4	N02BE05	propacetamol	parent.	1	GM	41,84	O
53748	PRO-EFFERALGAN 2GM	inj sic 8x2gm+solv.	UPS	F
382	N02CA	antimigrenika ze skupiny derivátů námelových alkaloidů	p.o.
---	---	---	---	---	---	---	---	---
382.1	N02CA01	dihydroergotamin	p.o.	4	MG	1,22
91031	CLAVIGRENIN FORTE	gtt 1x25ml/125mg	GNO	CZ
382.2	N02CA07	lisurid	p.o.	75	RG	0,73

382.3	N02CA52	ergotamin, kombinace	p.o.	4	DF	9,38
383	N02CA	antimigrenika ze skupiny derivátů námelových alkaloidů	parent.
---	---	---	---	---	---	---	---	---
383.1	N02CA01	dihydroergotamin	parent.	4	MG	113,50
90795	DIHYDERGOT	inj 5x1 ml 1 mg/ml	SAN	CH
383.2	N02CA01	dihydroergotamin nosní spray	inhal.	1	MG	50,00
384	N02C	jiná antimigrenika	p.o.
---	---	---	---	---	---	---	---	---
384.1	N02CC01	sumatriptan (do 0,05 GM včetně v jedné tabletě)	p.o.	0.1	GM	195,52

384.2	N02CC01	sumatriptan (nad 0,05 GM v jedné tabletě)	p.o.	0.1	GM	146,64

384.3	N02CC01	sumatriptan	parent.	1	DF	830,94	X

384.4	N02CC01	sumatriptan (nasal spray)	inhal.	1	DF	400,80	X

384.5	N02CC02	naratriptan	p.o.	2,5	MG	125,00	X

384.6	N02CC03	zolmitriptan	p.o.	2,5	MG	125,00	X

384.7	N02CC	eletriptan	p.o.	40	MG	146,64

384.8	N02CC04	rizatriptan	p.o.	10	MG	125,00	X

384.9	N02CX	pipethiaden	p.o.	3	DF	2,54
94583	MIGRENAL	tbl 50x1mg	LEX	CZ
384.10	N02CX01	pizotifen	p.o.	1.5	MG	5,87

384.11	N02CX06	oxetoron	p.o.	0.12	GM	5,87
385	N03AA	antiepileptika ze skupiny barbiturátů a jejich derivátů	p.o.
---	---	---	---	---	---	---	---	---
385.1	N03AA	fenobarbital pseudonorefedr.	p.o.	0.1	GM	2,05

385.2	N03AA02	fenobarbital (do 15 mg v jedné tabletě včetně)	p.o.	0.1	GM	6,31
68578	PHENAEMALETTEN	tbl 50x15mg	DET	D
385.3	N03AA02	fenobarbital (nad 15 mg v jedné tabletě)	p.o.	0.1	GM	2,40
68579	PHENAEMAL 0.1	tbl 50x100mg	DET	D
385.4	N03AA03	primidon (pevné lékové formy)	p.o.	1.25	GM	4,89
86621	MYSOLINE	tbl 100x250mg	ZNC	GB
385.5	N03AA03	primidon (tekuté lékové formy)	p.o.	1.25	GM	45,51
386	N03AA	antiepileptika ze skupiny barbiturátů a jejich derivátů	parent.	O
---	---	---	---	---	---	---	---	---
386.1	N03AA02	fenobarbital (do 40 mg včetně v jedné ampuli)	parent.	0.1	GM	132,22	O
66845	GARDENAL	inj sic 1x40mg+solv	SPC	F
386.2	N03AA02	fenobarbital (nad 40 mg v jedné ampuli)	parent.	0.1	GM	13,98	O
84449	LUMINAL	inj 5x1ml/219mg	DET	D
387	N03AB	antiepileptika ze skupiny hydantoinů	p.o.
---	---	---	---	---	---	---	---	---
387.1	N03AB02	fenytoin	p.o.	0.3	GM	2,81
62234	EPILAN D GEROT	tbl 100x100mg	GER	A
00297	SODANTON	tbl 20x100mg	SLO	SK
387.2	N03AB04	mefenytoin	p.o.	0.4	GM	2,44

387.3	N03AB52	fenytoin, kombinace	p.o.	3	DF	2,00
00291	SANEPIL	tbl 20	SLO	SK
388	N03AB	antiepileptika ze skupiny hydantoinů	parent.
---	---	---	---	---	---	---	---	---
388.1	N03AB02	fenytoin	parent.	0.3	GM	122,25	O
03300	EPANUTIN	inj 5x5ml/250mg	PDA	GB
66564	PHENHYDAN	inj 5x5ml/250mg	DET	D
389	N03AD	antiepileptika ze skupiny sukcinimidů	p.o.
---	---	---	---	---	---	---	---	---
389.1	N03AD01	ethosuximid (pevné lékové formy)	p.o.	1.25	GM	17,06
93710	SUXILEP	cps 120x250mg	VJP	D
389.2	N03AD01	ethosuximid (tekuté lékové formy)	p.o.	1.25	GM	23,07
02035	SUXILEP	gtt 50gm 50%	GMD	D
389.3	N03AD03	mesuximid	p.o.	0.9	GM	24,78
390	N03AE	antiepileptika ze skupiny benzodiazepinů	p.o.
---	---	---	---	---	---	---	---	---
390.1	N03AE01	klonazepam (tekuté lékové formy)	p.o.	8	MG	34,17
03029	RIVOTRIL	gtt 10ml 25mg	HLR	CH
390.2	N03AE01	klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně)	p.o.	8	MG	24,15
03031	RIVOTRIL	tbl 50x0.5mg	HLR	CH
390.3	N03AE01	klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě)	p.o.	8	MG	12,71
391	N03AE	antiepileptika ze skupiny benzodiazepinů	parent.	O
---	---	---	---	---	---	---	---	---
391.1	N03AE01	klonazepam	parent.	8	MG	238,53	O
03636	RIVOTRIL	inj 25x1mg/1ml+sol	HLR	CH
03030	RIVOTRIL	inj 5x1ml/1mg+solv.	HLR	CH
392	N03AF	antiepileptika ze skupiny derivátů karboxamidu	p.o.
---	---	---	---	---	---	---	---	---
392.1	N03AF01	karbamazepin (pevné lékové formy)	p.o.	1	GM	12,37
03417	BISTON	tbl 50x200mg	SLO	SK
62309	APO-CARBAMAZEPINE 200MG	tbl 100x200mg	APT	CND
98080	NEUROTOP	tbl 50x200mg	GER	A
392.2	N03AF01	karbamazepin (retardované pevné lékové formy)	p.o.	1	GM	17,21
60164	TIMONIL RETARD	tbl 50x300mg	DET	D
60165	TIMONIL RETARD	tbl 100x300mg	DET	D
60166	TIMONIL RETARD	tbl 50x600mg	DET	D
71954	TIMONIL RETARD	tbl 50x150mg	DET	D
75293	TIMONIL RETARD	tbl 100x150mg	DET	D
92039	TEGRETOL CR	tbl obd 50x200mg	CGC	CH
93619	TEGRETOL CR	tbl obd 30x400mg	CGC	CH
96305	NEUROTOP RETARD 300	tbl 50x300mg	GER	A
96306	NEUROTOP RETARD 600	tbl 50x600mg	GER	A
392.3	N03AF01	karbamazepin (tekuté lékové formy)	p.o.	1	GM	42,52

392.4	N03AF02	oxcarbazepin	p.o.	1	GM	11,10
393	N03AG	antiepileptika 2e skupiny derivátů mastných kyselin (kyselina valproová)	p.o.
---	---	---	---	---	---	---	---	---
393.1	N03AG01	valproová kyselina (pevné lékové formy, do 150 mg v 1 tabletě včetně)	p.o.	1.5	GM	19,40
61183	ORFIRIL 150	drg 50x150mg	DET	D
08768	CONVULEX	cps 100x150mg	GER	A
393.2	N03AG01	valproová kyselina (pevné lékové formy, nad 150 mg v 1 tabletě)	p.o.	1.5	GM	15,64
08769	CONVULEX	cps 100x300mg	GER	A
61184	ORFIRIL 300	drg 50x300mg	DET	D
61185	ORFIRIL 600	drg 50x600mg	DET	D
61187	ORFIRIL 300	drg 100x300mg	DET	D
75296	CONVULEX	cps 100x500mg	GER	A
93334	FVERIDEN	tbl 100x300mg	SLO	SK
393.3	N03AG01	valproová kyselina (retardované pevné lékové formy do 300 MG v jedné tabletě včetně)	p.o.	1.5	GM	31,90
62705	ORFIRIL 300 RETARD	drg ret 100x300mg	DET	D
57713	ORFIRIL LONG 300MGv	cps ret 100x300mg	DET	D
57712	ORFIRIL LONG 300MG	cps ret 50x300mg	DET	D
57710	ORFIRIL LONG 150MG	cps ret 100x150mg	DET	D
57709	ORFIRIL LONG 150MG	cps ret 50x150mg	DET	D
393.4	N03AG01	valproová kyselina (retardované pevné lékové formy nad 300 MG v jedné tabletě)	p.o.	1.5	GM	26,88

393.5	N03AG01	valproová kyselina (tekuté lékové formy)	p.o.	1.5	GM	26,54
08770	CONVULEX	gtt 100ml 300mg/ml	GER	A
394	N03AG	antiepileptika ze skupiny derivátů mastných kyselin (ostatní)	p.o.	L/NEU,PSY
---	---	---	---	---	---	---	---	---
394.1	N03AG02	valpromid	p.o.	1.5	GM	25,61	L/PSY,NEU

394.2	N03AG04	vigabatrin	p.o.	2	GM	138,48	L/PSY,NEU
80370	SABRIL	tbl obd 100x500mg	MDD	GB
394.3	N03AG06	tiagabin	p.o.	30	MG	140,00	L/PSY,NEU
395	N03AG	antiepileptika ze skupiny derivátů mastných kyselin	parent.	K
---	---	---	---	---	---	---	---	---
395.1	N03AG01	valproová kyselina	parent.	1.5	GM	1201,85	K
54238	ORFIRIL INJEKTIONSLOSUNG	inj 5x3ml/300mg	DET	D
396	N03AX	ostatní antiepileptika		L/PSY,NEU
---	---	---	---	---	---	---	---	---
396.1	N03AX03	sultiam	p.o.	0.4	GM	16,72	L/PSY,NEU
55852	OSPOLOT	tbl obd 50x200mg	DET	D
396.2	N03AX09	lamotrigin (do 5 mg v jedné tabletě včetně)	p.o.	0.3	GM	357,80	L/PSY,NEU
84511	LAMICTAL 5MG DISPERSIBLE/CHEW.	ctb 30x5mg	BWE	GB
396.3	N03AX09	lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě)	p.o.	0.3	GM	185,00	L/PSY, NEU
49488	LAMICTAL 25MG	tbl 21x25mg	BWE	GB
49489	LAMICTAL 25MG	tbl 42x25mg	BWE	GB
68800	LAMICTAL	tbl 30x25mg	BWE	GB
84512	LAMICTAL 25MG DISPERSIBLE/CHEW.	ctb 30x25mg	BWE	GB
396.4	N03AX09	lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě)	p.o.	0.3	GM	175,00	L/PSY,NEU
49490	LAMICTAL 50MG	tbl 42x50mg	BWE	GB
68801	LAMICTAL	tbl 30x50mg	BWE	GB
396.5	N03AX09	lamotrigin (nad 50 mg v jedné tabletě)	p.o.	0.3	GM	144,00	L/PSY,NEU
53799	LAMICTAL 100MG	tbl 100x100mg	BWE	GB
68802	LAMICTAL	tbl 30x100mg	BWE	GB
84513	LAMICTAL 100MG DISPERSIBLE/CHEW	ctb 30x100mg	BWE	GB
396.6	N03AX10	felbamat	p.o.	2.4	3M	283,03	L/PSY,NEU
77003	TALOXA	sus 230ml 120mg/ml	SCH	B
77004	TALOXA 400MG	tbl 100x400mg	SCH	B
396.7	N03AX11	topiramat tobolky (do 25 mg včetně v jedné tobolce)	p.o.	0.3	GM	300,00	P

Topiramat - léková forma tobolky, síla do 25 mg včetně v jedné tobolce: Pro děti předškolního věku, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.

| 396.8 | N03AX11 | topiramat (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 169,48 | L/PSY,NEU | | 44671 | TOPAMAX 25MG | tbl obd 28x25mg-bl. | CIL | CH | | | | | 396.9 | N03AX11 | topiramat (nad 25 mg v jedné tabletě) | p.o. | 0.3 | GM | 151,62 | L/PSY,NEU | | 44675 | TOPAMAX 50MG | tbl obd 28x50mg-bl. | CIL | CH | | | | | 44679 | TOPAMAX 100MG | tbl obd 28x100mg-bl | CIL | CH | | | | | 396.10 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 138,23 | L/PSY,NEU | | 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | | | | | 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | | | | | 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | | | | | 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | | | | | 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | | | | | 84402 | NEURONTIN 400MG | cps 100x400mg | PDA | D | | | | | 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 397.1 | NQ4AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 6,83 | | | 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | | | | | 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,22 | | | | | | | | | | | | 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | | | | | | | | | | | | 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | | | 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | | | | | 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,52 | O | | 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | | | | | 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | | | 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O | | 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,18 | | | 96751 | APO-BENZTROPINE 2MG | tbl 100x2mg | APT | CND | | | | | 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | | | | | | | | | | | | 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | | | 45241 | ISICOM 100MG | tbl 100x100mg | DET | D | | | | | 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | | | 03591 | NAKOM | tbl 100x275mg | LEK | SLO | | | | | 45244 | ISICOM 250MG | tbl 100x250mg | DET | D | | | | | 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 22,00 | | | 12095 | MADOPAR 250 | tbl 30x250mg | LEX | CZ | | | | | 54459 | MADOPAR 250 | tbl 100x250mg | LEX | CZ | | | | | 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 GM včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | | | | | | | | | | | | 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 GM v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | | | 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 4,94 | L/NEU,PSY,GER | | 02871 | VIREGYT-K | cps 50x100mg | EGI | H | | | | | 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY,GER | | | | | | | | | | | 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H | | 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 402.1 | N04BD01 | Selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 6,35 | L/NEU,PSY,GER | | 31036 | JUMEX 5MG | tbl 50x5mg | CHN | H | | | | | 55764 | COGNITIV 5MG | tbl obd 100x5mg | EBW | A | | | | | 92500 | SEPATREM 5 | tbl 50x5mg | LEX | CZ | | | | | 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,85 | L/NEU,PSY,GER | | 92501 | SEPATREM 10 | tbl 50x10mg | LEX | CZ | | | | | 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X | | | | | | | | | | | 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 176,94 | X | | | | | | | | | | | 402.5 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X | | | | | | | | | | | 402.6 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X | | 54412 | MIRAPEXIN 1MG | tbl 100x1mg | PAU | B | | | | | 54410 | MIRAPEXIN 0.25MG | tbl 100x0.25mg | PAU | B | | | | | 54407 | MIRAPEXIN 0.125MG | tbl 30x0.125mg | PAU | B | | | | | 402.7 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X | | | | | | | | | | | 402.8 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X | | | | | | | | | | | 402.9 | N04BX02 | entacapon | p.o. | 600 | MG | 116,72 | X | | 54466 | COMTAN | tbl obd 30x200mg | NPA | D | | | | | 402.10 | N04BC04 | ropinirol | p.o. | 6 | MG | 53,17 | X | | 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 10,56 | | | 02114 | PLEGOMAZIN | drg 50x25mg | EGI | H | | | | | 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,67 | | | 62313 | PLEGOMAZIN | drg 30x100mg | EGI | H | | | | | 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 62,76 | | | | | | | | | | | | 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 14,66 | | | 02429 | TISERCIN | tbl obd 50x25mg | EGI | H | | | | | 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | | | 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O | | 00560 | PLEGOMAZIN | inj 10x5ml/25mg | EGI | H | | | | | 00561 | PLEGOMAZIN | inj 10x2ml/50mg | EGI | H | | | | | 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O | | 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | | | | | 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,76 | | | 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | | | | | 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | | | 00274 | PROCHLORPERAZIN LECIVA | tbl 20x10mg | LEX | CZ | | | | | 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 6,99 | | | | | | | | | | | | 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,70 | | | 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 3,91 | O | | 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | | | | | 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,44 | L/NEU,PSY,GER | | 01559 | NEULEPTIL | gtt 1x125ml 4% | RRO | F | | | | | 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY,GER | | | | | | | | | | | 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 10,92 | | | 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | | | | | 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | | | | | 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | | | 67110 | HALOPER 2MG VON CT | tbl 50x2mg | CTA | D | | | | | 67111 | HALOPER 5MG VON CT | tbl 50x5mg | CTA | D | | | | | 67112 | HALOPER 10MG VON CT | tbl 20x10mg | CTA | D | | | | | 67113 | HALOPER 10MG VON CT | tbl 100x10mg | CTA | D | | | | | 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | | | | | 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,12 | | | 02539 | HALOPERIDOL | gtt 1x10ml/20mg | GED | H | | | | | 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,72 | | | | | | | | | | | | 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 3,91 | | | | | | | | | | | | 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 24,94 | | | 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 8,26 | O | | | | | | | | | | | 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16,72 | O | | 02538 | HALOPERIDOL | inj 5x1ml/5mg | GED | H | | | | | 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,52 | O | | | | | | | | | | | 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,83 | O | | | | | | | | | | | 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 50,83 | O | | 01443 | DEHYDROBENZPERIDOL | inj 50x10ml/25mg | JAN | B | | | | | 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,28 | | | | | | | | | | | | 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 15,70 | | | 88143 | FLUANXOL 1MG | drg 100x1 mg | LUN | DK | | | | | 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | | | | | | | | | | | | 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 7,82 | | | 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | | | | | 410.5 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,71 | | | 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | | | 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,83 | | | 57823 | CISORDINOL 10MG | tbl obd 50x10mg-pp | LUN | DK | | | | | 57827 | CISORDINOL 25MG | tbl obd 50x25mg-pp | LUN | DK | | | | | 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,44 | O | | 88379 | MECLOPIN | inj 5x1ml/25mg | SPX | CZ | | | | | 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 15,16 | O | | 91830 | FLUANXOL DEPOT | inj 10x2ml/40mg | LUN | DK | | | | | 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,03 | O | | | | | | | | | | | 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 94,25 | O | | 93252 | CISORDINOL-ACUTARD | inj 10x1ml/50mg | LUN | DK | | | | | 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK | | | | | 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O | | 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,80 | | | 02757 | ORAP FORTE | tbl 20x4mg | JAN | B | | | | | 98120 | ORAP | tbl 75x1mg | JAN | B | | | | | 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,11 | | | 09684 | SEMAP | tbl 12x20mg | JAN | B | | | | | 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,71 | O | | 09164 | IMAP | inj 1x6ml/12mg | JAN | B | | | | | 98114 | IMAP | inj 3x1ml/2mg | JAN | B | | | | | 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 414.1 | N05AH01 | loxapin | p.o. | 0.1 | GM | 52,20 | L/PSY | | | | | | | | | | | 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 75,03 | L/PSY,NEU | | 03617 | LEPONEX | tbl 50x25mg | SAN | CH | | | | | 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 66,18 | L/PSY,NEU | | | | | | | | | | | 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 60,37 | L/PSY | | 02970 | LEPONEX | tbl 50x100mg | SAN | CH | | | | | 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 143,00 | L/PSY | | | | | | | | | | | 414.6 | N05AH04 | quetiapin | p.o. | 0.4 | GM | 143,00 | L/PSY | | | | | | | | | | | 414.7 | N05AH | zotepin | p.o. | 0.3 | GM | 76,90 | L/PSY | | 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H | | 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 42,03 | | | 54432 | PROSULPIN 50 MG | tbl 30x50mg | PMP | CZ | | | | | 416.2 | N05AL01 | Sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 24,59 | L/PSY,NEU | | 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | | | | | 64590 | DOGMATIL 200MG TBL. | tbl 120x200mg | SSJ | F | | | | | 89923 | DOGMATIL 200MG TBL. | tbl 12x200mg | SSJ | F | | | | | 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 31,57 | | | | | | | | | | | | 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 46,53 | | | 55695 | TIAPRIDAL | gtt 1x30ml | LSY | F | | | | | 416.5 | N05AL05 | amisulprid (pevné lékové formy) | p.o. | 600 | MG | 119,26 | L/PSY | | 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 74,69 | 0/PSY,NEU | | 89922 | DOGMATIL 100 | inj 6x2ml/100mg | EGJ | F | | | | | 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 55,43 | O | | 91117 | TIAPRIDAL | inj 12x2ml/100mg | LSY | F | | | | | 418 | N05AN | lithium | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 418.1 | N05AN01 | lithium do 0,3 GM včetně v jedné tabletě | p.o. | 1 | GM | 4,84 | | | 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | | | 418.2 | N05AN01 | lithium nad 0,3 GM v jedné tabletě | p.o. | 1 | GM | 3,23 | | | 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | | | | | 419 | N05AX | ostatní antipsychotika | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 419.1 | N05AX08 | risperidon (pevné lékové formy) | p.o. | 5 | MG | 119,26 | L/PSY | | 46964 | RISPERDAL 1MG | tbl obd 20x1mg | JAG | I | | | | | 46965 | RISPERDAL 1MG | tbl obd 60x1mg | JAG | I | | | | | 46966 | RISPERDAL 2MG | tbl obd 20x2mg | JAG | I | | | | | 46967 | RISPERDAL 2MG | tbl obd 60x2mg | JAG | I | | | | | 46968 | RISPERDAL 3MG | tbl obd 20x3mg | JAG | I | | | | | 46969 | RISPERDAL 3MG | tbl obd 60x3mg | JAG | I | | | | | 46970 | RISPERDAL 4MG | tbl obd 20x4mg | JAG | I | | | | | 46971 | RISPERDAL 4MG | tbl obd 60x4mg | JAG | I | | | | | 419.2 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5 | MG | 131,97 | L/INT, PSY, NEU, GER | | | | | | | | | | | 419.3 | N05AE03 | sertindol | p.o. | 1 | DF | 143,12 | L/PSY | | 13039 | SERDOLECT 4MG | tbl obd 30x4mg | LUN | DK | | | | | 419.4 | N05AE04 | ziprasidon | p.o. | 80 | MG | 143,00 | L/PSY | | 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.

420.1	N05BA23	tofisopam	p.o.	0.15	GM	0,68
420.2	N05BA01	diazepam	p.o.	10	MG	0,68

420.3	N05BA02	chlordiazepoxid	p.o.	30	MG	0,68

420.4	N05BA03	medazepam	p.o.	20	MG	0,68

420.5	N05BA04	oxazepam	p.o.	50	MG	0,68

420.6	N05BA05	klorazepát draselný	p.o.	20	MG	0,68

420.7	N05BA06	lorazepam	p.o.	2.5	MG	0,68

420.8	N05BA08	bromazepam	p.o.	10	MG	0,68

420.9	N05BA09	klobazam	p.o.	20	MG	0,68

420.10	N05BA11	prazepam	p.o.	30	MG	0,68

420.11	N05BA12	alprazolam (do 1 mg v jedné tabletě)	p.o.	1	MG	0,68

420.12	N05BA12	alprazolam (1 mg a více v jedné tabletě)	p.o.	1	MG	2,49	P
86656	NEUROL 1.0	tbl 30x1mg	LEX	CZ
421	N05BA	anxiolytika ze skupiny derivátů benzodiazepinu	p.rect.	L/NEU,PSY,PDD
---	---	---	---	---	---	---	---
421.1	N05BA01	diazepam (do 5 mg v jednom čípku včetně)	p.rect.	10	MG	116,16	L/NEU,PSY, PDD
69417	DIAZEPAM DESITIN RECTAL TUBE	enm 5x2.5ml/5mg	DET	D
421.2	N05BA01	diazepam (nad 5 mg v jednom čípku)	p.rect.	10	MG	71,64	L/NEU,PSY, PDD
69418	DIAZEPAM DESITIN RECTAL TUBE	enm 5x2.5ml/10mg	DET	D
422	N05BA	anxiolytika ze skupiny derivátů benzodiazepinu	parent.
---	---	---	---	---	---	---	---
422.1	N05BA01	diazepam	parent.	10	MG	7,53
96610	APAURIN	inj 10x2ml/10mg	KRK	SLO
422.2	N05BA05	klorazepát draselný	parent.	20	MG	14,66
423	N05BX	ostatní anxiolytika	p.o.
---	---	---	---	---	---	---	---
423.1	N05BB01	hydroxyzin	p.o.	75	MG	0,68

423.2	N05BC01	meprobamat p.o.	1.2	GM	0,68

423.3	N05BX01	mefenoxalon	p.o.	1.2	GM	16,42
85656	DORSIFLEX	tbl 30x200mg	LEK	SLO
03645	DIMEXOL	tbl 30x200mg	LEX	CZ
423.4	N05BE01	buspiron	p.o.	30	MG	2,49
424	N05CA	hypnotika ze skupiny barbiturátů	parent.	H
---	---	---	---	---	---	---	---
424.1	N05CA01	pentobarbital	parent.	0.1	GM	23,32	H
425	N05CD	hypnotika ze skupiny benzodiazepinů	parent.	O
---	---	---	---	---	---	---	---
425.1	N05CD03	flunitrazepam	parent.	1	MG	6,35	O
90559	ROHYPNOL	inj 5x1ml+5x1ml sol	LEX	CZ
425.2	N05CD08	midazolam (do 5 mg v jedné ampuli včetně)	parent.	15	MG	118,87	O
93113	DORMICUM	inj 10x1ml/5mg	HLR	CH
425.3	N05CD08	midazolam (nad 5 mg v jedné ampuli)	parent.	15	MG	81,97	O
02104	DORMICUM	inj 10x3ml/15mg	HLR	CH
62486	DORMICUM	inj 25x3ml/15mg	HLR	CH
86633	DORMICUM	inj 5x10ml/50mg	HLR	CH
91131	DORMICUM	inj 5x3ml/15mg	HLR	CH
426	N06AA	antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů	p.o.
---	---	---	---	---	---	---	---
426.1	N06AA01	desipramin	p.o.	0.1	GM	17,11

426.2	N06AA02	imipramin	p.o.	0.1	GM	9,90
00200	MELIPRAMIN	drg 50x25mg	EGI	H
426.3	N06AA04	klomipramin	p.o.	0.1	GM	14,66
08557	ANAFRANIL	drg 30x25mg	CGC	CH
93828	ANAFRANIL SR GEIGY 75	tbl obd 20x75mg	CGC	CH
426.4	N06AA05	opipramol	p.o.	0.15	GM	12,02

426.5	N06AA07	lofepramin	p.o.	105	MG	14,66

426.6	N06AA08	dibenzepin	p.o.	0.3	GM	15,50

426.7	N06AA09	amitriptylin	p.o.	75	MG	2,85
87167	AMITRIPTYLIN SLOVAKOFARMA	drg 50x28,3mg	SLO	SK
426.8	N06AA10	nortriptylin	p.o.	75	MG	9,78
12343	NORTRILEN	tbl obd 50x25mg	LUN	DK
426.9	N06AA16	dosulepin	p.o.	150	MG	9,78
03851	PROTHIADEN 10	tbl obd 50x10mg	LEX	CZ
04207	PROTHIADEN 25	drg 30x25mg	LEX	CZ
77047	PROTHIADEN 75	tbl obd 30x75mg	LEX	CZ
426.10	N06AA21	maprotilin (do 50 mg včetně v jedné tabletě)	p.o.	100	MG	13,64
03792	LUDIOMIL	drg 30x25mg	CGC	CH
45757	MAPROTIBENE 25MG	tbl obd 20x25mg	MCK	D
45759	MAPROTIBENE 50MG	tbl obd 20x50mg	MCK	D
67088	MAPROTILIN 25 VON CT	tbl obd 20x25mg	CTA	D
67090	MAPROTILIN 50 VON CT	tbl obd 20x50mg	CTA	D
426.11	N06AA21	maprotilin (nad 50 mg v jedné tabletě)	p.o.	100	MG	12,71
67093	MAPROTILIN 75 VON CT	tbl obd 100x75mg	CTA	D
04257	LUDIOMIL 75	drg 20x75mg	CGC	CH
427	N06AA	antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů	parent.	O
---	---	---	---	---	---	---	---
427.1	N06AA01	desipramin	parent.	0.1	GM	96,44	O

427.2	N06AA02	imipramin	parent.	0.1	GM	48,39	O
01477	MELIPRAMIN	inj 10x2ml/25mg	EGI	H
427.3	N06AA04	klomipramin	parent.	0.1	GM	96,44	O
02884	ANAFRANIL	inj 10x2ml 25mg	CGC	CH
427.4	N06AA08	dibenzepin	parent.	0.3	GM	96,44	O

427.5	N06AA09	amitriptylin	parent.	75	MG	30,79	O
04079	AMITRIPTYLIN LECIVA	inj 10x2ml/20mg	LEX	CZ
427.6	N06AA21	maprotilin	parent.	100	MG	109,29	O
94560	LUDIOMIL	inj 10x5ml/25mg	CGC	CH
428	N06AB	antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu p.o.	L/PSY,SEX
---	---	---	---	---	---	---	---
428.1	N06AB03	fluoxetin	p.o.	20	MG	15,50
13022	PORTAL	cps 14x20mg	LEK	SLO
13023	PORTAL	cps 28x20mg	LEK	SLO
92346	DEPREX	cps 30x20mg	LEX	CZ
56984	DEPRENON	cps 20x20mg	SLO	SK
46900	FRAMEX	cps 14x20mg	GED	H
57527	FRAMEX	cps 28x20mg	GED	H
44397	APO-FLUOXETINE	cps 30x20mg	APT	CND
428.2	N06AB04	Citalopram	p.o.	20	MG	20,00	L/PSY,SEX, NEU,INT

428.3	N06AB05	Paroxetin	p.o.	20	MG	20,00	L/PSY,SEX, NEU,INT

428.4	N06AB06	sertralin	p.o.	50	MG	20,00	L/PSY,SEX, NEU,INT

428.5	N06AB08	fluvoxamin	p.o.	100	MG	20,00	L/PSY,SEX, NEU,INT
429	N06AB	antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu	parent.	O/PSY,SEX
---	---	---	---	---	---	---	---
429.1	N06AB04	Citalopram	parent.	20	MG	231,15	O/PSY,SEX
60113	SEROPRAM	inf 10x1ml/40mg	LUN	DK
430	N06A	ostatní antidepresiva	p.o.	L/PSY,SEX,NEU
---	---	---	---	---	---	---	---
430.1	N06AF01	isocarbaxazid	p.o.	15	MG	4,30	L/PSY,SEX, NEU

430.2	N06AF04	tranylcypromin	p.o.	10	MG	5,03	L/PSY,SEX, NEU

430.3	N06AG02	moklobemid	p.o.	0.3	GM	20,00	L/PSY,SEX, NEU

430.4	N06AX03	mianserin (do 10 mg v jedné tabletě včetně)	p.o.	60	MG	18,77	L/PSY,SEX, NEU
45769	MIABENE 10MG	tbl obd 20x10mg	MCK	D
67353	MIANSERIN 10 VON CT	tbl obd 20x10mg	CTA	D
430.5	N06AX03	mianserin (nad 10 mg v jedné tabletě)	p.o.	60	MG	17,60	L/PSY,SEX, NEU
45771	MIABENE 30MG	tbl obd 20x30mg	MCK	D
67355	MIANSERIN 30 VON CT	tbl obd 20x30mg	CTA	D
430.6	N06AX05	trazodon	p.o.	0.3	GM	14,22	L/PSY,SEX, NEU

430.7	N06AX06	nefazodon hydrochlorid	p.o.	400	MG	27,00	L/PSY,SEX, NEU

430.8	N06AX09	viloxazin	p.o.	0.2	GM	14,22	L/PSY,SEX, NEU

430.9	N06AX11	mirtazapin	p.o.	30	MG	29,00	L/PSY,SEX, NEU

430.10	N06AX14	tianeptin	p.o.	37.5	MG	20,00	L/PSY,SEX, NEU, INT

430.11	N06AX16	venlafaxin	p.o.	100	MG	29,00	L/NEU,PSY, SEX

430.12	N06AX17	milnacipran	p.o.	100	MG	29,00	L/NEU,PSY, SEX

430.13	N06AX18	reboxetin	p.o.	8	MG	27,00	L/NEU,PSY, SEX
431	N06BA	centrálně působící stimulancia	p.o.	L/NEU,PSY,PDD,SEX
---	---	---	---	---	---	---	---
431.1	N06BA04	methylphenidat	p.o.	30	MG	9,14	L/NEU,PSY, PDD, SEX
83328	RITALIN	tbl 30x10mg	CGC	CH
431.2	N06BA07	modafinil	p.o.	300	MG	9,14	L/NEU,PSY, PDD, SEX
432	N06BX	ostatní psychostimulancia a nootropika	p.o.
---	---	---	---	---	---	---	---
432.1	N06BX02	pyritinol (pevné lékové formy)	p.o.	0.3	GM	6,50

432.2	N06BX02	pyritinol (tekuté lékové formy)	p.o.	0.3	GM	18,87

432.3	N06BX03	piracetam (pevné lékové formy)	p.o.	2.4	GM	6,50

432.4	N06BX03	piracetam (tekuté lékové formy)	p.o.	2.4	GM	18,87
88156	NOOTROPIL 20% ORAL	sol 1x125ml 20%	UCB	B
04289	NOOTROPIL 33% ORAL	sol 1x125ml 33%	UCB	B
432.5	N06BX18	vinpocetin	p.o.	15	MG	6,50

432.6	N06BX19	extrakty z Ginkgo biloba (pevné lékové formy)	p.o.	120	MG	7,38

432.7	N06BX19	extrakty z Ginkgo biloba (tekuté lékové formy)	p.o.	120	MG	10,75
433	N06BX	ostatní psychostimulancia a nootropika	parent.	H
---	---	---	---	---	---	---	---
433.1	N06BX01	meklofenoxat	parent.	0.5	GM	83,53	H

433.2	N06BX02	pyritinol	parent.	0.3	GM	60,27	H

433.3	N06BX03	piracetam	parent.	6	GM	60,27	H
96719	OIKAMID	inj 10x5ml/1gm	PLI	CHO
433.4	N06BX18	vinpocetin	parent.	15	MG	24,98	H
04062	CAVINTON	inj 10x2ml/10mg	GED	H
434	N07AA	parasympatomimetika ze skupiny inhibitorů cholinesterázy	p.o.
---	---	---	---	---	---	---	---
434.1	N07AA01	neostigmin	p.o.	60	MG	19,75
00318	SYNTOSTIGMIN	tbl 20x15mg	SLO	SK
53940	SYNTOSTIGMIN	tbl 20x15mg (blistr)	SLO	SK
434.2	N07AA02	pyridostigmin (do 10 mg v jedné tabletě včetně)	p.o.	180	MG	25,86

434.3	N07AA02	pyridostigmin (nad 10 mg v jedné tabletě)	p.o.	180	MG	16,81
01356	MESTINON	drg 20x60mg	HLR	CH
434.4	N07AA03	distigmin	p.o.	5	MG	5,82
02130	UBRETID	tbl 50x5mg	HNP	A
02360	UBRETID	tbl 20x5mg	HNP	A
434.5	N07AA30	ambenonium	p.o.	60	MG	18,04
435	N07AA	parasympatomimetika ze skupiny inhibitorů cholinesterázy	parent.
---	---	---	---	---	---	---	---
435.1	N07AA01	neostigmin	parent.	2	MG	18,04
00612	SYNTOSTIGMIN	inj 10x1 ml/0.5mg	HBS	SK
435.2	N07AA02	pyridostigmin	parent.	10	MG	113,20

435.3	N07AA03	distigmin	parent.	0.25	MG	5,62
436	N07CA	léčiva s antivertiginózním účinkem	p.o.
---	---	---	---	---	---	---	---
436.1	N07CA	jiné piperazinové deriváty	p.o.	3	DF	4,79

436.2	N07CA01	betahistin	p.o.	24	MG	9,74

436.3	N07CA02	cinarizin (do 25 MG včetně v jedné tabletě)	p.o.	90	MG	1,86

436.4	N07CA02	cinarizin (nad 25 MG v jedné tabletě)	p.o.	90	MG	1,56
07390	CINEDIL	tbl 50x75mg	ALK	MAC
436.5	N07CA03	flunarizin	p.o.	10	MG	4,79
437	N07XX	ostatní léčiva nervové soustavy	parent.	X
---	---	---	---	---	---	---	---
437.1	N07XX01	tirilazad	parent.	150	MG	5226,44	X
83502	FREEDOX TM	inf 1x100ml/150mg	UPJ	B
438	P01AB	chemoterapeutika ze skupiny nitroimidazolových derivátů	p.o.
---	---	---	---	---	---	---	---
438.1	P01AB01	metronidazol	p.o.	2	GM	13,30
68997	MEDAZOL	tbl 20x250mg	BLU	CHO
438.2	P01AB01	metronidazol	p.rect.	2	GM	8,36

438.3	P01AB02	tinidazol	p.o.	2	GM	13,30

438.4	P01AB03	ornidazol	p.o.	1.5	GM	22,00
91132	AVRAZOR	tbl 6x500mg	LEX	CZ
439	P01BA	antimaiarika ze skupiny aminochinolonových derivátů	p.o.
---	---	---	---	---	---	---	---

Léčbu hydroxychlorochinem ordinuje infekcionista, revmatolog a dermatolog:

a) systémový lupus erythematodes,

b) revmatoidní arthritis,

c) juvenilní chronická arthritis,

d) diskoidní forma lupus erythematodes.

Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).

| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,42 | | | 00098 | DELAGIL | tbl 30x250mg | IDA | H | | | | | 439.2 | P01BA02 | hydroxychlorochin | p.o. | 0.4 | GM | 18,04 | P | | 01385 | PLAQUENIL | drg 100x200mg | WIN | GB | | | | | 439.3 | P01BA05 | meflochin | p.o. | 1 | GM | 366,98 | P | | 92441 | MEPHAQUIN | tbl obd 6x250mg | MHA | CH | | | | | 440 | P01BD | antimalarika ze skupiny diaminopyrimidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 440.1 | P01BD01 | pyrimethamin | p.o. | 75 | MG | 15,93 | | | 02443 | DARAPRIM | tbl 30x25mg | BWE | GB | | | | | 440.2 | P01BD51 | pyrimethamin, kombinace | p.o. | 75 | MG | 50,83 | | | 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1047,13 | X | | 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 14,03 | | | 59238 | VERMOX | tbl 6x100mg | JAG | I | | | | | 442.2 | P02CA02 | tiabendazol | p.o. | 3 | GM | 125,42 | | | | | | | | | | | | 442.3 | P02CA03 | albendazol | p.o. | 0.4 | GM | 61,59 | | | 443 | P02CB | anthelmintika ze skupiny piperazinu a jeho derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 443.1 | P02CB01 | piperazin | p.o. | 2 | GM | 3,96 | | | 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 25,51 | | | 04030 | DECARIS | tbl 2x50mg | GED | H | | | | | 445 | P02CX | ostatní anthelmintika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 17,69 | | | 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | | | | | 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 131,19 | | | 02969 | YOMESAN | tbl 4x500mg | BAY | D | | | | | 447 | P03AB | ektoparazitika ze skupiny halogenovaných léčiv | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 447.1 | P03AB02 | lindan (lékové formy gelu) | lok. | 1 | GM | 2,54 | | | | | | | | | | | | 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,08 | | | 62365 | JACUTIN | lot 1x1000ml | HEM | D | | | | | 92765 | SKABICID | lot 1x100gm | AVE | CZ | | | | | 97547 | JACUTIN | lot 1x200ml | HEM | D | | | | | 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,17 | | | 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 448.1 | P03AC | esdepallethrin | lok. | 1 | ML | 1,17 | | | | | | | | | | | | 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,17 | | | 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 449.1 | R01AC01 | kyselina kromogliková (do 15 mililitrů včetně v jednom balení) | lok. | 40 | MG | 13,88 | L/ALG,TRN, ORL | | 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D | | | | | 76418 | CROMOBENE | spr nas 1x15ml | MCK | D | | | | | 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | | | | | 449.2 | R01AC01 | kyselina kromogliková (nad 15 mililitrů v jednom balení) | lok. | 40 | MG | 13,59 | L/ALG,TRN, ORL | | 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | | | | | 449.3 | R01AC02 | levokabastin | lok. | 0.6 | MG | 10,80 | | | | | | | | | | | | 449.4 | R01AC03 | azelastin | lok. | 0.56 | MG | 10,80 | | | 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 450.1 | R01AD01 | beclomethason | lok. | 0.4 | MG | 4,30 | | | 66006 | BECLOMET NASAL AQUA | spr nas 23ml/200dav | OKU | SF | | | | | 99860 | BECLOMET NASAL AQUA 100 | aer 23ml 200df | ORN | SF | | | | | 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 7,00 | L/ALG,TRN, ORL | | | | | | | | | | | 450.3 | R01AD05 | budesonid lokálně do 50 RG v jedné dávce včetně | lok. | 0.3 | MG | 7,50 | L/ALG,TRN, ORL | | | | | | | | | | | 450.4 | R01AD05 | budesonid lokálně nad 50 RG v jedné dávce | lok. | 0.3 | MG | 6,75 | L/ALG,TRN, ORL | | | | | | | | | | | 450.5 | R01AD08 | flutikason | lok. | 0.2 | MG | 9,50 | L/ALG,TRN, ORL | | | | | | | | | | | 450.6 | R01AD | triamcinolon acetonid | lok. | 220 | RG | 7,50 | L/ALG,TRN, ORL | | 450.7 | R01AD09 | momethason | lok. | 200 | RG | 10,56 | L/ALG,TRN, ORL | | | | | | | | | | | 450.8 | R01AX03 | ipratropium bromid | lok. | 240 | RG | 8,60 | L/ALG,TRN, ORL | | 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu inhalačního salmeterolu a formoterolu indikuje alergolog a pneumolog u perzistujícího astmatu tam, kde astma není zcela pod kontrolou při podávání kortikosteroidu inhalační cestou a při dobré spolupráci pacienta.

451.1	R03AC	fenoterol/cromoglykat	inhal.	1	DF	1,56	L/ALG,TRN
451.2	R03AC02	salbutamol (lékové formy aerosolu)	inhal.	0.8	MG	3,37
89016	SALAMOL INHALER	aer dos 200x100rg	GNO	CZ
451.3	R03AC02	salbutamol (lékové formy prášku k inhalaci)	inhal.	0.8	MG	7,23
83047	VENTODISKS	inh plv 15x8x400rg	GLA	F
451.4	R03AC02	salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované)	inhal.	0.8	MG	7,23

451.5	R03AC02	salbutamol (lékové formy roztoku)	inhal.	10	MG	12,86
94814	VENTOLIN SOL.AD RESPIR.	inh 1x20ml/120mg	GLA	GB
451.6	R03AC03	terbutalin (lékové formy aerosolu)	inhal.	2	MG	3,52

451.7	R03AC03	terbutalin (lékové formy prášku k inhalaci)	inhal.	2	MG	7,23

451.8	R03AC04	fenoterol (lékové formy aerosolu)	inhal.	0.6	MG	2,74
02863	BEROTEC 200 DOSIER AEROSOL	aer 1x15ml(=21gm)	BOE	D
451.9	R03AC04	fenoterol (lékové formy roztoku)	inhal.	4	MG	24,64

451.10	R03AC04	fenoterol (lékové formy prášku k inhalaci)	inhal.	0.6	MG	7,23

451.11	R03AC06	hexoprenalin (lékové formy aerosolu)	inhal.	1.5	MG	2,74

451.12	R03AC12	salmeterol (lékové formy aerosolu)	inhal.	0.1	MG	20,63	P

451.13	R03AC12	salmeterol (lékové formy prášku k inhalaci) do 0,025 miligramů včetně v jedné dávce	inhal.	0.1	MG	33,53	P

451.14	R03AC12	salmeterol (lékové formy prášku k inhalaci) nad 0,025 miligramů v jedné dávce	inhal.	0.1	MG	30,65	P

451.15	R03AC13	formoterol (lékové formy prášku k inhalaci) do 4,5 RG včetně v jedné dávce	inhal.	24	RG	33,53	P

451.16	R03AC13	formoterol (lékové formy prášku k inhalaci) nad 4,5 RG v jedné dávce	inhal.	24	RG	30,65	P
452	R03AK	inhalační sympatomimetika a jiná antiastmatika	inhal.
---	---	---	---	---	---	---	---
452.1	R03AK03	fenoterol a jiná antiastmatika (lékové formy aerosolu)	inhal.	6	DF	5,03
87899	BERODUAL	aer dos 15ml/300df	BOE	D
452.2	R03AK03	fenoterol a jiná antiastmatika (lékové formy roztoku)	inhal.	4	ML	20,63

452.3	R03AK03	fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci)	inhal.	3	DF	13,00

452.4	R03AK04	salbutamol v kombinaci s bromidem ipratropia	inhal.	6	DF	7,33	L/ALG,TRN

452.5	R03AK04	salbutamol v kombinaci s kromoglykátem	inhal.	8	DF	11,73	L/ALG,TRN

452.6	R03AK06	salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/100	inhal.	2	DF	45,40	L/ALG,TRN

452.7	R03AK06	salmeterol a flutikason ve fixní kombinaci (lékova forma prášku k inhalaci) 50/250	inhal.	2	DF	49,80	L/ALG,TRN

452.8	R03AK06	salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/500	inhal.	2	DF	65,20	L/ALG,TRN
453	R03BA	inhalační kortikosteroidy	inhal.
---	---	---	---	---	---	---	---
453.1	R03BA01	beklomethason (lékové formy aerosolu) do 100 RG včetně v jedné dávce	inhal.	0.8	MG	6,35
12828	BECLAZONE 100RG	aer dos 200x100rg	GNO	CZ
453.2	R03BA01	beklomethason (lékové formy aerosolu) nad 100 RG v jedné dávce	inhal.	0.8	MG	5,23
12829	BECLAZONE 250RG	aer dos 200x250rg	GNO	CZ
64664	BECLOMET FORTE	aer dos 12.5ml/200d	OKU	SF
92415	BECLOFORTE INHALER	inh 200dav.x250rg	GLA	E
453.3	R03BA01	beklomethason (lékové formy prášku k inhalaci) do 0,2 mg včetně v jedné dávce	inhal.	0.8	MG	20,77
83045	BECODISKS	plv inh 15x8x200rg	GLA	F
453.4	R03BA01	beklomethason (lékové formy prášku k inhalaci) nad 0,2 mg v jedné dávce	inhal.	0.8	MG	15,97

453.5	R03BA01	beklomethason (lékové formy vdechem aktivované do 200 RG včetně v jedné dávce) balení obsahující 1 zásobník	inhal.	0.8	MG	19,70

453.6	R03BA01	beklomethason (lékové formy vdechem aktivované do 200 RG včetně v jedné dávce) balení obsahující 3 zásobníky	inhal.	0.8	MG	16,62

453.7	R03BA01	beklomethason (lékové formy vdechem aktivované nad 200 RG v jedné dávce) balení obsahující 1 zásobník	inhal.	0.8	MG	16,00

453.8	R03BA01	beklomethason (lékové formy vdechem aktivované nad 200 RG v jedné dávce) balení obsahující 3 zásobníky	inhal.	0.8	MG	13,45

453.9	R03BA02	budesonid (lékové formy aerosolu)	inhal.	0.8	MG	13,00

453.10	R03BA02	budesonid (lékové formy prášku k inhalaci, do 200 RG v 1 dávce včetně)	inhal.	0.8	MG	20,77

453.11	R03BA02	budesonid (lékové formy prášku k inhalaci, nad 200 RG v 1 dávce)	inhal.	0.8	MG	15,97

453.12	R03BA02	budesonid (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml	inhal.	0.8	MG	20,77

453.13	R03BA02	budesonid (lékové formy suspense k inhalaci) nad 0,25 mg v 1 ml.	inhal.	0.8	MG	16,81

453.14	R03BA03	flunisolid (lékové formy aerosolu)	inhal.	1	MG	13,00

453.15	R03BA03	flunisolid (lékové formy prášku k inhalaci)	inhal.	1	MG	20,77

453.16	R03BA05	flutikason (lékové formy aerosolu)	inhal.	0.6	MG	13,00

453.17	R03BA05	flutikason (lékové formy prášku k inhalaci do 100 RG včetně v jedné dávce)	inhal.	0.6	MG	30,00

453.18	R03BA05	flutikason (lékové formy prášku k inhalaci nad 100 RG do 250 RG včetně v jedné dávce)	inhal.	0.6	MG	26,75

453.19	R03BA05	flutikason (lékové formy prášku k inhalaci nad 250 RG v jedné dávce)	inhal.	0.6	MG	22,30
454	R03BB	inhalační anticholinergika	inhal.
---	---	---	---	---	---	---	---
454.1	R03BB01	bromid ipratropia (lékové formy aerosolu)	inhal.	0.12	MG	5,38

454.2	R03BB01	bromid ipratropia (lékové formy prášku k inhalaci)	inhal.	0.12	MG	2,25
75847	ATROVENT INHALETTEN	cps inh 100x0.2mg	BOE	D
454.3	R03BB01	bromid ipratropia (lékové formy roztoku)	inhal.	4	ML	34,31	L/ALG,TRN, ORL
455	R03BC	inhalační protialergická léčiva	inhal.
---	---	---	---	---	---	---	---
455.1	R03BC01	kyselina kromoglyková (lékové formy aerosolu)	inhal.	40	MG	17,50
92439	CROMOGEN 5MG	inh aer dos 112x5mg	GNO	CZ
455.2	R03BC01	kyselina kromoglyková (lékové formy prášku k inhalaci)	inhal.	80	MG	21,65

455.3	R03BC01	kyselina kromoglyková (lékové formy roztoku)	inhal.	80	MG	13,49

455.4	R03BC01	kyselina kromoglyková (lékové formy prášku k insuflad)	lok.	40	MG	19,11

455.5	R03BC03	nedokromil	inhal.	8	MG	22,40	L/ALG,TRN

455.6	R03BC01	kyselina kromoglyková (lékové formy aerosolu vdechem aktivované)	inhal.	40	MG	21,65
456	R03CB	celkově podávaná neselektivní sympatomimetika	p.o.
---	---	---	---	---	---	---	---
456.1	R03CA02	efedrin	p.o.	50	MG	1,42

456.2	R03CB03	orciprenalin	p.o.	60	MG	6,55
457	R03CB	celkově podávaná neselektivní sympatomimetika	parent.	O
---	---	---	---	---	---	---	---
457.1	R03CA02	efedrin	parent.	50	MG	5,28	O
00447	EPHEDRIN BIOTIKA	inj 10x1ml/50mg	HBS	SK
457.2	R03CB03	orciprenalin	parent.	0.5	MG	7,28	O
458	R03CC	celkově podávaná selektivní sympatomimetika	p.o.
---	---	---	---	---	---	---	---
458.1	R03CC02	salbutamol (pevné lékové formy)	p.o.	12	MG	5,52
91085	SALBUTAMOL POLFA	tbl 30x4mg	POL	PL
458.2	R03CC02	salbutamol (tekuté lékové formy)	p.o.	12	MG	13,10

458.3	R03CC03	terbutalin	p.o.	15	MG	5,24

458.4	R03CC05	hexoprenalin	p.o.	1.5	MG	5,24

458.5	R03CC08	prokaterol (pevné lékové formy)	p.o.	0.1	MG	5,24

458.6	R03CC08	prokaterol (tekuté lékové formy)	p.o.	0.1	MG	15,45

458.7	R03CC13	klenbuterol (pevné lékové formy)	p.o.	0.04	MG	6,70
91845	SPIROPENT	tbl 20x0.02mg	BOE	D
458.8	R03CC13	klenbuterol (tekuté lékové formy)	p.o.	0.04	MG	26,58
459	R03CC	celkově podávaná selektivní sympatomimetika	parent.	O
---	---	---	---	---	---	---	---
459.1	R03CC03	terbutalin	parent.	0.5	MG	19,84	O
80134	BRICANYL	inj 10x1ml/0.5mg	EGI	H
459.2	R03CC05	hexoprenalin	parent.	5	RG	19,84	O
460	R03D	ostatní antiastmatika k celkovému podání	p.o.
---	---	---	---	---	---	---	---
460.1	R03DA04	teofylin (retardované lékové formy první skupiny)	p.o.	0.4	GM	2,88
99137	SPOPHYLLIN RETARD 100MG	tbl ret 50x100mg	SLO	SK
98064	SPOPHYLLIN RETARD 250MG	tbl ret 50x250mg	SLO	SK
460.2	R03DA04	teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě)	p.o.	0.4	GM	4,79
94192	TEOTARD	cps ret 40x200mg	KRK	SLO
460.3	R03DA04	teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě)	p.o.	0.4	GM	4,50
94191	TEOTARD	cps ret 40x350mg	KRK	SLO
460.4	R03DA05	aminofylin	p.o.	0.6	GM	4,89

460.5	R03DA05	aminofylin (retardované lékové formy do 150 mg včetně)	p.o.	0.6	GM	9,92

460.6	R03DA05	aminofylin (retardované lékové formy nad 150 do 250 mq včetně)	p.o.	0.6	GM	4,79

460.7	R03DA05	aminofylin (retardované lékové formy nad 250 mg)	p.o.	0.6	GM	4,69
91741	AMINOPHYLLINUM RETARD	tbl ret 20x350mg	LEK	SLO
460.8	R03DC01	zafirlukast	p.o.	40	MG	48,59	Z
12330	ACCOLATE 20	tbl obd 56x20mg	ZNC	GB
460.9	R03DC03	montelukast (s obsahem 10 mg v jedné tabletě)	p.o.	10	MG	48,59	Z

460.10	R03DC03	montelukast (s obsahem 5 mg v jedné tabletě)	p.o.	10	MG	120,54	P
53076	SINGULAIR 5 JUNIOR	ctb 28x5mg	MSD	NL

Montelukast s obsahem 5 mg účinné látky v jedné tabletě předepisuje alergolog nebo pneumolog v následujících indikacích u pacientů od 6 do 12 let:

a) nově diagnostikované nebo nově potvrzené lehké perzistující astma se zřetelnými pozátěžovými příznaky dosud neléčené inhalačními kortikosteroidy

b) námahou indukované astma

c) aspirinové astma

Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikována. U pacientů, kde léčba montelukastem s obsahem 5 mg účinné látky v jedné tabletě byla indikována již před 12 rokem věku a u nichž vykazuje zřetelný efekt, mohou výše uvedení specialisté pokračovat v léčbě až do 14 let věku pacienta.

461	R03DA	ostatní antiastmatika k celkovému podání ze skupiny xantinů	p.rect.
461.1	R03DA05	aminofylin	p.rect.	0.6	GM	6,35
00950	SYNTOPHYLLIN	sup 10	LEC	CZ
462	R03DA	ostatní antiastmatika k celkovému podání ze skupiny xantinů	parent.	O
---	---	---	---	---	---	---	---
462.1	R03DA05	aminofylin	parent.	0.6	GM	29,23	O
00610	SYNTOPHYLLIN	inj 5x10ml/240mg	HBS	SK
93129	AMINOPHYLLINUM LEK	inj 10x10ml/250mg	LEK	SLO
96371	AMINOPHYLLINUM I.V.	inj 50x10ml/250mg	LEK	SLO
463	R05CB	jmukolytika	p.o.
---	---	---	---	---	---	---	---
463.1	R05CB	prednoxdiazin	p.o.	300	MG	1,96

463.2	R05CB01	acetylcystein - pevné formy	p.o.	0.5	GM	6,00

463.3	R05CB01	acetylcystein - tekuté formy	p.o.	0.5	GM	8,80

463.4	R05CB02	bromhexin (pevné lékové formy)	p.o.	24	MG	1,96

463.5	R05CB02	bromhexin (tekuté lékové formy)	p.o.	24	MG	3,23

463.6	R05CB03	karbocystein (pevné lékové formy)	p.o.	1.5	GM	8,10

463.7	R05CB03	karbocystein (tekuté lékové formy)	p.o.	1.5	GM	11,72

463.8	R05CB06	ambroxol (pevné lékové formy)	p.o.	0.15	GM	8,10
43947	AMBROXOL AL 75 RETARD	cps ret 20x75mg	APA	D
463.9	R05CB06	ambroxol (tekuté lékové formy)	p.o.	0.15	GM	11,72
72991	AMBROXOL AL KAPKY	gtt 1x50ml/375mg	APA	D
72992	AMBROXOL AL KAPKY	gtt 1x100ml/750mg	APA	D
463.10	R05CB15	erdostein (pevné lékové formy)	p.o.	600	MG	8,10

463.11	R05CB15	erdostein (tekuté lékové formy)	p.o.	600	MG	11,72
464	R05CB	mukolytika	inhal.
---	---	---	---	---	---	---	---

Léčbu alfadornázou předepisuje ošetřující lékař na doporučení specializovaného pracoviště, které zajišťuje péči o pacienty s cystickou fibrózou, při zajištění dobré spolupráce pacienta:

a) při nedostatečné účinnosti inhalačních mukolytik nebo amiloridu,

b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.

464.1	R05CB01	acetylcystein	inhal.	1.6	GM	12,07
464.2	R05CB02	bromhexin	inhal.	24	MG	3,47

464.3	R05CB05	mesna	inhal.	600	MG	40,67
03614	MISTABRON	sol 6x3ml/600mg	UCB	B
464.4	R05CB13	alfadornáza	inhal.	2.5	MG	1197,58	P
77521	PULMOZYME 2500UT(2.5MG)	inh sol 6x2.5ml	HLR	CH
464.5	R05CB15	erdostein	inhal.	450	MG	8,31
465	R05CB	mukolytika	parent.
---	---	---	---	---	---	---	---
465.1	R05CB01	acetylcystein	parent.	0.5	GM	16,76
58889	BRONCHOLYSIN SPOFA	inj 5x5ml/1gm	SPX	CZ
465.2	R05CB02	bromhexin	parent.	24	MG	40,37

465.3	R05CB06	ambroxol	parent.	0.15	GM	226,02

465.4	R05CA03	guaifenesin	parent.	0.9	GM	16,57
58249	GUAJACURAN 5%	inj 10x10ml/0.5gm	LEX	CZ
92347	GUAJACURAN 5%	inj 6x20ml/1gm	LEX	CZ
465.5	R05CB06	ambroxol (koncentrat k infuzi)	parent.	1	DF	343,81	H
12839	MUCOSOLVAN	inf 1x50ml/1000mg	BOE	D
466	R05DA	antitusika ze skupiny derivátů opioidů	p.o.
---	---	---	---	---	---	---	---
466.1	R05DA01	ethylmorfin do 15 MG včetně	p.o.	50	MG	6,10
44590	DIOLAN 15MG	tbl 10x15mg(blistr)	SLO	SK
466.2	R05DA01	ethylmorfin nad 15 MG	p.o.	50	MG	5,43
44589	DIOLAN 30MG	tbl 10x30mg(blistr)	SLO	SK
466.3	R05DA04	kodein	p.o.	0.1	GM	12,40
56992	CODEIN SLOVAKOFARMA 15MG	tbl 10x15mg-blistr	SLO	SK
56993	CODEIN SLOVAKOFARMA 30MG	tbl 10x30mg-b1istr	SLO	SK
466.4	R05DA08	folkodin	p.o.	50	MG	3,67

466.5	R05DA09	dextromethorphan	p.o.	90	MG	3,67

466.6	R05DA20	kombinace antitusik	p.o.	3	DF	3,67
467	R05DB	antitusika chemicky blízká lokálním anestetikům	p.o., p.rect., parent.
---	---	---	---	---	---	---	---
467.1	R05DB19	dropropizin	p.o.	25	MG	2,44
04212	DITUSTAT	gtt 1x10ml	GNO	CZ
467.2	R05DB13	butamirát (pevné lékové formy)	p.o.	25	MG	3,00

467.3	R05DB13	butamirát (tekuté lékové formy-kapky)	p.o.	25	MG	10,56
94859	TUSSIN	gtt 1x10ml	GNO	CZ
467.4	R05DB13	butamirát (tekuté lékové formy-sirup)	p.o.	25	MG	8,90

467.5	R05DB03	klobutinol	parent.	120	MG	112,03	H

467.6	R05DB05	pentoxyverin (do 8 mg v jednom čípku včetně)	p.rect.	100	MG	139,11	L/PDD
92252	SEDOTUSSIN 8MG BABIES	sup 6x8mg	UCB	B
467.7	R05DB05	pentoxyverin (nad 8 mg v jednom čípku)	p.rect.	100	MG	63,40	L/PDD

467.8	R05DB27	levodropropizin	p.o.	25	MG	2,44
468	R06AA	antihistaminika ze skupiny derivátů aminoalkyletherů	p.o.
---	---	---	---	---	---	---	---
468.1	R06AA	embramin	p.o.	50	MG	1,32

468.2	R06AA02	difenhydramin (pevné lékové formy)	p.o.	0.2	GM	8,36

468.3	R06AA04	klemastin	p.o.	2	MG	6,56
09789	TAVEGYL	tbl 20x1mg	KRK	SLO
468.4	R06AA07	difenylpyralin	p.o.	10	MG	7,72

468.5	R06AA02	difenhydramin (tekuté lékové formy)	p.o.	0.2	GM	8,99
469	R06AA	antihistaminika ze skupiny derivátů aminoalkyletherů	parent.	O
---	---	---	---	---	---	---	---
469.1	R06AA04	klemastin	parent.	2	MG	32,65	O
02559	TAVEGYL	inj 5x2ml/2mg	SAN	CH
470	R06AB	antihistaminika ze skupiny derivátů alkylaminů	p.o.
---	---	---	---	---	---	---	---
470.1	R06AB03	dimetinden (pevné lékové formy)	p.o.	4	MG	10,71
12514	FENISTIL 24	cps ret 10x4mg	NCH	CH
12515	FENISTIL 24	cps ret 20x4mg	NCH	CH
470.2	R06AB03	dimetinden (tekuté lékové formy)	p.o.	4	MG	8,99
470.3	R06AB56	dexbromfeniramin, kombinace	p.o.	2	DF	8,50
471	R06AD	antihistaminika ze skupiny derivátů fenothiazinu	p.o.
---	---	---	---	---	---	---	---
471.1	R06AD02	prometazin (pevné lékové formy)	p.o.	25	MG	4,49

471.2	R06AD02	prometazin (tekuté lékové formy)	p.o.	25	MG	8,99

471.3	R06AD03	thiethylperazin	p.o.	13	MG	4,25
09844	TORECAN	drg 50x6.5mg	KRK	SLO
471.4	R06AD03	thiethylperazin	p.rect.	13	MG	21,65
09847	TORECAN	sup 6x6.5mg	KRK	SLO
472	R06AD	antihistaminika ze skupiny derivátů fenothiazinu	parent.	O
---	---	---	---	---	---	---	---
472.1	R06AD02	prometazin	parent.	25	MG	7,48	O

472.2	R06AD03	thiethylperazin	parent.	13	MG	26,00	O
91836	TORECAN	inj 5x1 ml/6.5mg	KRK	SLO
473	R06AX	jiná antihistaminika k systémovému použití	p.o.
---	---	---	---	---	---	---	---
473.1	R06AE06	oxatomid	p.o.	60	MG	7,04

473.2	R06AE07	Cetirizin (pevné lékové formy)	p.o.	10	MG	7,25
64867	ALERID	tbl obd 20x10mg	CIA	IND
64868	ALERID	tbl obd 50x10mg	CIA	IND
66029	ZODAC	tbl obd 10x10mg	LEX	CZ
66030	ZODAC	tbl obd 30x10mg	LEX	CZ
473.3	R06AE07	Cetirizin (tekuté lékové formy)	p.o.	10	MG	8,99

473.4	R06AK	kombinace antihistaminik	p.o.	2	DF	1,08

473.5	R06AX	bisulepin	p.o.	4	MG	3,96
02479	DITHIADEN	tbl 20x2mg	LEX	CZ
473.6	R06AX01	bamipin	p.o.	0.1	GM	6,06

473.7	R06AX02	cyproheptadin (pevné lékové formy)	p.o.	12	MG	6,06

473.8	R06AX02	cyproheptadin (tekuté lékové formy)	p.o.	12	MG	8,99

473.9	R06AX09	azatadin	p.o.	2	MG	6,06

473.10	R06AX11	astemizol (pevné lékové formy)	p.o.	10	MG	6,80

473.11	R06AX11	astemizol (tekuté lékové formy)	p.o.	10	MG	8,99

473.12	R06AX12	terfenadin	p.o.	0.12	GM	6,80

473.13	R06AX13	loratadin (pevné lékové formy)	p.o.	10	MG	7,25
53639	FLONIDAN	tbl 30x10mg	LEK	SLO
88734	FLONIDAN	tbl 10x10mg	LEK	SLO
473.14	R06AX13	loratadin (tekuté lékové formy)	p.o.	10	MG	8,99
01700	FLONIDAN	sus 1x120ml	LEK	SLO
473.15	R06AX17	ketotifen (pevné lékové formy)	p.o.	2	MG	6,50

473.16	R06AX17	ketotifen (tekuté lékové formy)	p.o.	2	MG	8,99
44744	ZADITEN 1MG/5ML	sir 1x100ml/20mg	SLO	SK
53181	KETOF	sir 1x200ml 1mg/5ml	TRM	D
68574	KETOF	sir 1x100ml 1mg/5ml	TRM	D
473.17	R06AX 18	akrivastin	p.o.	24	MG	6,80

473.18	R06AX25	mizolastin	p.o.	10	MG	7,25

473.19	R06AX26	fexofenadin	p.o.	120	MG	7,25
474	R06AX	jiná antihistaminika k systémovému použití	parent.	O
---	---	---	---	---	---	---	---
474.1	R06AX	bisulepin	parent.	4	MG	25,12	O
04071	DITHIADEN	inj 10x2ml/1mg	LEX	CZ
474.2	R06AX	medosulepin/vápník	parent.	2	DF	30,79	O
00508	METHIADEN CALCIUM	inj 5x10ml	LEX	CZ
475	R07AA	plicní surfaktanty	parent.	T
---	---	---	---	---	---	---	---
475.1	R07AA01	kolfosceril palmitát	parent.	160	MG	20087,47	T

475.2	R07AA02	přirozené fosfolipidy (zvířecího původu)	parent.	160	MG	20087,47	T
87226	CUROSURF	sus 2x1.5ml/120mg	CHS	I
475.3	R07AA30	beraktant	parent.	160	MG	20087,47	T
476	S01AA	antibiotika k lokálnímu podání	lok.
---	---	---	---	---	---	---	---
476.1	S01AA	neomycin/polymyxin/fenylefrin	lok.	1	ML	19,55	L/OPH

476.2	S01AA01	chloramfenikol (lékové formy očních kapek)	lok.	1	ML	2,79

476.3	S01AA01	chloramfenikol (lékové formy očních mastí)	lok.	1	GM	4,45
03016	OPHTHALMO-CHLORAMPHENICOL LECIVA	ung oph 1x5gm 1%	LEX	CZ
476.4	S01AA11	gentamicin	lok.	1	ML	3,03

476.5	S01AA12	tobramycin (lékové formy očních kapek)	lok.	1	ML	3,03

476.6	S01AA12	tobramycin (lékové formy očních mastí)	lok.	1	GM	3,03

476.7	S01AA20	neomycin/bacitracin/hydrokortison	lok.	1	GM	6,43
01077	OPHTHALMO-FRAMYKOIN COMPOSITUM	ung oph 1x5gm	LEX	CZ
476.8	S01AA20	antibiotika v kombinaci s jinými léčivy	lok.	1	ML	3,03

476.9	S01AA24	kanamycin	lok.	1	ML	3,03

476.10	S01AA25	azidamfenikol	lok.	1	ML	3,03

476.11	S01AA30	neomycin/bacitracin	lok.	1	GM	5,82
01076	OPHTHALMO-FRAMYKOIN	ung oph 1x5gm	LEX	CZ
476.12	S01AA30	neomycin/polymyxin	lok.	1	ML	19,55	L/OPH
477	S01AB	chemoteraputika k lokálnímu podání	lok.
---	---	---	---	---	---	---	---
477.1	S01AB	sulfathiazol	lok.	1	GM	3,42

477.2	S01AB04	sulfacetamid	lok.	1	ML	7,23
93577	SULPHACETAMID	gtt oph 12x0.5ml	POL	PL
478	S01AD	antivirotika k lokálnímu podání	lok.	L/OPH
---	---	---	---	---	---	---	---
478.1	S01AD02	trifluorothimidin (lékové formy očních mastí)	lok.	1	GM	79,92	L/OPH

478.2	S01AD02	trifluorothimidin (lékové formy očních kapek)	lok.	1	ML	53,23	L/OPH

478.3	S01AD03	acyklovir	lok.	1	GM	79,92	L/OPH
93990	VIROLEX	ung oph 1x4.5gm 3%	KRK	SLO
479	S01AX	ostatní antiinfektiva	lok.	L/OPH
---	---	---	---	---	---	---	---
479.1	S01AX	jiná antiinfektiva (lékové formy očních kapek)	lok.	1	ML	2,40
00802	OPHTHALMO-SEPTONEX	gtt oph 1x10ml	GNO	CZ
479.2	S01AX	jiná antiinfektiva (lékové formy očních mastí)	lok.	1	GM	4,30
00876	OPHTHALMO-SEPTONEX	ung oph 1x5gm	LEX	CZ
479.3	S01AX13	Ciprofloxacin	lok.	1	ML	27,37	L/OPH, ORL

479.4	S01AX17	lomefloxacin k lokálnímu podání	lok.	1	ML	27,37	L/OPH

479.5	S01AX11	Ofloxacin	lok.	1	ML	18,00	L/OPH
480	S01BA	kortikosteroidy k lokálnímu podání	lok.
---	---	---	---	---	---	---	---
480.1	S01BA01	dexamethason (lékové formy očních kapek)	lok.	1	ML	3,47
93718	DEXAMETHASONE POLFA	sus oph 10ml 0.1%	POL	PL
480.2	S01BA01	dexamethason (lékové formy očních mastí)	lok.	1	GM	3,62

480.3	S01BA02	hydrokortison	lok.	1	GM	5,77
02668	OPHTHALMO-HYDROCORTISON LECIVA	ung oph 1x5gm 0.5%	LEX	CZ
480.4	S01BA03	kortison	lok.	1	ML	19,55	L/OPH
00757	CORTISON SPOFA	gtt oph 1x3ml	SPX	CZ
480.5	S01BA04	prednizolon (lékové formy očních kapek)	lok.	1	ML	17,00	L/OPH

480.6	S01BA04	prednizolon (lékové formy očních mastí)	lok.	1	GM	17,00	L/OPH

480.7	S01BA07	fluorometholon	lok.	1	ML	17,00	L/OPH
481	S01BC	nesteroidní protizánětlivá léčiva k lokálnímu podání	lok.
---	---	---	---	---	---	---	---
481.1	S01BC	alkylazuleny	lok.	1	GM	3,81
00874	OPHTHALMO-AZULEN	ung oph 1x5gm	LEX	CZ
481.2	S01BC02	oxyfenbutazon	lok.	1	GM	14,66

481.3	S01BC03	diklofenak	lok.	1	ML	36,17	L/OPH

481.4	S01BC04	flurbiprofen	lok.	1	ML	36,17	L/OPH
482	S01CA	kortikosteroidy a antiinfektiva k lokálnímu podání	lok.	L/OPH
---	---	---	---	---	---	---	---
482.1	S01CA	chloramfenikol/dexamethason	lok.	1	ML	17,60	L/OPH

482.2	S01CA	gentamicin/betamethason (lékové formy očních kapek)	lok.	1	ML	12,05	L/OPH,ORL
91712	GARASONE	gtt oph 1x5ml	SCH	B
482.3	S01CA	gentamicin/betamethason (lékové formy očních mastí)	lok.	1	GM	15,84	L/OPH,ORL
91711	GARASONE	ung oph 1x5gm	SCH	B
482.4	S01CA01	dexamet./neomycin/polymyxin (lékové formy očních kapek)	lok.	1	ML	15,84	L/OPH

482.5	S01CA01	dexamet./neomycin/polymyxin (lékové formy očních mastí)	lok.	1	GM	17,60	L/OPH

482.6	S01CA01	oxytetracyklin/dexamethason	lok.	1	GM	17,60	L/OPH

482.7	S01CA01	dexamethason a tobramycin (lékové formy očních kapek)	lok.	1	ML	15,84	L/OPH

482.8	S01CA02	prednizolon a antiinfektiva (lékové formy očních kapek)	lok.	1	ML	17,60	L/OPH

482.9	S01CA02	prednizolon a antiinfektiva (lékové formy očních mastí)	lok.	1	GM	17,60	L/OPH

482.10	S01CA07	fluorometolon a antiinfektiva (lékové formy očních kapek)	lok.	1	ML	19,55	L/OPH

482.11	S01CA07	fluorometolon a antiinfektiva (lékové formy očních mastí)	lok.	1	GM	24,44	L/OPH

482.12	S01CA05	betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí)	lok.	1	GM	17,60	L/OPH

482.13	S01CA05	betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek)	lok.	1	ML	17,60	L/OPH
483	S01EA	lokální sympatomimetika k léčbě glaukómu	lok.	L/OPH
---	---	---	---	---	---	---	---
483.1	S01EA01	epinefrin	lok.	1	ML	26,65	L/OPH

483.2	S01EA02	dipivefrin	lok.	1	ML	26,65	L/OPH
54270	OFTANEX	gtt oph 1x10 ml	SOY	SF
483.3	S01EA04	klonidin	lok.	1	ML	10,70	L/OPH

483.4	S01EA05	brimonidin	lok.	1	ML	66,48	P

Léčbu brimonidinem indikuje oční lékař u pacientů s glaukomem při netoleranci nebo neúčinnosti betablokátorů.

484	S01EB	lokální parasympatomimetika k léčbě glaukómu	lok.	L/OPH
484.1	S01EB01	pilokarpin (lékové formy gelu)	lok.	1	GM	29,00

484.2	S01EB01	pilokarpin (lékové formy olejových očních kapek)	lok.	1	ML	9,70

484.3	S01EB01	pilokarpin (lékové formy očních kapek, koncentrace do 1 % včetně)	lok.	1	ML	6,00
44445	PILOPOS 1%	gtt oph 1x10ml	URS	D
484.4	S01EB01	pilokarpin (lékové formy očních kapek, koncentrace více než 1%)	lok.	1	ML	6,87
04146	PILOCARPIN ANKERPHARM 2%	gtt oph 1x10ml	ANW	D
57337	PILOCARPIN ANKERP.OCNI KAPKY 2%	gtt oph 3x10ml	CHV	D
44446	PILOPOS 2%	gtt oph 1x10ml	URS	D
484.5	S01EB02	karbachol (koncentrace do 1% včetně)	lok.	1	ML	8,50	L/OPH

484.6	S01EB02	karbachol (koncentrace nad 1% do 1,5% včetně)	lok.	1	ML	6,06	L/OPH

484.7	S01EB02	karbachol (koncentrace nad 1,5%)	lok.	1	ML	6,60	L/OPH

484.8	S01EB06	neostigmin	lok.		ML	13,88	L/OPH

484.9	S01EB51	pilokarpin v kombinaci s timololem	lok.	1	ML	29,72	L/OPH
485	S01EC	inhibitory karboanhydrázy k celkovému podání	p.o.
---	---	---	---	---	---	---	---
485.1	S01EC01	acetazolamid	p.o.	0.75	GM	6,18
00113	DILURAN	tbl 20x250mg	LEX	CZ
485.2	S01EC01	acetazolamid (lékové formy s řízeným uvolňováním)	p.o.	0.75	GM	29,33

485.3	S01EC02	diklofenamid	p.o.	0.1	GM	6,26

485.4	S01EC03	dorzolamid	lok.	1	ML	66,48	P

Léčba dorzolamidem včetně kombinací je ordinována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.

486	S01ED	lokální beta-blokátory k léčbě glaukómu	lok.
486.1	S01ED01	timolol (koncentrace do 0,25% včetně)	lok.	1	ML	14,25
01760	TIMOLOL-POS 0.25%	gtt oph 3x5ml	URS	D
12729	TIMOHEXAL 0.1%	gtt oph 1x5ml/5mg	HEX	D
12730	TIMOHEXAL 0.25%	gtt oph1x5ml/12.5mg	HEX	D
12732	TIMOHEXAL 0.1%	gtt oph 3x5ml/5mg	HEX	D
12733	TIMOHEXAL 0.25%	gtt oph3x5ml/12.5mg	HEX	D
70474	ARUTIMOL 0.25%	gtt oph 3x5ml	ANW	D
87113	TIMOLOL-POS 0.25%	gtt oph 1x5ml	URS	D
96022	OFTENSIN 0.25%	gtt oph 1x10ml	POL	PL
54476	OFTAN TIMOLOL 0.25%	gtt oph 1x5ml	SOY	SF
54494	OFTAN TIMOLOL 0.25%	gtt oph 3x5ml	SOY	SF
98210	TIMOPTOL(LAHV.PE)	gtt oph 5ml 0.25%	LEX	CZ
486.2	S01ED01	timolol (koncentrace nad 0,25%)	lok.	1	ML	16,60
01759	TIMOLOL-POS 0.5%	gtt oph 3x5ml	URS	D
12731	TIMOHEXAL 0.5%	gtt oph 1x5ml/25mg	HEX	D
12734	TIMOHEXAL 0.5%	gtt oph 3x5ml/25mg	HEX	D
70475	ARUTIMOL 0.5%	gtt oph 3x5ml	ANW	D
87114	TIMOLOL-POS 0.5%	gtt oph 1x5ml	URS	D
96020	OFTENSIN 0.5%	gtt oph 1x10ml	POL	PL
56123	TIMOLOL 0.5% UNIMED PHARMA	gtt oph 1x10ml	UPA	SA
54477	OFTAN TIMOLOL 0.50%	gtt oph 1x5ml	SOY	SF
59928	OFTAN TIMOLOL 0.50%	gtt oph 3x5ml	SOY	SF
98211	TIMOPTOL(LAHV.PE)	gtt oph 5ml 0.50%	LEX	CZ
486.3	S01ED02	betaxolol	lok.	1	ML	20,00	L/OPH

486.4	S01ED03	levobunolol	lok.	1	ML	20,00	L/OPH

486.5	S01ED04	metipranolol	lok.		ML	13,20

486.6	S01ED05	Carteolol	lok.		ML	20,00	L/OPH

486.7	S01EX03	latanoprost	lok.		ML	267,60	P

486.8	S01EX	unoproston	lok.	1	ML	117,00	P

Latanoprost a unoprost:

léčba je ordinována v případě, není-li po vyčerpání všech možností antiglaukomatosní terapie léčba dostatečně účinná a operační výkon není indikován.

| 486.9 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1 | ML | 92,38 | P | | 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 487.1 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,10 | O/OPH | | | | | | | | | | | 487.2 | S01FA06 | tropikamid | lok. | 1 | ML | 8,99 | O/OPH | | 21155 | MYDRUM | gtt oph 10ml 0.5% | ANW | D | | | | | 487.3 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 40,33 | O/OPH | | | | | | | | | | | 487.4 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,18 | | | 83770 | ATROPIN-POS 0.5% | gtt oph 1x10ml | URS | D | | | | | 487.5 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,87 | | | 83771 | ATROPIN-POS 1% | gtt oph 1x10ml | URS | D | | | | | 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 488.1 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG | | | | | | | | | | | 488.2 | S01GX | antazolin/tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG | | | | | | | | | | | 488.3 | S01GX01 | kyselina kromoglyková (lékové formy očních kapek) | lok. | 1 | ML | 4,06 | | | | | | | | | | | | 488.4 | S01GX01 | kyselina kromoglyková (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,43 | L/OPH,ALG, ORL | | 54241 | ALLERGOCROM EYE+NAS.KOMBI-PACK | oph 10ml+nas 15ml | URS | D | | | | | 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | | | | | 488.5 | S01GX02 | levokabastin | lok. | 1 | ML | 17,60 | L/OPH,ALG | | | | | | | | | | | 488.6 | S01GX05 | lodoxamid | lok. | | ML | 14,66 | L/OPH,ALG | | | | | | | | | | | 488.7 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 14,66 | L/OPH,ALG | | | | | | | | | | | 488.8 | S01GX06 | emedastin | lok. | 1 | ML | 17,60 | L/OPH, ALG | | | | | | | | | | | 488.9 | S01GX07 | azelastin | lok. | 1 | ML | 17,60 | L/OPH, ALG | | 489 | S01HA | lokální místní anestetika | lok. | L/OPH | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 11,83 | L/OPH | | | | | | | | | | | 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 11,83 | L/OPH | | 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | | | | | 490 | S01 | jiná oftalmologika | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 14,91 | L/OPH | | | | | | | | | | | 490.2 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 2,93 | | | 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | | | | | 490.3 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z | | | | | | | | | | | 490.4 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | | | | | | | | | | | | 490.5 | S01XA04 | jodid draselný | lok. | 1 | ML | 4,89 | | | 56118 | JODID DRASELNY 2% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | | | 490.6 | S01XA | jodid draselný a sodný | lok. | 1 | ML | 4,89 | | | 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | gtt oph 1x10ml | UPA | SK | | | | | 490.7 | S01XA | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 2,93 | | | | | | | | | | | | 490.8 | S01XA11 | nandrolon | lok. | 1 | ML | 11,20 | | | 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 27,37 | L/ORL | | | | | | | | | | | 491.2 | S02AA11 | polymyxin B | lok. | 1 | ML | 2,64 | L/ORL | | | | | | | | | | | 491.3 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | GM | 22,92 | L/ORL, PDD | | 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | | | | | 492 | V01AA | extrakty alergenů | p.o. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 492.1 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, úvodní dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.2 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, udržovací dávka) | p.o. | 1 | BA | 432,70 | L/ALG | | 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ | | | | | 492.3 | V01AA | extrakty alergenů (nestandardizované, úvodní dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.4 | V01AA | extrakty alergenů (nestandardizované, udržovací dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.5 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | p.o. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 492.6 | V01AA | extrakty alergenů (standardizované, udržovací dávka) | p.o. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 492.7 | V01AA | extrakty alergenů (standardizované, pro sublinguální podání, úvodní dávka) | p.o. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 492.8 | V01AA | extrakty alergenů (stadnardizované, pro sublinguální podání, udržovací dávka) | p.o. | 1 | DF | 692,22 | L/ALG | | 493 | V01AA | extrakty alergenů | intrader. | O/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 134,61 | O/ALG | | 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | | | | | 494 | V01AA | extrakty alergenů | PRICK test | O/ALG | | | | | 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG | | 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | | | | | 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | | | 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | | | 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG | | 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | | | 495 | V01AA | extrakty alergenů | parent. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 495.1 | V01AA | extrakty alergenů (nestandardizované, vodné, úvodní dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.2 | V01AA | extrakty alergenů (nestandardizované, vodné, udržovací dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.3 | V01AA | extrakty alergenů (standardizované, vodné, úvodní dávka) | parent. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 495.4 | V01AA | extrakty alergenů (standardizované, vodné, udržovací dávka) | parent. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 495.5 | V01AA | extrakty alergenů (nestandardizované, depotní, úvodní dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.6 | V01AA | extrakty alergenů (nestandardizované, depotní, udržovací dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.7 | V01AA | extrakty alergenů (standardizované, depotní, úvodní dávka) | parent. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 495.8 | V01AA | extrakty alergenů (standardizované, depotní, udržovací dávka) | parent. | 1 | DF | 1168,01 | L/ALG | | 69201 | ALUTARD SQ (TERAP.) 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | | | | | 495.9 | V01AA | extrakty alergenů (standardizované, depotní, z hmyzu, úvodní dávka) | parent. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 495.10 | V01AA | extrakty alergenů (standardizované, depotní, z hmyzu, udržovací dávka) | parent. | 1 | DF | 1168,01 | L/ALG | | 57371 | ALUTARD SQ INSECT. 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | | | | | 496 | V03A | všechny jiné terapeutické přípravky | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 496.1 | V03A | antistafylokokový fág. lyzát | lok. | 20 | ML | 289,60 | | | 86170 | STAFAL SEVAC | sus 1x10ml | SEV | CZ | | | | | 497 | V03AB | antidota | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 497.1 | V03AB | deferoxamin | parent. | 1 | GM | 393,57 | K | | 01445 | DESFERAL | inj sic 10x500mg | CGC | CH | | | | | 497.2 | V03AB | trimedoxim + atropin | parent. | | | plně | K | | | | | | | | | | | 497.3 | V03AB | obedoxim | parent. | | | plně | K | | | | | | | | | | | 497.4 | V03AB03 | edetáty | parent. | | | plně | K | | | | | | | | | | | 497.5 | V03AB06 | thiosulfát | parent. | | | plně | K | | | | | | | | | | | 497.6 | V03AB08 | dusitan sodný | parent. | | | plně | K | | | | | | | | | | | 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,01 | K | | 85787 | PROTAMIN SULFAT 1% GALENIKA | inj 5x5ml/50mg 1% | GLN | YU | | | | | 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 11,83 | K | | 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | | | | | 94763 | NALOXONE POLFA | inj 10x1 ml/0.4mg | POL | PL | | | | | 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 20,43 | K | | 69638 | ARDEANUTRISOL GSP | inf 1x500ml | ARD | CZ | | | | | 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,31 | K | | | | | | | | | | | 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 32726,64 | K | | | | | | | | | | | 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 777,86 | K | | 93214 | ANEXATE | inj 5x5ml/0.5mg | HLR | CH | | | | | 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 498.1 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 113,99 | | | 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | | | | | 498.2 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 117,55 | | | 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | | | | | 498.3 | V03AF01 | mesna | p.o. | 1,2 | GM | 297,04 | B/ONK,HEM | | 87251 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | ASD | D | | | | | 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29,72 | B/ONK,HEM | | | | | | | | | | | 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 49,42 | B/ONK,HEM | | 75274 | UROMITEXAN 400MG | inj 15x4ml/400mg | ASD | D | | | | | 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4391,10 | B/ONK,HEM | | 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL | | | | | 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM | | 12440 | LEUCOVORIN CA LACHEMA 10 | inj 10x1ml/10mg | LCM | CZ | | | | | 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | | | 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | | | | | 12771 | LEUCOVORIN-TEVA | inj sic 1x50mg | AIC | IL | | | | | 12831 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | AIC | IL | | | | | 12832 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | AIC | IL | | | | | 12833 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | AIC | IL | | | | | 12834 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | AIC | IL | | | | | 12835 | LEUCOVORIN-TEVA | inj 1x30ml/300mg | AIC | IL | | | | | 12836 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | AIC | IL | | | | | 12837 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | AIC | IL | | | | | 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | | | | | 75005 | LEUCOVORIN CA LACHEMA 10 | inj sic 1x10mg | LCM | CZ | | | | | 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | | | | | 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | | | | | 96966 | CALCIUMFOLINAT EBEWE 30MG | inj 5x3ml/30mg | EBW | A | | | | | 96967 | CALCIUMFOLINAT EBEWE 100MG | inj 5x10ml/100mg | EBW | A | | | | | 500 | V03AK | tkáňová lepidla | lok. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3227,24 | X | | 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | | | | | 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | | | | | 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | | | | | 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | | | | | 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,53 | X | | 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | | | | | 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | | | | | 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 421,88 | K/END | | 01359 | METOPIRONE | cps 50x250mg | CGC | CH | | | | | 502 | V04CF | tuberkulinový test | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 277,44 | H | | 68918 | TUBERCULIN PPD RT 23,SSI | inj 10x1.5ml/0.6rg | SST | DK | | | | | 68920 | TUBERCULIN PPD RT 23,SSI | inj 10x5ml/2rg | SST | DK | | | | | 68919 | TUBERCULIN PPD RT 23,SSI | inj 1x5ml/2rg | SST | DK | | | | | 503 | V04CL | testy pro alergické choroby | intrader. | O/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | intrader. | 1 | BA | 134,61 | O/ALG | | 54551 | D-AL POLLENS | inj 1x5ml jsk,jsa | SVF | CZ | | | | | 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | | | | | 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 495,05 | O/ALG | | 69220 | ALK WASSERIG SQ(DIAG.)100KU/ML | lyo 1x4.5ml+solv. | EAS | A | | | | | 503.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG | | 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | | | | | 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | | | 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | | | 84296 | D-AL PRICK TEST POLLENS | sol 1x3ml jsk,jsa | SVF | CZ | | | | | 84300 | D-AL PRICK TEST POLLENS | sol 1x3ml jsk,jsa | SVF | CZ | | | | | 84304 | D-AL PRICK TEST | sol 1x3ml pnu | SVF | CZ | | | | | 503.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG | | 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | | | 504 | V04CX | jiná diagnostika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 22,88 | | | 46684 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GMG | F | | | | | 505 | V04CX | jiná diagnostika | intrader. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 127,09 | O | | 45918 | IMUNOSKINTEST | inj 2x1.5+6x1.3ml | SVF | CZ | | | | | 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 251,00 | O | | 90636 | PATENTBLAU V | inj 1x2ml/50mg | BGL | D | | | | | 506 | V04CX | jiná diagnostika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,07 | O | | | | | | | | | | | 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,47 | O | | | | | | | | | | | 506.3 | V04CH01 | inulin | parent. | 5 | GM | 489,33 | O | | | | | | | | | | | 506.4 | V04CJ02 | protirelin | parent. | 0.2 | MG | 215,75 | O | | | | | | | | | | | 506.5 | V04CK01 | sekretin | parent. | 29 | RG | 919,90 | O | | | | | | | | | | | 506.6 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.1 | MG | 225,63 | O | | 506.7 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.1 | MG | 680,30 | O | | | | | | | | | | | 506.8 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1 | ML | 34,56 | O | | | | | | | | | | | 506.9 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1 | ML | 126,50 | O | | 90567 | FLUORESCITE | inj 12x2ml 25% | ALC | USA | | | | | 506.10 | V04CE01 | galaktóza | parent. | 1 | DF | 903,92 | O | | | | | | | | | | | 506.11 | V04CX | urea | p.o. | 1 | DF | 1270,85 | Z | | 507 | V06CA | výživa bez fenylalaninu | p.o | L/J4 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 507.1 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,33 | L/J4 | | | | | | | | | | | 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,08 | L/J4 | | 88063 | SINFENAL | plv 1x250gm | IMA | SK | | | | | 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,81 | L/J4 | | 93088 | MILUPA PKU 2 | plv po 1x500gm | MLP | D | | | | | 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | | | | | 93089 | MILUPA PKU 3 | plv po 1x500gm | MLP | D | | | | | 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 25,27 | L/J4 | | 68847 | ANALOG PKU | plv 6x400gm | SGR | GB | | | | | 94414 | ANALOG PKU | plv 1x400gm | SGR | GB | | | | | 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,17 | L/J4 | | 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 508.1 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80 | GM | 87,40 | H | | | | | | | | | | | 508.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 74,25 | H | | 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 44,87 | H | | 61454 | NUTRISON | plv 1x430gm | NUT | NL | | | | | 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 79,38 | H | | 56245 | INKODIET FIBRE | sus por 1x500ml | NDP | D | | | | | 509.3 | V06DC | kombinace sacharidů | p.o. | 100 | GM | 44,87 | H | | 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 90,33 | L/J7 | | 88115 | KETOSTERIL | tbl obd 100 | FRE | D | | | | | 88116 | KETOSTERIL | tbl obd 300 (3x100) | FRE | D | | | | | 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D | | | | | 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 511.1 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | | | 72883 | ENFALAC PRAEMATURE FORMULA | plv 1x400gm | BMS | USA | | | | | 511.2 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 | | | | | | | | | | | 511.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 | | | | | | | | | | | 511.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 | | | | | | | | | | | 511.5 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |

Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergií, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch terapie extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií, u syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordinuje dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbovou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpozici proteinovým hydrolyzátem.

512	V06DF	náhrady mléka obsahující sojovou bílkovinu	p.o.	L/J11
512.1	V06DF	náhrady mléka obsahující sojovou bílkovinu	p.o.	100	GM	27,96	L/J11
75946	ISOMIL	plv 1x400gm	ABB	USA
513	V06DX	jiné kombinace přípravků pro výživu	p.o.	L/J11
---	---	---	---	---	---	---	---
513.1	V06DX	MCT olej	p.o.	100	ML	103,13	L/J11

513.2	V06DX	kombinace s vysokým obsahem mléčné bílkoviny a kalcia	p.o.	100	GM	44,87	L/J11
514	V07AB	rozpouštědla a ředidla, včetně irigačních roztoků	parent.
---	---	---	---	---	---	---	---
514.1	V07AB	voda pro injekci (do 2 ml v jedné ampuli včetně)	parent.	1	ML	2,69
00383	AQUA PRO INJECTIONE BIOTIKA	inj 10x2ml	BTA	SK
514.2	V07AB	voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně)	parent.	10	ML	3,32
00387	AQUA PRO INJECTIONE BIOTIKA	inj 10x10ml	BTA	SK
00388	AQUA PRO INJECTIONE BIOTIKA	inj 50x10ml	BTA	SK
55807	AQUA PRO INJECTIONE BIOTIKA	inj 100x10ml	BTA	SK
83699	WATER FOR INJECTION B.P.CORE	inj 50x5ml	CPL	IND
83700	WATER FOR INJECTION B.P.CORE	inj 50x10ml	CPL	IND
514.3	V07AB	voda pro injekci nad 10 ml v jedné ampuli nebo lahvi	parent.	100	ML	13,98
00657	AQUA PRO INJECTIONE IMUNA	inf 1x400ml	IMA	SK
43759	STERILE WATER F.INJ.U.S.P.SIFRA	inf 1x250ml	SFR	I
43760	STERILE WATER F.INJ.U.S.P.SIFRA	inf 1x500ml	SFR	I
43761	STERILE WATER F.INJ.U.S.P.SIFRA	inf 1x1000ml	SFR	I
44557	STERILE WATER F.INJ.U.S.P.SIFRA	inf 6x1000ml	SFR	I
44559	STERILE WATER F.INJ.U.S.P.SIFRA	inf 16x250ml	SFR	I
44560	STERILE WATER F.INJ.U.S.P.SIFRA	inf 12x500ml	SFR	I
53363	AQUA PRO INJECTIONE INFUSIA	sol 1x250ml(sklo)	IHO	CZ
53364	AQUA PRO INJECTIONE INFUSIA	sol 1x500ml(sklo)	IHO	CZ
57773	WATER FOR INJECTIONS BIEFFE	inf 1x250ml(vak)	BFH	E
57775	WATER FOR INJECTIONS BIEFFE	inf 1x500ml(vak)	BFH	E
57776	WATER FOR INJECTIONS BIEFFE	inf 1x1000ml(vak)	BFH	E
67802	AQUA PRO INJECTIONE IMUNA	inf 1x500ml	IMA	SK
69788	AQUA PRO INJECTIONE ARDEAPHARMA	inf 1x300ml	ARD	CZ
69789	AQUA PRO INJECTIONE ARDEAPHARMA	inf 1x500ml	ARD	CZ
70484	WATER FOR INJECTIONS BIEFFE	inf 1x1000ml(plast)	BFF	I
70528	AQUA PRO INJECTIONE MEDICAMENTA	inf 1x500ml	MVM	CZ
80486	AQUA PRO INJECTIONE MEDICAMENTA	inf 1x250ml	MVM	CZ
83943	AQUA PRO INJECTIONE MEDIEKOS	sol 1x500ml(vak)	MKS	CZ
85557	WATER FOR INJECTIONS BIEFFE	inf 1x250ml(plast)	BFF	I
85558	WATER FOR INJECTIONS BIEFFE	inf 1x500ml(plast)	BFF	I
85899	AQUA PRO INJECTIONE IMUNA	inf 1x500ml(vak)	IMA	SK
85900	AQUA PRO INJECTIONE IMUNA	inf 1x1000ml(vak)	IMA	SK
89244	AQUA PRO INJECTIONE ARDEAPHARMA	inf 1x250ml	ARD	CZ
89245	AQUA PRO INJECTIONE ARDEAPHARMA	inf 1x400ml	ARD	CZ
91876	AQUA PRO INJECTIONE INFUSIA	sol 1x500ml	IHO	CZ
92782	AQUA PRO INJECTIONE MEDIEKOS	sol 1x1000ml(vak)	MKS	CZ
92783	AQUA PRO INJECTIONE MEDIEKOS	sol 1x2000ml(vak)	MKS	CZ
97726	WATER FOR INJECTIONS BIEFFE	inf 1x250ml(sklo)	BFF	I
97727	WATER FOR INJECTIONS BIEFFE	inf 1x500ml(sklo)	BFF	I
515	V08A	rozpustné nefrotropní RTG kontrastní látky	p.o.	K
---	---	---	---	---	---	---	---
515.1	V08AA05	kyselina ioxitalamová	p.o.	10	ML	59,19	K
93497	TELEBRIX GASTRO	sol 1x100ml	BGL	D
515.2	V08AB04	iopamidol	p.o.	10	ML	59,19	K
516	V08AA	rozpustné nefrotropní hyperosmolární RTG kontrastní látky	parent.	K
---	---	---	---	---	---	---	---
516.1	V08A	meglumin amidotrizoát	parent.	10	ML	73,51	K

516.2	V08AA03	iodamid (koncentrace 300 mg l/ml)	parent.	10	ML	41,06	K

516.3	V08AA03	iodamid (koncentrace 380 mg l/ml)	parent.	10	ML	44,97	K

516.4	V08AA03	iodamid (koncentrace 410 mg l/ml)	parent.	10	ML	87,40	K

516.5	V08AA05	kyselina ioxitalamová (koncentrace 300 mg l/ml)	parent.	10	ML	57,00	K
92348	TELEBRIX N 300	inj 6x20ml	LEX	CZ
516.6	V08AA05	kyselina ioxitalamová (koncentrace 350 mg l/ml a více)	parent.	10	ML	66,00	K
92349	TELEBRIX N 350	inj 6x20ml	LEX	CZ
92350	TELEBRIX N 380	inj 6x20ml	LEX	CZ
517	V08AB	rozpustné nefrotropní nízkoosmolání RTG kontrastní látky	parent.	K
---	---	---	---	---	---	---	---

Vyšetření iotrolanem ordinuje rentgenolog:

a) pro intrathekální podání,

b) v ostatních případech po předchozím schválení revizním lékařem.

| 517.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 231,11 | K | | 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N | | | | | 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N | | | | | 517.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 199,40 | K | | 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | | | | | 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N | | | | | 517.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 276,10 | K | | 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N | | | | | 517.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N | | | | | 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N | | | | | 517.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N | | | | | 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N | | | | | 517.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K | | 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N | | | | | 517.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N | | | | | 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N | | | | | 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N | | | | | 517.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N | | | | | 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N | | | | | 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N | | | | | 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N | | | | | 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N | | | | | 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 236,91 | K | | | | | | | | | | | 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K | | | | | | | | | | | 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 242,54 | K | | 71989 | IOPAMIRO 200 | inj 5x10ml | BCC | I | | | | | 88657 | IOPAMIRO 200 | inj 1x10ml | BCC | I | | | | | 517.13 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 299,78 | K | | 71993 | IOPAMIRO 300 | inj 5x10ml | BCC | I | | | | | 88654 | IOPAMIRO 300 | inj 1x10ml | BCC | I | | | | | 517.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,92 | K | | 88655 | IOPAMIRO 300 | inj 1x30ml | BCC | I | | | | | 517.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,67 | K | | 71994 | IOPAMIRO 300 | inj 1x100ml | BCC | I | | | | | 88656 | IOPAMIRO 300 | inj 1x50ml | BCC | I | | | | | 517.16 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 365,98 | K | | 88658 | IOPAMIRO 370 | inj 1x10ml | BCC | I | | | | | 517.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 224,93 | K | | 88659 | IOPAMIRO 370 | inj 1x30ml | BCC | I | | | | | 517.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 181,10 | K | | 71988 | IOPAMIRO 370 | inj 1x100ml | BCC | I | | | | | 88660 | IOPAMIRO 370 | inj 1x50ml | BCC | I | | | | | 517.19 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 77015 | ULTRAVIST-240 | inj 10x50ml | SAG | D | | | | | 517.20 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D | | | | | 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 77017 | ULTRAVIST-300 | inj 10x100ml | SAG | D | | | | | 77016 | ULTRAVIST-300 | inj 10x50ml | SAG | D | | | | | 93628 | ULTRAVIST-300 | inj 1x100ml | SAG | D | | | | | 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 207,38 | K | | 77019 | ULTRAVIST-370 | inj 10x100ml | SAG | D | | | | | 77018 | ULTRAVIST-370 | inj 10x50ml | SAG | D | | | | | 93625 | ULTRAVIST-370 | inj 1x100ml | SAG | D | | | | | 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 429,71 | K/P | | 96349 | ISOVIST 240 | inj 1x10ml 240mg/ml | SAG | D | | | | | 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 534,28 | K/P | | 96351 | ISOVIST 300 | inj 1x10ml 300mg/ml | SAG | D | | | | | 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 119,48 | K | | 68772 | OPTIRAY 160 | inj 10x50ml | MME | D | | | | | 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 68922 | OPTIRAY 240 | inj 10x100ml | MME | D | | | | | 98298 | OPTIRAY 240 | inj 10x50ml | MME | D | | | | | 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K | | 92365 | OPTIRAY 300 | inj 10x10ml | MME | D | | | | | 517.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 68923 | OPTIRAY 300 | inj 10x20ml | MME | D | | | | | 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 45779 | OPTIRAY 300 | inj 10x125ml(typ c) | MME | D | | | | | 68850 | OPTIRAY 300 | inj 10x50ml | MME | D | | | | | 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | | | | | 92367 | OPTIRAY 300 | inj 10x100ml | MME | D | | | | | 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | | | | | 92369 | OPTIRAY 300 | inj 10x200ml | MME | D | | | | | 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K | | 68773 | OPTIRAY 320 | inj 10x50ml | MME | D | | | | | 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | 92370 | OPTIRAY 350 | inj 10x30ml | MME | D | | | | | 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | 45787 | OPTIRAY 350 | inj 10x125ml(typ c) | MME | D | | | | | 68851 | OPTIRAY 350 | inj 10x50ml | MME | D | | | | | 92371 | OPTIRAY 350 | inj 10x200ml | MME | D | | | | | 517.33 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 115,90 | K | | | | | | | | | | | 517.34 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 137,12 | K | | | | | | | | | | | 517.35 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 157,46 | K | | | | | | | | | | | 517.36 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | | | | | | | | | | 517.37 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | | | | | | | | | | 517.38 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | | | | | | | | | | 517.39 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | | | | | | | | | | 517.40 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 285,86 | K | | | | | | | | | | | 517.41 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 219,87 | K | | | | | | | | | | | 517.42 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 215,46 | K | | 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45115 | VISIPAQUE 150MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84339 | VISIPAQUE 150MG l/ML | inj 10x50ml | NYI | N | | | | | 84340 | VISIPAQUE 150MG l/ML | inj 6x200ml | NYI | N | | | | | 517.43 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 336,60 | K | | 84341 | VISIPAQUE 270MG l/ML | inj 10x20ml | NYI | N | | | | | 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL | | | | | 517.44 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 282,14 | K | | 45119 | VISIPAQUE 270MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45120 | VISIPAQUE 270MG l/ML | inj 10x100ml | NRI | IRL | | | | | 45121 | VISIPAQUE 270MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84342 | VISIPAQUE 270MG l/ML | inj 10x50ml | NYI | N | | | | | 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N | | | | | 84344 | VISIPAQUE 270MG l/ML | inj 6x200ml | NYI | N | | | | | 517.45 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 357,46 | K | | 84345 | VISIPAQUE 320MG l/ML | inj 10x20ml | NYI | N | | | | | 45122 | VISIPAQUE 320MG l/ML | inj 10x20ml | NRI | IRL | | | | | 517.46 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 287,25 | K | | 45123 | VISIPAQUE 320MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45124 | VISIPAQUE 320MG l/ML | inj 10x100ml | NRI | IRL | | | | | 45125 | VISIPAQUE 320MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84346 | VISIPAQUE 320MG l/ML | inj 10x50ml | NYI | N | | | | | 84347 | VISIPAQUE 320MG l/ML | inj 10x100ml | NYI | N | | | | | 84348 | VISIPAQUE 320MG l/ML | inj 6x200ml | NYI | N | | | | | 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10 | ML | 74,25 | K | | | | | | | | | | | 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10 | ML | 37,39 | K | | | | | | | | | | | 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K | | 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K | | | | | | | | | | | 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K | | 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | | | | | 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 33,29 | K | | 06303 | MICROPAQUE | sus 1x2000ml | GUE | D | | | | | 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | | | | | 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 154,12 | K | | 44367 | MICROPAQUE CT | sus 1x2000ml/ 100gm | GUE | D | | | | | 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F | | | | | 520.3 | V08BA01 | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 45,75 | K | | 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D | | | | | 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K | | 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I | | | | | 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,08 | K | | 56578 | PRONTOBARIO HD | plv 24x340gm | BCC | I | | | | | 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D | | | | | 521 | V08CA | paramagnetické kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | 44487 | MAGNEVIST | inj 5x10ml | SAG | D | | | | | 75659 | MAGNEVIST | inj 1x5ml | SAG | D | | | | | 75660 | MAGNEVIST | inj 1x10ml | SAG | D | | | | | 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | 96352 | MAGNEVIST | inj 1x20ml | SAG | D | | | | | 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N | | | | | 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N | | | | | 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N | | | | | 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N. | | | | | 521.5 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | | | | | | | | | | 521.6 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | | | | | | | | | | 521.7 | V08CA05 | manganfodipir | parent. | 10 | ML | 1249,06 | K | | 49539 | TESLASCAN | sol 10x50ml | NYI | N | | | | | 521.8 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H | | | | | | | | | | | 521.9 | V08DA02 | mikročástice galaktózy | parent. | 1 | GM | 1142,99 | H | | 43916 | LEVOVIST | inj sic 1x4gm+solv. | SAG | D | | | |